<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://zibs.test-nictiz.nl/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Linda+Mook</id>
	<title>Zorginformatiebouwstenen - Gebruikersbijdragen [nl]</title>
	<link rel="self" type="application/atom+xml" href="https://zibs.test-nictiz.nl/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Linda+Mook"/>
	<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/wiki/Speciaal:Bijdragen/Linda_Mook"/>
	<updated>2026-04-10T18:56:28Z</updated>
	<subtitle>Gebruikersbijdragen</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=22240</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=22240"/>
		<updated>2020-12-03T08:17:17Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TNMTumorClassificatie||4.27||Actief&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Diversen||rowspan=&amp;quot;6&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|Signaal||16.5||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgTeam||17.3||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Actief&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21427</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21427"/>
		<updated>2020-09-25T17:41:27Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan = &amp;quot;41&amp;quot;|4||rowspan=&amp;quot;41&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;12&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||DEPRECATED&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||DEPRECATED&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Afstandsmetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||N_RegionaleLymfeklieren&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||m_AantalPrimaireTumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&amp;quot;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21422</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21422"/>
		<updated>2020-09-22T14:01:22Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;41&amp;quot;|4||rowspan=&amp;quot;41&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;12&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_RegionaleLymfeklieren&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Afstandsmetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||m_AantalPrimaireTumoren&lt;br /&gt;
|-&lt;br /&gt;
style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21421</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21421"/>
		<updated>2020-09-22T14:00:53Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;40&amp;quot;|4||rowspan=&amp;quot;40&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;12&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_RegionaleLymfeklieren&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Afstandsmetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||m_AantalPrimaireTumoren&lt;br /&gt;
|-&lt;br /&gt;
style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21420</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21420"/>
		<updated>2020-09-22T14:00:16Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;56&amp;quot;|4||rowspan=&amp;quot;56&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;27&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_RegionaleLymfeklieren&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Afstandsmetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||&amp;lt;nog vrij&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||m_AantalPrimaireTumoren&lt;br /&gt;
|-&lt;br /&gt;
style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21419</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21419"/>
		<updated>2020-09-22T13:36:50Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;56&amp;quot;|4||rowspan=&amp;quot;56&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;27&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.13||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.14||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.15||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.17||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.18||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.19||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.20||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.21||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.22||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.23||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.24||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.25||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.26||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.27||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.28||naam&lt;br /&gt;
|-&lt;br /&gt;
style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21418</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21418"/>
		<updated>2020-09-22T13:10:30Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;56&amp;quot;|4||rowspan=&amp;quot;56&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;28&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.10||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.11||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.13||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.14||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.15||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.17||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.18||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.19||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.20||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.21||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.22||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.23||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.24||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.25||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.26||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.27||naam&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.28||naam&lt;br /&gt;
|-&lt;br /&gt;
style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21417</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21417"/>
		<updated>2020-09-22T12:17:52Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht codestelsels */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||AnatomischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||PrognostischStadium&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||TNMVersie&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21416</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21416"/>
		<updated>2020-09-22T11:57:59Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=TNMTumorClassificatie-v1.0(2020NL)&amp;diff=21316</id>
		<title>TNMTumorClassificatie-v1.0(2020NL)</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=TNMTumorClassificatie-v1.0(2020NL)&amp;diff=21316"/>
		<updated>2020-09-08T13:30:32Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Instructions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.4.27(NL)|1|TNMTumorClassificatie-v1.0(2020NL)}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Algemeen&amp;lt;!--hdGeneralInformation--&amp;gt;==&lt;br /&gt;
Naam&amp;lt;!--hdName--&amp;gt;: &#039;&#039;&#039;nl.zorg.TNMTumorClassificatie&#039;&#039;&#039; [[Bestand:EN.png|link=TNMTumorClassification-v1.0(2020EN)]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Versie&amp;lt;!--hdVersion--&amp;gt;: &#039;&#039;&#039;1.0&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
ZIB Status&amp;lt;!--hdStatus--&amp;gt;:Final&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie&amp;lt;!--hdPublication--&amp;gt;: &#039;&#039;&#039;2020&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: Published&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;: 01-09-2020&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Metadata==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:90%; width: 750px&amp;quot;&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CoderList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Address||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Telecom||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContentAuthorList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CreationDate||15/05/2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DeprecatedDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DescriptionLanguage||nl&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Address||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Telecom||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.4.27&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::LifecycleStatus||Final&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.TNMTumorClassificatie&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationDate||01-09-2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationStatus||Published&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::RevisionDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Supersedes||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Version||1.0&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|HCIM::PublicationLanguage||NL&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Revision History==&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&#039;&#039; &amp;lt;!--noTranslation--&amp;gt;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.0&amp;lt;/u&amp;gt; (01-09-2020).&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Concept==&lt;br /&gt;
TNM Classificatie van Maligne Tumoren (TNM) is het systeem voor de stadiëring van kanker dat is ontwikkeld door de Union Internationale Contre le Cancer of International Union Against Cancer (UICC). De TNM-classificatie wordt ook gebruikt door de American Joint Committee on Cancer (AJCC) en de International Federation of Gynecology and Obstetrics (FIGO). In 1987 werden de TNM-classificaties van de UICC en de AJCC tot één systeem gecombineerd met dezelfde definities. Desondanks zitten er nog altijd verschillen tussen beide systemen.&amp;lt;BR&amp;gt;&lt;br /&gt;
De TNM-classificatie is ontwikkeld voor solide tumoren (waaronder carcinomen en sarcomen); niet-solide tumoren (bijvoorbeeld lymfomen en gliomen) kennen een ander systeem voor stadiëring. De algemene opzet is als volgt: De T staat voor tumor en beschrijft de grootte van de tumor en de lokale uitbreiding, de N staat voor lymfekliermetastasering (Engels: node) en de M staat voor metastase op afstand (uitbreiding van de kanker van één locatie in het lichaam naar een andere. Naast T, N en M bevat de classificatie nog een aantal andere parameters.&lt;br /&gt;
&lt;br /&gt;
==Purpose==&lt;br /&gt;
TNM-classificatie is een belangrijke bepalende factor voor de juiste behandeling en prognose. Het stadium is een steeds belangrijker onderdeel van kankersurveillance en kankerbestrijding en een eindpunt voor de evaluatie van populatie screening en vroege detectie.&amp;lt;BR&amp;gt;&lt;br /&gt;
Het TNM-stadiëringssysteem is de gemeenschappelijke taal waarin zorgprofessionals in de oncologie kunnen communiceren over de uitbreiding en verspreiding van kanker bij individuele patiënten als basis voor besluitvorming over behandeling en individuele prognose. Het kan ook worden gebruikt voor het opstellen en evalueren van behandelrichtlijnen, nationale beleid t.a.v. zorgplanning en onderzoek.&amp;lt;BR&amp;gt;&lt;br /&gt;
De doelstellingen van de TNM-classificatie zijn:&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Hulp bij het plannen van de behandeling.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Het geven van een indicatie van prognose op basis van historische gegevens over uitkomsten.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Ondersteuning bij de evaluatie van behandelresultaten.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;De uitwisseling van informatie tussen behandelcentra vergemakkelijken.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Bijdragen aan doorlopend onderzoek naar kanker.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Ondersteuning van kankerbestrijding, onder meer via kankerregisters.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De TNM-classificatie is een uniforme standaard. Het doel is breder dan alleen de toepassing binnen het primaire zorgproces en zorgt voor essentiële informatie voor beleidsmakers die kankerbestrijdings- en preventieplannen ontwikkelen of uitvoeren.&lt;br /&gt;
&lt;br /&gt;
==Patient Population==&lt;br /&gt;
Volwassen patiënten met een solide tumor waarop een TNM-classificatie kan worden toegepast.&lt;br /&gt;
&lt;br /&gt;
==Information Model==&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:TNMTumorClassificatie-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 38 422 177 472 [[#R_ResidueleTumorCodelijst]]&lt;br /&gt;
rect 35 328 181 378 [[#PrognostischStadiumCodelijst]]&lt;br /&gt;
rect 37 234 179 284 [[#AnatomischStadiumCodelijst]]&lt;br /&gt;
rect 839 413 976 463 [[#V_VeneuzeInvasieCodelijst]]&lt;br /&gt;
rect 839 323 992 373 [[#Pn_PerineuraleInvasieCodelijst]]&lt;br /&gt;
rect 841 231 989 281 [[#L_LymfatischeInvasieCodelijst]]&lt;br /&gt;
rect 378 43 487 93 [[#TNMVersieCodelijst]]&lt;br /&gt;
rect 230 318 332 388 [[#14147]]&lt;br /&gt;
rect 621 511 749 581 [[#14193]]&lt;br /&gt;
rect 447 511 575 581 [[#14178]]&lt;br /&gt;
rect 276 511 404 581 [[#14170]]&lt;br /&gt;
rect 230 412 332 482 [[#14152]]&lt;br /&gt;
rect 712 403 802 473 [[#14151]]&lt;br /&gt;
rect 707 312 806 382 [[#14150]]&lt;br /&gt;
rect 711 221 801 291 [[#14138]]&lt;br /&gt;
rect 711 130 801 200 [[#14146]]&lt;br /&gt;
rect 230 224 332 294 [[#14135]]&lt;br /&gt;
rect 534 130 655 200 [[#14137]]&lt;br /&gt;
rect 388 130 478 200 [[#14149]]&lt;br /&gt;
rect 230 130 332 200 [[#14143]]&lt;br /&gt;
rect 446 275 576 345 [[#14140]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:PrimaireTumor-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 670 351 836 387 [[#aT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 303 836 339 [[#rpT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 255 836 291 [[#rcT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 206 836 242 [[#ypT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 151 836 187 [[#pT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 103 836 139 [[#ycT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 50 836 86 [[#cT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 143 268 316 318 [[#m_AantalPrimaireTumorenCodelijst]]&lt;br /&gt;
rect 327 740 442 810 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 463 662 667 712 [[#G_DifferentiatiegraadTumorCodelijst]]&lt;br /&gt;
rect 612 454 719 504 [[#MorfologieCodelijst]]&lt;br /&gt;
rect 340 617 430 687 [[#14156]]&lt;br /&gt;
rect 194 477 284 547 [[#14173]]&lt;br /&gt;
rect 496 444 586 514 [[#14172]]&lt;br /&gt;
rect 501 547 629 617 [[#14167]]&lt;br /&gt;
rect 492 179 582 249 [[#14175]]&lt;br /&gt;
rect 172 179 286 249 [[#14164]]&lt;br /&gt;
rect 340 477 430 547 [[#14162]]&lt;br /&gt;
rect 342 179 432 249 [[#14170]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:RegionaleLymfeklieren-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 551 464 722 514 [[#aN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 401 722 451 [[#rpN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 338 722 388 [[#rcN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 275 722 325 [[#ypN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 212 722 262 [[#pN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 149 722 199 [[#ycN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 86 722 136 [[#cN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 217 367 318 437 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 180 249 355 319 [[#14179]]&lt;br /&gt;
rect 377 76 490 146 [[#14183]]&lt;br /&gt;
rect 216 76 317 146 [[#14178]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:AfstandsMetastasen-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 515 207 686 257 [[#aM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
rect 194 318 307 388 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 178 187 323 257 [[#14189]]&lt;br /&gt;
rect 353 57 458 127 [[#14192]]&lt;br /&gt;
rect 200 57 300 127 [[#14193]]&lt;br /&gt;
rect 518 67 686 117 [[#cpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
rect 514 138 690 188 [[#rcrpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
{| border= &amp;quot;1&amp;quot;  width=&amp;quot;1500px&amp;quot; style = &amp;quot;font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;&amp;quot; cellpadding = &amp;quot;3px&amp;quot; cellspacing =&amp;quot;0px&amp;quot; &lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; &amp;quot;&lt;br /&gt;
|style=&amp;quot;width:30px;&amp;quot;|Type&amp;lt;!--imType--&amp;gt;||style=&amp;quot;width:100px;&amp;quot;|Id&amp;lt;!--imId--&amp;gt;||colspan=&amp;quot;6 &amp;quot; style=&amp;quot;width:140px;&amp;quot;|Concept&amp;lt;!--imConcept--&amp;gt;||Card.&amp;lt;!--imCard--&amp;gt;||style=&amp;quot;width: 600px;&amp;quot;|Definitie&amp;lt;!--imDefinition--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|DefinitieCode&amp;lt;!--imDefinitionCode--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|Verwijzing&amp;lt;!--imReference--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: block.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.1&lt;br /&gt;
|colspan =&amp;quot;6&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14140 Title=&amp;quot;EN: TNMTumorClassification&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]TNMTumorClassificatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|&lt;br /&gt;
|Rootconcept van de bouwsteen TNMTumorClassificatie. Dit rootconcept bevat alle gegevenselementen van de bouwsteen TNMTumorClassificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385379008 385379008] TNM tumor staging finding&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.25&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14193 Title=&amp;quot;EN: DistantMetastasis&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]AfstandsMetastasen&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept AfstandsMetastasen. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasen.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385380006 385380006] Metastasis category finding&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.26&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14192 Title=&amp;quot;EN: M_DistantMetastasis &amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]M_AfstandsMetastasen&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de aan- of afwezigheid van metastasen op afstand, de M-categorie van de TNM classificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277208005 277208005] M category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aM_AfstandsMetastasenCodelijst]]||[[#aM_AfstandsMetastasenCodelijst|aM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cpM_AfstandsMetastasenCodelijst]]||[[#cpM_AfstandsMetastasenCodelijst|cpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcrpM_AfstandsMetastasenCodelijst]]||[[#rcrpM_AfstandsMetastasenCodelijst|rcrpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.27&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14189 Title=&amp;quot;EN: DistantMetastasisLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]AfstandsMetastasenLocalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept AfstandsMetastasenLocalisatie. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasenLocalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.28&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14195 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Metastasen::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie(s) van de afstandsmetastasen, die aangedaan zijn door de primaire tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.21&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14178 Title=&amp;quot;EN: RegionalLymphnodes&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]RegionaleLymfeklieren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept RegionaleLymfeklieren. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklieren.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=301855007 301855007] Finding of lymph node&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.22&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14183 Title=&amp;quot;EN: N_RegionalLymphnodes&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]N_RegionaleLymfeklieren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de aan- of afwezigheid en omvang regionale lymfekliermetastase, de N-categorie van de TNM classificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277206009 277206009] N category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aN_RegionaleLymfeklierenCodelijst]]||[[#aN_RegionaleLymfeklierenCodelijst|aN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cN_RegionaleLymfeklierenCodelijst]]||[[#cN_RegionaleLymfeklierenCodelijst|cN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#pN_RegionaleLymfeklierenCodelijst]]||[[#pN_RegionaleLymfeklierenCodelijst|pN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcN_RegionaleLymfeklierenCodelijst]]||[[#rcN_RegionaleLymfeklierenCodelijst|rcN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rpN_RegionaleLymfeklierenCodelijst]]||[[#rpN_RegionaleLymfeklierenCodelijst|rpN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ycN_RegionaleLymfeklierenCodelijst]]||[[#ycN_RegionaleLymfeklierenCodelijst|ycN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ypN_RegionaleLymfeklierenCodelijst]]||[[#ypN_RegionaleLymfeklierenCodelijst|ypN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.23&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14179 Title=&amp;quot;EN: RegionalLymphNodesLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]RegionaleLymfeklierenLocalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept RegionaleLymfeklierenLocalisatie. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklierenLocalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=364108009 364108009] Lymph node observable&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.24&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14186 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Lymfeklieren::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie(s) van de aangedane regionale lymfeklieren door de primaire tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=397440000 397440000] Site of involved lymph node&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.12&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14170 Title=&amp;quot;EN: PrimaryTumor&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]PrimaireTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept PrimaireTumor. Deze container bevat alle gegevenselementen van het concept PrimaireTumor.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Neoplasm, malignant (primary) (morphologic abnormality)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=86049000 86049000] Primaire maligniteit&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.13&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14164 Title=&amp;quot;EN: m_NumberOfPrimaryTumors &amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]m_AantalPrimaireTumoren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het aantal primaire tumoren. Indien er meerdere primaire tumoren in één orgaan aanwezig zijn wordt de afwijking met de hoogste T-categorie geclassificeerd en de multipliciteit of het aantal primaire tumoren uitgedrukt in een aanvulling op de T-categorie in de vorm van (m) of een (&amp;lt;getal&amp;gt;), bijv. T2(m) of T2(2). Bij één primaire tumor wordt deze weggelaten uit de ‘GeintegreerdeTNMWaardeoverallTNMClassificatie’.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT&amp;amp;#xA;Onbekende code&amp;quot; style = &amp;quot;color:red&amp;quot;&amp;gt;133641000146103 number of primary tumors&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#m_AantalPrimaireTumorenCodelijst]]||[[#m_AantalPrimaireTumorenCodelijst|m_AantalPrimaireTumorenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.14&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14175 Title=&amp;quot;EN: T_PrimaryTumor&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]T_PrimaireTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de omvang van de primaire tumor, de T-categorie inclusief prefix en suffix.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=78873005 78873005] T category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aT_PrimaireTumorCodelijst]]||[[#aT_PrimaireTumorCodelijst|aT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cT_PrimaireTumorCodelijst]]||[[#cT_PrimaireTumorCodelijst|cT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#pT_PrimaireTumorCodelijst]]||[[#pT_PrimaireTumorCodelijst|pT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcT_PrimaireTumorCodelijst]]||[[#rcT_PrimaireTumorCodelijst|rcT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rpT_PrimaireTumorCodelijst]]||[[#rpT_PrimaireTumorCodelijst|rpT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ycT_PrimaireTumorCodelijst]]||[[#ycT_PrimaireTumorCodelijst|ycT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ypT_PrimaireTumorCodelijst]]||[[#ypT_PrimaireTumorCodelijst|ypT_PrimaireTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.15&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14162 Title=&amp;quot;EN: Abnormality&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]Afwijking&amp;lt;/span&amp;gt;&lt;br /&gt;
|1..*&lt;br /&gt;
|Container van het concept Afwijking. Deze container bevat alle gegevenselementen van het concept Afwijking.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Neoplasm (morphologic abnormality)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=108369006 108369006] Neoplasma&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: INT.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.16&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14173 Title=&amp;quot;EN: AbnormalityNumber&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]AfwijkingNummer&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het aan de afwijking toegewezen nummer, noodzakelijk om bij verschillende onderzoeken eenduidig aan te kunnen geven op welke afwijking de informatie betrekking heeft .&lt;br /&gt;
Bij meerdere afwijkingen in één orgaan wordt de afwijking met de hoogste T-categorie geclassificeerd.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.17&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14172 Title=&amp;quot;EN: Morphology&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Morfologie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Gedrag van de tumor en het celtype van de tumor uitgedrukt in de ICD-O-3 morfologie code. Beschrijft het celtype of histologie van de tumor als ook het gedrag van die cel (maligne of benigne). &lt;br /&gt;
Deze wordt door een patholoog bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=396984004 396984004] Histologic feature of tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#MorfologieCodelijst]]||[[#MorfologieCodelijst|MorfologieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.18&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14167 Title=&amp;quot;EN: G_HistopathologicalGrading&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]G_DifferentiatiegraadTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de G-categorie, de differentiatiegraad van de tumor, die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371469007 371469007] Histologic grade&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#G_DifferentiatiegraadTumorCodelijst]]||[[#G_DifferentiatiegraadTumorCodelijst|G_DifferentiatiegraadTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.19&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14156 Title=&amp;quot;EN: TumorLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]TumorLokalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept TumorLokalisatie. Deze container bevat alle gegevenselementen van het concept TumorLokalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.20&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;2&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14159 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Tumor::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie van de primaire tumor(en), welke (o.a.) bepalend is voor het toekennen van de TNM-classificatie aan de tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.2&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14143 Title=&amp;quot;EN: DateOfTNMClassification&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]DatumTNMClassificatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De datum waarop de TNM-Classificatie (de waarde) is vastgesteld.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399651003 399651003] Date of report&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.3&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14149 Title=&amp;quot;EN: TNMVersion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]TNMVersie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| TNM-classificatie versie (AJCC of UICC) en de gebruikte editie (7e, 8e etc.).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (assessment scale)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=273249006 273249006] Assessment scales&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#TNMVersieCodelijst]]||[[#TNMVersieCodelijst|TNMVersieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.4&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14137 Title=&amp;quot;EN: IntegratedTNMValue&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]GeintegreerdeTNMWaarde&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De vastgestelde TNM-classificatie (de waarde), op basis van elke T-, N- en M-categorie (evt. incl. het aantal primaire tumoren (m) en/of de lokalisatie van M).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399703000 399703000] Integrated TNM category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.5&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14146 Title=&amp;quot;EN: Explanation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Toelichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Toelichting met betrekking tot de interpretatie van de geïntegreerde TNM waarde zoals deze is geclassificeerd.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=243814003 243814003] Interpretation of findings&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.6&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14138 Title=&amp;quot;EN: TL_LymphaticInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]L_LymfatischeInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van lymfatische invasie, de L-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=395715009 395715009] Status of lymphatic (small vessel) invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#L_LymfatischeInvasieCodelijst]]||[[#L_LymfatischeInvasieCodelijst|L_LymfatischeInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.7&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14150 Title=&amp;quot;EN: Pn_PerineuralInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Pn_PerineuraleInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van perineurale invasie, de Pn-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371513001 371513001] Status of perineural invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#Pn_PerineuraleInvasieCodelijst]]||[[#Pn_PerineuraleInvasieCodelijst|Pn_PerineuraleInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.8&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14151 Title=&amp;quot;EN: V_VenousInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]V_VeneuzeInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van veneuze invasie, de V-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371493002 371493002] Status of venous (large vessel) invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#V_VeneuzeInvasieCodelijst]]||[[#V_VeneuzeInvasieCodelijst|V_VeneuzeInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.9&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14135 Title=&amp;quot;EN: AnatomicalStage&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]AnatomischStadium&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het stadium van de ziekte is de groepering op basis van de anatomische uitbreiding en verspreiding van de ziekte (de T, N en M categorieën).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399390009 399390009] TNM stage grouping&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#AnatomischStadiumCodelijst]]||[[#AnatomischStadiumCodelijst|AnatomischStadiumCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.10&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14147 Title=&amp;quot;EN: PrognosticStage&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]PrognostischStadium&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het prognostisch stadium van de ziekte. Hierin wordt in de groepering naast de anatomische uitbreiding en verspreiding van de ziekte ook additionele prognostische factoren meegenomen.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399390009 399390009] TNM stage grouping&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#PrognostischStadiumCodelijst]]||[[#PrognostischStadiumCodelijst|PrognostischStadiumCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.11&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14152 Title=&amp;quot;EN: R_ResidualTumor&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]R_ResidueleTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De aan- of afwezigheid van residuele tumor na behandeling, de R-categorie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=17964000 17964000] Residual tumor stage&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#R_ResidueleTumorCodelijst]]||[[#R_ResidueleTumorCodelijst|R_ResidueleTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
Kolommen Concept en DefinitieCode: houdt de muis boven de waarde voor meer informatie&amp;lt;!--imHover--&amp;gt;&amp;lt;BR&amp;gt;&lt;br /&gt;
Voor uitleg over de gebruikte symbolen, zie de legenda pagina&amp;lt;!--imLegend--&amp;gt; [[Bestand:list2.png|link=Legenda&amp;lt;!--wikiLegend--&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
==Example Instances==&lt;br /&gt;
{|class=&amp;quot;wikitable&amp;quot; width=&amp;quot;689px&amp;quot; style= &amp;quot;font-size: 9.5pt;&amp;quot;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;TNMTumorClassificatie&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;datumTNMClassificatie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;TNMVersie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Geintegreerde TNMWaarde&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|01/08/2020&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|AJCC 8e editie&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|cT3N2M1&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AnatomischStadium&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;PrognostischStadium&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;R_ResidueleTumor&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Stage IV&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|Stage IV&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Opmerking&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|HER2 negatief, ER negatief, PR negatief&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;L_LymfatischeInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Pn_PerineuraleInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;V_VeneuzeInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Primaire Tumor&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;m_PrimaireTumorAantal&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;T_tumor&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;G_DifferentiatiegraadTumor&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|1&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|cT3&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|G2&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;Afwijking&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #D9E2F3; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AfwijkingNummer&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #D9E2F3; width: 69%; &amp;quot;|&amp;lt;b&amp;gt;Morfologie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|1&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|Infiltrerend ductaal carcinoom, (8500/3)&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;TumorLokalisatie -  AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie SNOMED CT&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|(C50.5) Laterale onderkwadrant van borst&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van laterale onderkwadrant van mamma (33564002)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #D9E2F3; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AfwijkingNummer&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #D9E2F3; width: 69%; &amp;quot;|&amp;lt;b&amp;gt;Morfologie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|2&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|Fibroadenoom (9010/0)&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Regionale Lymfeklieren&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;N_RegionaleLymfeklieren&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|cN2&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;RegionaleLymfeklieren Localisatie - AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie &amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C77.3 Infraclaviculaire lymfeklier&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van infraclaviculaire lymfeklier (9659009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;RegionaleLymfeklieren Localisatie - AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie &amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C77.3 Axillaire lymfeklier&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van nodus lymphoideus axillaris (68171009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 31%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;AfstandsMetastasen&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 38%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 31%; &amp;quot;|&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;M_Afstandsmetastasen&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|cM1&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;AfstandsMetastasen Lokalisatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt; Locatie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C34.1 Bovenkwab van long&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|Structuur van lobus superior pulmonis (45653009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&amp;lt;b&amp;gt;Van een generieke TNM classificatie naar een ziekte specifieke TNM classificatie&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het uitwerken van een tumor specifieke TNM-bouwsteen of implementatie moet gekeken worden hoe de waardelijsten kunnen worden &amp;lt;u&amp;gt;ingeperkt&amp;lt;/u&amp;gt;, &amp;lt;u&amp;gt;toegepast&amp;lt;/u&amp;gt; of &amp;lt;u&amp;gt;uitgebreid&amp;lt;/u&amp;gt;.&amp;lt;BR&amp;gt;&lt;br /&gt;
Inperken wil zeggen dat items in een codelijst worden weggelaten of specifiek worden gemaakt door binnen het voorgeschreven code systeem andere termen te kiezen. Het is de bedoeling dat in de toekomst kant en klare codelijsten per kankeraandoening beschikbaar worden gemaakt (zie ook issues).&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Codesystemen&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
In deze zib worden 2 internationale codesystemen gebruikt:&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;SNOMED CT (beheerder international SNOMED international, Nederlands beheer door Nictiz)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;International Classification of Diseases for Oncology, version 3 (ICD-O-3) beheerd door de WHO.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
Waar toepassing van één van deze codesystemen niet zinvol werd geacht of mogelijk was is gekozen voor beheer ervan als onderdeel van het beheer van de zibs. Wanneer er een eenduidige internationale verwijzing mogelijk is naar de TNM standaard zelf als codesysteem met waardelijsten kunnen deze worden aangepast in een volgende versie van de zib. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Uitgangspunten vanuit de TNM standaard&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Eén TNM-classificatie per orgaan, maar in geval van gepaarde organen is er één classificatie per zijde. Bijvoorbeeld bij borstkanker met in iedere borst een primaire tumor zijn er dan dus ook twee instantiaties van de zib, waarbij de ene lateraliteit links en de andere lateraliteit rechts heeft (beiderzijds is niet toegestaan bij gepaarde organen).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Niet alleen de uitkomst van de TNM, maar ook de exacte lokalisatie van de primaire tumor(en), positieve lymfeklieren en metastasen kan worden aangeduid.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;In het geval van meerdere primaire tumoren in één orgaan, moet de tumor met de hoogste T-categorie worden geclassificeerd en moet de veelvoud of het aantal tumoren tussen haakjes worden vermeld, bijvoorbeeld T2 (m) of T2 (5).De afwijking met de hoogste T-categorie bepaalt de classificatie van de tumor. Om het onderscheid hierin te maken en alle afwijkingen te kunnen weergeven bestaat de container ‘afwijking’ in de zib. Elke afwijking heeft een nummer. Welke afwijking (b.v. 1, 2 of 4) de hoogste t-categorie heeft wordt niet in de zib aangegeven. Dit is logische want dit is pas duidelijk na de inschatting van de zorgverlener o.b.v. de pathologie dan wel beeldvorming.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Gebruikte versie van de [http://www.uicc.org/resources/tnm UICC]/[//http://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx AJCC] TNM Classification of Malignant Tumours.&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Hoewel er geen verschillen in definities en verwoordingen tussen AJCC en UICC TNM classificaties zouden mogen voorkomen zijn er helaas wel enkele verschillen ingeslopen (bijvoorbeeld bij de definitie van regionale lymfeklieren bij slokdarm- en endometriumcarcinomen). Daarom kan in deze zib gekozen worden tussen de UICC en AJCC versie. Criteria die in het TNM-classificatiesysteem worden gebruikt, zijn in de loop van de jaren veranderd en er zijn verschillende edities uitgebracht. Als gevolg hiervan kan een bepaalde stagering een heel andere prognose hebben, afhankelijk van welke editie wordt gebruikt. Verder is een belangrijke overweging het effect van een verbeterde behandeling in de tijd&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Naast de stagering via UICC of AJCC classificaties is er ook ‘Essential TNM’. Dit is een versimpelde vorm van TNM die is gemaakt voor het weergeven van het voorkomen van kanker in lage lonen landen. In deze landen zijn vaak de middelen voor vroege diagnose niet aanwezig en het gebruik van TNM beperkt (kanker wordt in de regel in deze landen pas in een zeer laat stadium ontdekt). Deze speciale TNM is niet meegenomen in de uitwerking van deze zib. Overigens wordt deze speciale TNM meestal alleen gebruikt voor het kunnen betrekken van deze landen in de statistiek over het voorkomen van bepaalde kankers in deze landen.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Prefix en suffix zijn geïntegreerd in codelijsten.&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Alhoewel het mogelijk zou zijn om voor de mogelijke voor en achtervoegsels op zowel de T, N en M losse codelijsten te maken is voor het eenvoudig toepassen ervan gekozen om deze te integreren in de codelijsten. Dit is besloten omdat de huidige inzichten zijn dat hiermee het maken van verkeerde combinaties wordt voorkomen&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Prefix &amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;c: &amp;lt;/b&amp;gt;Klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;yc:&amp;lt;/b&amp;gt; Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;p:&amp;lt;/b&amp;gt; De post-chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;yp:&amp;lt;/b&amp;gt; Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;rc:&amp;lt;/b&amp;gt; Klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;rp:&amp;lt;/b&amp;gt; Post-operatieve pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;a:&amp;lt;/b&amp;gt; Classificatie vastgesteld tijdens autopsie&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Suffix&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mi): Gevallen met alleen micrometastase&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(sn): Gevallen waarbij schildwachtklier onderzoek heeft plaatsgevonden.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(f): Gevallen waarbij FNA of biopsie heeft plaatsgevonden op de regionale lymfeklieren&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(i-): negatieve morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(i+): positieve morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mol-): negatieve niet-morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mol+): positieve niet- morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(0): zonder verhoogd lactaatdehydrogenase (LDH)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(1): met verhoogd lactaatdehydrogenase (LDH)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Issues==&lt;br /&gt;
Bruikbaarheid van deze zib als ook de ziekte specifieke codelijsten worden gemaakt in de eerste proeftuin(en), gepland in de zomer van 2020. Gedurende dit project zal IKNL het beheer voor deze codelijsten verzorgen. Wanneer deze proeftuin(en) zijn afgerond worden de bevindingen meegenomen als wijzigingsverzoeken in het reguliere beheerproces van het zib centrum.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;ol&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;TNM Classification of Malignant Tumours, 8th Edition -  James D. Brierley (Editor), Mary K. Gospodarowicz (Editor), Christian Wittekind (Editor)- International Union Against Cancer (UICC)- ISBN:  9781119263562 (epub)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;https://www.uicc.org/resources/tnm [ONLINE geraadpleegd: 04 mei 2020]&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;International Classification of diseases for oncology (ICD-O) – 3&amp;lt;sup&amp;gt;rd&amp;lt;/sup&amp;gt; edition, 1&amp;lt;sup&amp;gt;st&amp;lt;/sup&amp;gt; revision – April Frits, Constance Percy, Andrew Jack, Kanagaratnam Shanmugaratnam, Leslie Sobin, D Max Parkin, Sharon Whelan – World Health Organisation – WHO library cataloguing – ISBN 978 92 4 069212 1 (PDF)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Valuesets ==&lt;br /&gt;
=== aM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.25&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0&lt;br /&gt;
|aM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1&lt;br /&gt;
|aM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a&lt;br /&gt;
|aM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b&lt;br /&gt;
|aM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c&lt;br /&gt;
|aM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d&lt;br /&gt;
|aM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand voor een classificatie vastgesteld tijdens autopsie. &lt;br /&gt;
=== aN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.24&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX&lt;br /&gt;
|aNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0&lt;br /&gt;
|aN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1&lt;br /&gt;
|aN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi&lt;br /&gt;
|aN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a&lt;br /&gt;
|aN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b&lt;br /&gt;
|aN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c&lt;br /&gt;
|aN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2&lt;br /&gt;
|aN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a&lt;br /&gt;
|aN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b&lt;br /&gt;
|aN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c&lt;br /&gt;
|aN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3&lt;br /&gt;
|aN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a&lt;br /&gt;
|aN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b&lt;br /&gt;
|aN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c&lt;br /&gt;
|aN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De regionale lymfeklieren (N) voor een classificatie vastgesteld tijdens autopsie&lt;br /&gt;
=== AnatomischStadiumCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.1&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|Stage0&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium I&lt;br /&gt;
|StageI&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium I&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|StageIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|StageIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|StageIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|StageIA3&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|StageIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|StageIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|StageIB1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|StageIB2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|StageIs&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium II&lt;br /&gt;
|StageII&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium II&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|StageIIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|StageIIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|StageIIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|StageIIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|StageIIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium III&lt;br /&gt;
|StageIII&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium III&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|StageIIIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|StageIIIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|StageIIIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|StageIIIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|StageIIIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|StageIIIC1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|StageIIIC2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|StageIIID&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|StageIV&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|StageIVA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|StageIVB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|StageIVC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|}&lt;br /&gt;
=== aT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.15&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTx&lt;br /&gt;
|aTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT0&lt;br /&gt;
|aT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTa&lt;br /&gt;
|aTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis&lt;br /&gt;
|aTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis pu&lt;br /&gt;
|aTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1&lt;br /&gt;
|aT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1mi&lt;br /&gt;
|aT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a&lt;br /&gt;
|aT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a1&lt;br /&gt;
|aT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a2&lt;br /&gt;
|aT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b&lt;br /&gt;
|aT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b1&lt;br /&gt;
|aT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b2&lt;br /&gt;
|aT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c&lt;br /&gt;
|aT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c1&lt;br /&gt;
|aT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c2&lt;br /&gt;
|aT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c3&lt;br /&gt;
|aT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1d&lt;br /&gt;
|aT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2&lt;br /&gt;
|aT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a&lt;br /&gt;
|aT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a1&lt;br /&gt;
|aT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a2&lt;br /&gt;
|aT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2b&lt;br /&gt;
|aT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2c&lt;br /&gt;
|aT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2d&lt;br /&gt;
|aT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3&lt;br /&gt;
|aT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3a&lt;br /&gt;
|aT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3b&lt;br /&gt;
|aT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3c&lt;br /&gt;
|aT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3d&lt;br /&gt;
|aT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3e&lt;br /&gt;
|aT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4&lt;br /&gt;
|aT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4a&lt;br /&gt;
|aT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4b&lt;br /&gt;
|aT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4c&lt;br /&gt;
|aT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4d&lt;br /&gt;
|aT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4e&lt;br /&gt;
|aT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een classificatie vastgesteld tijdens autopsie.&lt;br /&gt;
=== cN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.18&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX&lt;br /&gt;
|cNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0&lt;br /&gt;
|cN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1&lt;br /&gt;
|cN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi&lt;br /&gt;
|cN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a&lt;br /&gt;
|cN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b&lt;br /&gt;
|cN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c&lt;br /&gt;
|cN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2&lt;br /&gt;
|cN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a&lt;br /&gt;
|cN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b&lt;br /&gt;
|cN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c&lt;br /&gt;
|cN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3&lt;br /&gt;
|cN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a&lt;br /&gt;
|cN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b&lt;br /&gt;
|cN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c&lt;br /&gt;
|cN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De regionale lymfeklieren (N) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.&lt;br /&gt;
=== cpM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.28&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0&lt;br /&gt;
|cM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1&lt;br /&gt;
|cM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a&lt;br /&gt;
|cM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b&lt;br /&gt;
|cM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c&lt;br /&gt;
|cM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d&lt;br /&gt;
|cM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1&lt;br /&gt;
|pM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a&lt;br /&gt;
|pM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b&lt;br /&gt;
|pM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c&lt;br /&gt;
|pM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d&lt;br /&gt;
|pM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie. &lt;br /&gt;
=== cT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.9&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTx&lt;br /&gt;
|cTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT0&lt;br /&gt;
|cT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTa&lt;br /&gt;
|cTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis&lt;br /&gt;
|cTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis pu&lt;br /&gt;
|cTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1&lt;br /&gt;
|cT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1mi&lt;br /&gt;
|cT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a&lt;br /&gt;
|cT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a1&lt;br /&gt;
|cT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a2&lt;br /&gt;
|cT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b&lt;br /&gt;
|cT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b1&lt;br /&gt;
|cT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b2&lt;br /&gt;
|cT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c&lt;br /&gt;
|cT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c1&lt;br /&gt;
|cT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c2&lt;br /&gt;
|cT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c3&lt;br /&gt;
|cT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1d&lt;br /&gt;
|cT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2&lt;br /&gt;
|cT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a&lt;br /&gt;
|cT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a1&lt;br /&gt;
|cT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a2&lt;br /&gt;
|cT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2b&lt;br /&gt;
|cT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2c&lt;br /&gt;
|cT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2d&lt;br /&gt;
|cT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3&lt;br /&gt;
|cT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3a&lt;br /&gt;
|cT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3b&lt;br /&gt;
|cT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3c&lt;br /&gt;
|cT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3d&lt;br /&gt;
|cT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3e&lt;br /&gt;
|cT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4&lt;br /&gt;
|cT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4a&lt;br /&gt;
|cT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4b&lt;br /&gt;
|cT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4c&lt;br /&gt;
|cT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4d&lt;br /&gt;
|cT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4e&lt;br /&gt;
|cT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken&lt;br /&gt;
=== G_DifferentiatiegraadTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.17&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|GX&lt;br /&gt;
|GX&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Differentiatiegraad kan niet beoordeeld worden.Grade cannot be assessed.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G1&lt;br /&gt;
|G1&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Goed gedifferentieerd.Well differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G2&lt;br /&gt;
|G2&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Matig gedifferentieerd.Moderately differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G3&lt;br /&gt;
|G3&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Slecht gedifferentieerd.Poorly differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G3-4&lt;br /&gt;
|G3-4&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Slecht gedifferentieerd of ongedifferentieerd.poorly differentiated or undifferentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G4&lt;br /&gt;
|G4&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Ongedifferentieerd.Undifferentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G5&lt;br /&gt;
|G5&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|G5&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|}&lt;br /&gt;
=== L_LymfatischeInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.2&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|LX&lt;br /&gt;
|LX&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Aanwezigheid van Lymfatische invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|L0&lt;br /&gt;
|L0&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Geen Lymfatische invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|L1&lt;br /&gt;
|L1&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Lymfatische invasie&lt;br /&gt;
|}&lt;br /&gt;
=== m_AantalPrimaireTumorenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.8&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(m)&lt;br /&gt;
|(m)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|Meerdere primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(1)&lt;br /&gt;
|(1)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|1 primaire tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(2)&lt;br /&gt;
|(2)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|2 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(3)&lt;br /&gt;
|(3)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|3 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(4)&lt;br /&gt;
|(4)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|4 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(5)&lt;br /&gt;
|(5)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|5 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(6)&lt;br /&gt;
|(6)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|6 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(7)&lt;br /&gt;
|(7)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|7 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(8)&lt;br /&gt;
|(8)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|8 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(9)&lt;br /&gt;
|(9)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|9 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(10)&lt;br /&gt;
|(10)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|10 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Other&lt;br /&gt;
|OTH&lt;br /&gt;
|nullflavor&lt;br /&gt;
|2.16.840.1.113883.5.1008&lt;br /&gt;
|Anders, specificeer.&lt;br /&gt;
|}&lt;br /&gt;
=== MorfologieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.16&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|International Classification of Diseases for Oncology, version 3 (Morphology codes)&lt;br /&gt;
|ICD-O-3&lt;br /&gt;
|2.16.840.1.113883.6.43.1&lt;br /&gt;
|}&lt;br /&gt;
=== Pn_PerineuraleInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.3&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|PnX&lt;br /&gt;
|PnX&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.&lt;br /&gt;
|Aanwezigheid van Perineurale invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Pn0&lt;br /&gt;
|Pn0&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3&lt;br /&gt;
|Geen Perineurale invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Pn1&lt;br /&gt;
|Pn1&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3&lt;br /&gt;
|Perineurale invasie&lt;br /&gt;
|}&lt;br /&gt;
=== pN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.20&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX&lt;br /&gt;
|pNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0&lt;br /&gt;
|pN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1&lt;br /&gt;
|pN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi&lt;br /&gt;
|pN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a&lt;br /&gt;
|pN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b&lt;br /&gt;
|pN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c&lt;br /&gt;
|pN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2&lt;br /&gt;
|pN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a&lt;br /&gt;
|pN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b&lt;br /&gt;
|pN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c&lt;br /&gt;
|pN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3&lt;br /&gt;
|pN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a&lt;br /&gt;
|pN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b&lt;br /&gt;
|pN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c&lt;br /&gt;
|pN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&lt;br /&gt;
=== PrognostischStadiumCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.4&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|Stage0&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium I&lt;br /&gt;
|StageI&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium I&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|StageIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|StageIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|StageIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|StageIA3&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|StageIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|StageIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|StageIB1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|StageIB2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|StageIS&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium II&lt;br /&gt;
|StageII&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium II&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|StageIIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|StageIIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|StageIIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|StageIIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|StageIIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium III&lt;br /&gt;
|StageIII&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium III&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|StageIIIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|StageIIIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|StageIIIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|StageIIIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|StageIIIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|StageIIIC1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|StageIIIC2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|StageIIID&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|StageIV&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|StageIVA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|StageIVB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|StageIVC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|}&lt;br /&gt;
=== pT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.11&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTx&lt;br /&gt;
|pTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT0&lt;br /&gt;
|pT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTa&lt;br /&gt;
|pTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis&lt;br /&gt;
|pTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis pu&lt;br /&gt;
|pTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1&lt;br /&gt;
|pT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1mi&lt;br /&gt;
|pT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a&lt;br /&gt;
|pT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a1&lt;br /&gt;
|pT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a2&lt;br /&gt;
|pT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b&lt;br /&gt;
|pT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b1&lt;br /&gt;
|pT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b2&lt;br /&gt;
|pT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c&lt;br /&gt;
|pT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c1&lt;br /&gt;
|pT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c2&lt;br /&gt;
|pT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c3&lt;br /&gt;
|pT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1d&lt;br /&gt;
|pT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2&lt;br /&gt;
|pT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a&lt;br /&gt;
|pT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a1&lt;br /&gt;
|pT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a2&lt;br /&gt;
|pT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2b&lt;br /&gt;
|pT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2c&lt;br /&gt;
|pT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2d&lt;br /&gt;
|pT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3&lt;br /&gt;
|pT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3a&lt;br /&gt;
|pT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3b&lt;br /&gt;
|pT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3c&lt;br /&gt;
|pT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3d&lt;br /&gt;
|pT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4&lt;br /&gt;
|pT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4a&lt;br /&gt;
|pT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4b&lt;br /&gt;
|pT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4c&lt;br /&gt;
|pT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4d&lt;br /&gt;
|pT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4e&lt;br /&gt;
|pT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een post chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&lt;br /&gt;
=== R_ResidueleTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.5&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|RX&lt;br /&gt;
|RX&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Aanwezigheid van residuele tumor kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R0&lt;br /&gt;
|R0&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Geen residuele tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R1&lt;br /&gt;
|R1&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Microscopische residuele tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R2&lt;br /&gt;
|R2&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Macroscopische residuele tumor&lt;br /&gt;
|}&lt;br /&gt;
=== rcN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.22&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX&lt;br /&gt;
|rcNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0&lt;br /&gt;
|rcN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1&lt;br /&gt;
|rcN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a&lt;br /&gt;
|rcN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b&lt;br /&gt;
|rcN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c&lt;br /&gt;
|rcN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2&lt;br /&gt;
|rcN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a&lt;br /&gt;
|rcN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b&lt;br /&gt;
|rcN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c&lt;br /&gt;
|rcN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3&lt;br /&gt;
|rcN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a&lt;br /&gt;
|rcN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b&lt;br /&gt;
|rcN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c&lt;br /&gt;
|rcN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rcrpM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.27&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0&lt;br /&gt;
|rcM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1&lt;br /&gt;
|rcM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a&lt;br /&gt;
|rcM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b&lt;br /&gt;
|rcM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c&lt;br /&gt;
|rcM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d&lt;br /&gt;
|rcM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1&lt;br /&gt;
|rpM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a&lt;br /&gt;
|rpM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b&lt;br /&gt;
|rpM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c&lt;br /&gt;
|rpM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d&lt;br /&gt;
|rpM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rcT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.13&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTx&lt;br /&gt;
|rcTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT0&lt;br /&gt;
|rcT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTa&lt;br /&gt;
|rcTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis&lt;br /&gt;
|rcTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1&lt;br /&gt;
|rcT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a&lt;br /&gt;
|rcT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b&lt;br /&gt;
|rcT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c&lt;br /&gt;
|rcT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1d&lt;br /&gt;
|rcT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2&lt;br /&gt;
|rcT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a&lt;br /&gt;
|rcT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2b&lt;br /&gt;
|rcT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2c&lt;br /&gt;
|rcT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2d&lt;br /&gt;
|rcT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3&lt;br /&gt;
|rcT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3a&lt;br /&gt;
|rcT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3b&lt;br /&gt;
|rcT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3c&lt;br /&gt;
|rcT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3d&lt;br /&gt;
|rcT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3e&lt;br /&gt;
|rcT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4&lt;br /&gt;
|rcT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4a&lt;br /&gt;
|rcT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4b&lt;br /&gt;
|rcT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4c&lt;br /&gt;
|rcT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4d&lt;br /&gt;
|rcT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4e&lt;br /&gt;
|rcT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rpN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.23&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX&lt;br /&gt;
|rpNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0&lt;br /&gt;
|rpN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1&lt;br /&gt;
|rpN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a&lt;br /&gt;
|rpN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b&lt;br /&gt;
|rpN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c&lt;br /&gt;
|rpN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2&lt;br /&gt;
|rpN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a&lt;br /&gt;
|rpN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b&lt;br /&gt;
|rpN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c&lt;br /&gt;
|rpN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3&lt;br /&gt;
|rpN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a&lt;br /&gt;
|rpN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b&lt;br /&gt;
|rpN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c&lt;br /&gt;
|rpN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rpT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.14&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTx&lt;br /&gt;
|rpTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT0&lt;br /&gt;
|rpT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTa&lt;br /&gt;
|rpTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis&lt;br /&gt;
|rpTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1&lt;br /&gt;
|rpT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a&lt;br /&gt;
|rpT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b&lt;br /&gt;
|rpT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c&lt;br /&gt;
|rpT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1d&lt;br /&gt;
|rpT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2&lt;br /&gt;
|rpT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a&lt;br /&gt;
|rpT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2b&lt;br /&gt;
|rpT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2c&lt;br /&gt;
|rpT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2d&lt;br /&gt;
|rpT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3&lt;br /&gt;
|rpT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3a&lt;br /&gt;
|rpT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3b&lt;br /&gt;
|rpT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3c&lt;br /&gt;
|rpT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3d&lt;br /&gt;
|rpT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4&lt;br /&gt;
|rpT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4a&lt;br /&gt;
|rpT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4b&lt;br /&gt;
|rpT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4c&lt;br /&gt;
|rpT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4d&lt;br /&gt;
|rpT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4e&lt;br /&gt;
|rpT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een post chirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== TNMVersieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.6&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 1ste editie&lt;br /&gt;
|AJCCTNM1&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 1ste editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 2e editie&lt;br /&gt;
|AJCCTNM2&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 2e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 3e editie&lt;br /&gt;
|AJCCTNM3&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 3e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 4e editie&lt;br /&gt;
|AJCCTNM4&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 4e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 5e editie&lt;br /&gt;
|AJCCTNM5&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 5e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 6e editie&lt;br /&gt;
|AJCCTNM6&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 6e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 7e editie&lt;br /&gt;
|AJCCTNM7&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 7e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 8e editie&lt;br /&gt;
|AJCCTNM8&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 8e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 9e editie&lt;br /&gt;
|AJCCTNM9&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 9e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC  1ste editie&lt;br /&gt;
|UICCTNM1&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 1ste editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 2e editie&lt;br /&gt;
|UICCTNM2&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 2e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 3e editie&lt;br /&gt;
|UICCTNM3&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 3e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 4e editie&lt;br /&gt;
|UICCTNM4&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 4e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 5e editie&lt;br /&gt;
|UICCTNM5&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 5e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 6e editie&lt;br /&gt;
|UICCTNM6&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 6e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 7e editie&lt;br /&gt;
|UICCTNM7&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 7e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 8e editie&lt;br /&gt;
|UICC TNM8&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 8e editie&lt;br /&gt;
|}&lt;br /&gt;
=== V_VeneuzeInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.7&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|VX&lt;br /&gt;
|VX&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Aanwezigheid van veneuze invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V0&lt;br /&gt;
|V0&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Geen veneuze invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V1&lt;br /&gt;
|V1&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Microscopische veneuze invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V2&lt;br /&gt;
|V2&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Macroscopische veneuze invasie&lt;br /&gt;
|}&lt;br /&gt;
=== ycN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.19&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX&lt;br /&gt;
|ycNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0&lt;br /&gt;
|ycN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1&lt;br /&gt;
|ycN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a&lt;br /&gt;
|ycN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b&lt;br /&gt;
|ycN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c&lt;br /&gt;
|ycN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2&lt;br /&gt;
|ycN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a&lt;br /&gt;
|ycN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b&lt;br /&gt;
|ycN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c&lt;br /&gt;
|ycN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c(sn)&lt;br /&gt;
|ycN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3&lt;br /&gt;
|ycN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3(f)&lt;br /&gt;
|ycN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3(sn)&lt;br /&gt;
|ycN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a&lt;br /&gt;
|ycN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a(f)&lt;br /&gt;
|ycN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a(sn)&lt;br /&gt;
|ycN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b&lt;br /&gt;
|ycN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b(f)&lt;br /&gt;
|ycN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b(sn)&lt;br /&gt;
|ycN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c&lt;br /&gt;
|ycN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c(f)&lt;br /&gt;
|ycN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c(sn)&lt;br /&gt;
|ycN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&lt;br /&gt;
=== ycT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.10&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTx&lt;br /&gt;
|ycTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT0&lt;br /&gt;
|ycT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTa&lt;br /&gt;
|ycTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis&lt;br /&gt;
|ycTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1&lt;br /&gt;
|ycT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a&lt;br /&gt;
|ycT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b&lt;br /&gt;
|ycT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c&lt;br /&gt;
|ycT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1d&lt;br /&gt;
|ycT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2&lt;br /&gt;
|ycT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a&lt;br /&gt;
|ycT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2b&lt;br /&gt;
|ycT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2c&lt;br /&gt;
|ycT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2d&lt;br /&gt;
|ycT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3&lt;br /&gt;
|ycT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3a&lt;br /&gt;
|ycT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3b&lt;br /&gt;
|ycT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3c&lt;br /&gt;
|ycT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3d&lt;br /&gt;
|ycT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3e&lt;br /&gt;
|ycT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4&lt;br /&gt;
|ycT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4a&lt;br /&gt;
|ycT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4b&lt;br /&gt;
|ycT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4c&lt;br /&gt;
|ycT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4d&lt;br /&gt;
|ycT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4e&lt;br /&gt;
|ycT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&lt;br /&gt;
=== ypN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.21&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX&lt;br /&gt;
|ypNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0&lt;br /&gt;
|ypN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1&lt;br /&gt;
|ypN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a&lt;br /&gt;
|ypN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b&lt;br /&gt;
|ypN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c&lt;br /&gt;
|ypN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2&lt;br /&gt;
|ypN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a&lt;br /&gt;
|ypN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b&lt;br /&gt;
|ypN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c&lt;br /&gt;
|ypN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3&lt;br /&gt;
|ypN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a&lt;br /&gt;
|ypN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b&lt;br /&gt;
|ypN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c&lt;br /&gt;
|ypN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&lt;br /&gt;
=== ypT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.12&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTx&lt;br /&gt;
|ypTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT0&lt;br /&gt;
|ypT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTa&lt;br /&gt;
|ypTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis&lt;br /&gt;
|ypTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1&lt;br /&gt;
|ypT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a&lt;br /&gt;
|ypT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b&lt;br /&gt;
|ypT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c&lt;br /&gt;
|ypT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1d&lt;br /&gt;
|ypT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2&lt;br /&gt;
|ypT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a&lt;br /&gt;
|ypT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2b&lt;br /&gt;
|ypT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2c&lt;br /&gt;
|ypT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2d&lt;br /&gt;
|ypT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3&lt;br /&gt;
|ypT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3a&lt;br /&gt;
|ypT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3b&lt;br /&gt;
|ypT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3c&lt;br /&gt;
|ypT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3d&lt;br /&gt;
|ypT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4&lt;br /&gt;
|ypT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4a&lt;br /&gt;
|ypT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4b&lt;br /&gt;
|ypT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4c&lt;br /&gt;
|ypT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4d&lt;br /&gt;
|ypT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4e&lt;br /&gt;
|ypT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&lt;br /&gt;
&lt;br /&gt;
==Deze bouwsteen in overige publicaties&amp;lt;!--ftOtherReleases--&amp;gt;==&lt;br /&gt;
&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.4.27(NL)|2|2020}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Bouwsteen verwijzingen&amp;lt;!--ftReferences--&amp;gt;==&lt;br /&gt;
====Deze bouwsteen verwijst naar&amp;lt;!--ftRefersTo--&amp;gt;====&lt;br /&gt;
*[[AnatomischeLocatie-v1.0(2020NL)|AnatomischeLocatie-v1.0]]&lt;br /&gt;
====Deze bouwsteen wordt gebruikt in&amp;lt;!--ftReferredBy--&amp;gt;====&lt;br /&gt;
:--&lt;br /&gt;
==Technische specificaties in HL7v3 CDA en HL7 FHIR&amp;lt;!--ftHeader--&amp;gt;==&lt;br /&gt;
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.&amp;lt;BR&amp;gt;Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:&amp;lt;!--ftReferenceIntro--&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving&amp;lt;!--ftArtDecorReference--&amp;gt; [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2020bbr-?id=2.16.840.1.113883.2.4.3.11.60.10.4.2.4.27&amp;amp;effectiveDate=2020-09-01T00:00:00&amp;amp;language=nl-NL&amp;amp;scenariotree=false [[File:artdecor.jpg|16px|link=]]]&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry&amp;lt;!--ftSimplifierReference--&amp;gt; {{SimplefierLinks|2020}}&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
==Downloads&amp;lt;!--ftDownloadTitle--&amp;gt;==&lt;br /&gt;
De bouwsteen is ook beschikbaar als [[Media:nl.zorg.TNMTumorClassificatie-v1.0(2020NL).pdf|pdf bestand]] [[File:PDF.png|link=]] of als [[Media:nl.zorg.TNMTumorClassificatie-v1.0(2020NL).xlsx|spreadsheet]] [[File:xlsx.png|link=]]&amp;lt;!--ftDownloads--&amp;gt;&lt;br /&gt;
==Over deze informatie&amp;lt;!--ftHeader2--&amp;gt;==&lt;br /&gt;
De informatie in deze wiki pagina is gebaseerd op de&amp;lt;!--ftInfoBase--&amp;gt; Publicatie 2020 &amp;lt;BR&amp;gt;&lt;br /&gt;
SNOMED CT en LOINC codes zijn gebaseeerd op:&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;SNOMED Clinical Terms version: 20200309 [R] (March 2020 Interim Release)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;LOINC version 2.67&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Deze pagina is gegenereerd op 05/09/2020 22:12:20 met ZibExtraction v. 4.0.7553.39553&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=TNMTumorClassificatie-v1.0(2020NL)&amp;diff=21315</id>
		<title>TNMTumorClassificatie-v1.0(2020NL)</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=TNMTumorClassificatie-v1.0(2020NL)&amp;diff=21315"/>
		<updated>2020-09-08T12:08:45Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Instructions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.4.27(NL)|1|TNMTumorClassificatie-v1.0(2020NL)}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Algemeen&amp;lt;!--hdGeneralInformation--&amp;gt;==&lt;br /&gt;
Naam&amp;lt;!--hdName--&amp;gt;: &#039;&#039;&#039;nl.zorg.TNMTumorClassificatie&#039;&#039;&#039; [[Bestand:EN.png|link=TNMTumorClassification-v1.0(2020EN)]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Versie&amp;lt;!--hdVersion--&amp;gt;: &#039;&#039;&#039;1.0&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
ZIB Status&amp;lt;!--hdStatus--&amp;gt;:Final&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie&amp;lt;!--hdPublication--&amp;gt;: &#039;&#039;&#039;2020&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: Published&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;: 01-09-2020&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Metadata==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:90%; width: 750px&amp;quot;&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CoderList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Address||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Telecom||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContentAuthorList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CreationDate||15/05/2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DeprecatedDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DescriptionLanguage||nl&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Address||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Telecom||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.4.27&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::LifecycleStatus||Final&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.TNMTumorClassificatie&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationDate||01-09-2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationStatus||Published&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::RevisionDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Supersedes||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Version||1.0&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|HCIM::PublicationLanguage||NL&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Revision History==&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&#039;&#039; &amp;lt;!--noTranslation--&amp;gt;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.0&amp;lt;/u&amp;gt; (01-09-2020).&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Concept==&lt;br /&gt;
TNM Classificatie van Maligne Tumoren (TNM) is het systeem voor de stadiëring van kanker dat is ontwikkeld door de Union Internationale Contre le Cancer of International Union Against Cancer (UICC). De TNM-classificatie wordt ook gebruikt door de American Joint Committee on Cancer (AJCC) en de International Federation of Gynecology and Obstetrics (FIGO). In 1987 werden de TNM-classificaties van de UICC en de AJCC tot één systeem gecombineerd met dezelfde definities. Desondanks zitten er nog altijd verschillen tussen beide systemen.&amp;lt;BR&amp;gt;&lt;br /&gt;
De TNM-classificatie is ontwikkeld voor solide tumoren (waaronder carcinomen en sarcomen); niet-solide tumoren (bijvoorbeeld lymfomen en gliomen) kennen een ander systeem voor stadiëring. De algemene opzet is als volgt: De T staat voor tumor en beschrijft de grootte van de tumor en de lokale uitbreiding, de N staat voor lymfekliermetastasering (Engels: node) en de M staat voor metastase op afstand (uitbreiding van de kanker van één locatie in het lichaam naar een andere. Naast T, N en M bevat de classificatie nog een aantal andere parameters.&lt;br /&gt;
&lt;br /&gt;
==Purpose==&lt;br /&gt;
TNM-classificatie is een belangrijke bepalende factor voor de juiste behandeling en prognose. Het stadium is een steeds belangrijker onderdeel van kankersurveillance en kankerbestrijding en een eindpunt voor de evaluatie van populatie screening en vroege detectie.&amp;lt;BR&amp;gt;&lt;br /&gt;
Het TNM-stadiëringssysteem is de gemeenschappelijke taal waarin zorgprofessionals in de oncologie kunnen communiceren over de uitbreiding en verspreiding van kanker bij individuele patiënten als basis voor besluitvorming over behandeling en individuele prognose. Het kan ook worden gebruikt voor het opstellen en evalueren van behandelrichtlijnen, nationale beleid t.a.v. zorgplanning en onderzoek.&amp;lt;BR&amp;gt;&lt;br /&gt;
De doelstellingen van de TNM-classificatie zijn:&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Hulp bij het plannen van de behandeling.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Het geven van een indicatie van prognose op basis van historische gegevens over uitkomsten.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Ondersteuning bij de evaluatie van behandelresultaten.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;De uitwisseling van informatie tussen behandelcentra vergemakkelijken.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Bijdragen aan doorlopend onderzoek naar kanker.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Ondersteuning van kankerbestrijding, onder meer via kankerregisters.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De TNM-classificatie is een uniforme standaard. Het doel is breder dan alleen de toepassing binnen het primaire zorgproces en zorgt voor essentiële informatie voor beleidsmakers die kankerbestrijdings- en preventieplannen ontwikkelen of uitvoeren.&lt;br /&gt;
&lt;br /&gt;
==Patient Population==&lt;br /&gt;
Volwassen patiënten met een solide tumor waarop een TNM-classificatie kan worden toegepast.&lt;br /&gt;
&lt;br /&gt;
==Information Model==&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:TNMTumorClassificatie-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 38 422 177 472 [[#R_ResidueleTumorCodelijst]]&lt;br /&gt;
rect 35 328 181 378 [[#PrognostischStadiumCodelijst]]&lt;br /&gt;
rect 37 234 179 284 [[#AnatomischStadiumCodelijst]]&lt;br /&gt;
rect 839 413 976 463 [[#V_VeneuzeInvasieCodelijst]]&lt;br /&gt;
rect 839 323 992 373 [[#Pn_PerineuraleInvasieCodelijst]]&lt;br /&gt;
rect 841 231 989 281 [[#L_LymfatischeInvasieCodelijst]]&lt;br /&gt;
rect 378 43 487 93 [[#TNMVersieCodelijst]]&lt;br /&gt;
rect 230 318 332 388 [[#14147]]&lt;br /&gt;
rect 621 511 749 581 [[#14193]]&lt;br /&gt;
rect 447 511 575 581 [[#14178]]&lt;br /&gt;
rect 276 511 404 581 [[#14170]]&lt;br /&gt;
rect 230 412 332 482 [[#14152]]&lt;br /&gt;
rect 712 403 802 473 [[#14151]]&lt;br /&gt;
rect 707 312 806 382 [[#14150]]&lt;br /&gt;
rect 711 221 801 291 [[#14138]]&lt;br /&gt;
rect 711 130 801 200 [[#14146]]&lt;br /&gt;
rect 230 224 332 294 [[#14135]]&lt;br /&gt;
rect 534 130 655 200 [[#14137]]&lt;br /&gt;
rect 388 130 478 200 [[#14149]]&lt;br /&gt;
rect 230 130 332 200 [[#14143]]&lt;br /&gt;
rect 446 275 576 345 [[#14140]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:PrimaireTumor-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 670 351 836 387 [[#aT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 303 836 339 [[#rpT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 255 836 291 [[#rcT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 206 836 242 [[#ypT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 151 836 187 [[#pT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 103 836 139 [[#ycT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 670 50 836 86 [[#cT_PrimaireTumorCodelijst]]&lt;br /&gt;
rect 143 268 316 318 [[#m_AantalPrimaireTumorenCodelijst]]&lt;br /&gt;
rect 327 740 442 810 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 463 662 667 712 [[#G_DifferentiatiegraadTumorCodelijst]]&lt;br /&gt;
rect 612 454 719 504 [[#MorfologieCodelijst]]&lt;br /&gt;
rect 340 617 430 687 [[#14156]]&lt;br /&gt;
rect 194 477 284 547 [[#14173]]&lt;br /&gt;
rect 496 444 586 514 [[#14172]]&lt;br /&gt;
rect 501 547 629 617 [[#14167]]&lt;br /&gt;
rect 492 179 582 249 [[#14175]]&lt;br /&gt;
rect 172 179 286 249 [[#14164]]&lt;br /&gt;
rect 340 477 430 547 [[#14162]]&lt;br /&gt;
rect 342 179 432 249 [[#14170]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:RegionaleLymfeklieren-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 551 464 722 514 [[#aN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 401 722 451 [[#rpN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 338 722 388 [[#rcN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 275 722 325 [[#ypN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 212 722 262 [[#pN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 149 722 199 [[#ycN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 551 86 722 136 [[#cN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
rect 217 367 318 437 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 180 249 355 319 [[#14179]]&lt;br /&gt;
rect 377 76 490 146 [[#14183]]&lt;br /&gt;
rect 216 76 317 146 [[#14178]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:AfstandsMetastasen-v1.0Model(2020NL).png | center &lt;br /&gt;
rect 515 207 686 257 [[#aM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
rect 194 318 307 388 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 178 187 323 257 [[#14189]]&lt;br /&gt;
rect 353 57 458 127 [[#14192]]&lt;br /&gt;
rect 200 57 300 127 [[#14193]]&lt;br /&gt;
rect 518 67 686 117 [[#cpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
rect 514 138 690 188 [[#rcrpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
{| border= &amp;quot;1&amp;quot;  width=&amp;quot;1500px&amp;quot; style = &amp;quot;font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;&amp;quot; cellpadding = &amp;quot;3px&amp;quot; cellspacing =&amp;quot;0px&amp;quot; &lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; &amp;quot;&lt;br /&gt;
|style=&amp;quot;width:30px;&amp;quot;|Type&amp;lt;!--imType--&amp;gt;||style=&amp;quot;width:100px;&amp;quot;|Id&amp;lt;!--imId--&amp;gt;||colspan=&amp;quot;6 &amp;quot; style=&amp;quot;width:140px;&amp;quot;|Concept&amp;lt;!--imConcept--&amp;gt;||Card.&amp;lt;!--imCard--&amp;gt;||style=&amp;quot;width: 600px;&amp;quot;|Definitie&amp;lt;!--imDefinition--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|DefinitieCode&amp;lt;!--imDefinitionCode--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|Verwijzing&amp;lt;!--imReference--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: block.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.1&lt;br /&gt;
|colspan =&amp;quot;6&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14140 Title=&amp;quot;EN: TNMTumorClassification&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]TNMTumorClassificatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|&lt;br /&gt;
|Rootconcept van de bouwsteen TNMTumorClassificatie. Dit rootconcept bevat alle gegevenselementen van de bouwsteen TNMTumorClassificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385379008 385379008] TNM tumor staging finding&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.25&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14193 Title=&amp;quot;EN: DistantMetastasis&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]AfstandsMetastasen&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept AfstandsMetastasen. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasen.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385380006 385380006] Metastasis category finding&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.26&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14192 Title=&amp;quot;EN: M_DistantMetastasis &amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]M_AfstandsMetastasen&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de aan- of afwezigheid van metastasen op afstand, de M-categorie van de TNM classificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277208005 277208005] M category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aM_AfstandsMetastasenCodelijst]]||[[#aM_AfstandsMetastasenCodelijst|aM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cpM_AfstandsMetastasenCodelijst]]||[[#cpM_AfstandsMetastasenCodelijst|cpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcrpM_AfstandsMetastasenCodelijst]]||[[#rcrpM_AfstandsMetastasenCodelijst|rcrpM_AfstandsMetastasenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.27&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14189 Title=&amp;quot;EN: DistantMetastasisLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]AfstandsMetastasenLocalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept AfstandsMetastasenLocalisatie. Deze container bevat alle gegevenselementen van het concept AfstandsMetastasenLocalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.28&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14195 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Metastasen::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie(s) van de afstandsmetastasen, die aangedaan zijn door de primaire tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=385421009 385421009] Site of distant metastasis&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.21&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14178 Title=&amp;quot;EN: RegionalLymphnodes&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]RegionaleLymfeklieren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept RegionaleLymfeklieren. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklieren.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (finding)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=301855007 301855007] Finding of lymph node&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.22&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14183 Title=&amp;quot;EN: N_RegionalLymphnodes&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]N_RegionaleLymfeklieren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de aan- of afwezigheid en omvang regionale lymfekliermetastase, de N-categorie van de TNM classificatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=277206009 277206009] N category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aN_RegionaleLymfeklierenCodelijst]]||[[#aN_RegionaleLymfeklierenCodelijst|aN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cN_RegionaleLymfeklierenCodelijst]]||[[#cN_RegionaleLymfeklierenCodelijst|cN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#pN_RegionaleLymfeklierenCodelijst]]||[[#pN_RegionaleLymfeklierenCodelijst|pN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcN_RegionaleLymfeklierenCodelijst]]||[[#rcN_RegionaleLymfeklierenCodelijst|rcN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rpN_RegionaleLymfeklierenCodelijst]]||[[#rpN_RegionaleLymfeklierenCodelijst|rpN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ycN_RegionaleLymfeklierenCodelijst]]||[[#ycN_RegionaleLymfeklierenCodelijst|ycN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ypN_RegionaleLymfeklierenCodelijst]]||[[#ypN_RegionaleLymfeklierenCodelijst|ypN_RegionaleLymfeklierenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.23&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14179 Title=&amp;quot;EN: RegionalLymphNodesLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]RegionaleLymfeklierenLocalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept RegionaleLymfeklierenLocalisatie. Deze container bevat alle gegevenselementen van het concept RegionaleLymfeklierenLocalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=364108009 364108009] Lymph node observable&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.24&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14186 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Lymfeklieren::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie(s) van de aangedane regionale lymfeklieren door de primaire tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=397440000 397440000] Site of involved lymph node&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.12&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14170 Title=&amp;quot;EN: PrimaryTumor&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]PrimaireTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Container van het concept PrimaireTumor. Deze container bevat alle gegevenselementen van het concept PrimaireTumor.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Neoplasm, malignant (primary) (morphologic abnormality)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=86049000 86049000] Primaire maligniteit&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.13&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14164 Title=&amp;quot;EN: m_NumberOfPrimaryTumors &amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]m_AantalPrimaireTumoren&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het aantal primaire tumoren. Indien er meerdere primaire tumoren in één orgaan aanwezig zijn wordt de afwijking met de hoogste T-categorie geclassificeerd en de multipliciteit of het aantal primaire tumoren uitgedrukt in een aanvulling op de T-categorie in de vorm van (m) of een (&amp;lt;getal&amp;gt;), bijv. T2(m) of T2(2). Bij één primaire tumor wordt deze weggelaten uit de ‘GeintegreerdeTNMWaardeoverallTNMClassificatie’.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT&amp;amp;#xA;Onbekende code&amp;quot; style = &amp;quot;color:red&amp;quot;&amp;gt;133641000146103 number of primary tumors&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#m_AantalPrimaireTumorenCodelijst]]||[[#m_AantalPrimaireTumorenCodelijst|m_AantalPrimaireTumorenCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.14&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14175 Title=&amp;quot;EN: T_PrimaryTumor&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]T_PrimaireTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de omvang van de primaire tumor, de T-categorie inclusief prefix en suffix.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=78873005 78873005] T category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#aT_PrimaireTumorCodelijst]]||[[#aT_PrimaireTumorCodelijst|aT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#cT_PrimaireTumorCodelijst]]||[[#cT_PrimaireTumorCodelijst|cT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#pT_PrimaireTumorCodelijst]]||[[#pT_PrimaireTumorCodelijst|pT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rcT_PrimaireTumorCodelijst]]||[[#rcT_PrimaireTumorCodelijst|rcT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#rpT_PrimaireTumorCodelijst]]||[[#rpT_PrimaireTumorCodelijst|rpT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ycT_PrimaireTumorCodelijst]]||[[#ycT_PrimaireTumorCodelijst|ycT_PrimaireTumorCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#ypT_PrimaireTumorCodelijst]]||[[#ypT_PrimaireTumorCodelijst|ypT_PrimaireTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.15&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;4&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14162 Title=&amp;quot;EN: Abnormality&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]Afwijking&amp;lt;/span&amp;gt;&lt;br /&gt;
|1..*&lt;br /&gt;
|Container van het concept Afwijking. Deze container bevat alle gegevenselementen van het concept Afwijking.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Neoplasm (morphologic abnormality)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=108369006 108369006] Neoplasma&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: INT.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.16&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14173 Title=&amp;quot;EN: AbnormalityNumber&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]AfwijkingNummer&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het aan de afwijking toegewezen nummer, noodzakelijk om bij verschillende onderzoeken eenduidig aan te kunnen geven op welke afwijking de informatie betrekking heeft .&lt;br /&gt;
Bij meerdere afwijkingen in één orgaan wordt de afwijking met de hoogste T-categorie geclassificeerd.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.17&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14172 Title=&amp;quot;EN: Morphology&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Morfologie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Gedrag van de tumor en het celtype van de tumor uitgedrukt in de ICD-O-3 morfologie code. Beschrijft het celtype of histologie van de tumor als ook het gedrag van die cel (maligne of benigne). &lt;br /&gt;
Deze wordt door een patholoog bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=396984004 396984004] Histologic feature of tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#MorfologieCodelijst]]||[[#MorfologieCodelijst|MorfologieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.18&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14167 Title=&amp;quot;EN: G_HistopathologicalGrading&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]G_DifferentiatiegraadTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Uitkomst van stadiëring van de G-categorie, de differentiatiegraad van de tumor, die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371469007 371469007] Histologic grade&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#G_DifferentiatiegraadTumorCodelijst]]||[[#G_DifferentiatiegraadTumorCodelijst|G_DifferentiatiegraadTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E8D7BE; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: folder.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.19&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;3&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14156 Title=&amp;quot;EN: TumorLocalization&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]TumorLokalisatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Container van het concept TumorLokalisatie. Deze container bevat alle gegevenselementen van het concept TumorLokalisatie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:4.27.20&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;&amp;quot; |&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;2&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14159 Title=&amp;quot;EN: AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Tumor::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het betreft de lokalisatie van de primaire tumor(en), welke (o.a.) bepalend is voor het toekennen van de TNM-classificatie aan de tumor. &lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399687005 399687005] Primary tumor site&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.2&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14143 Title=&amp;quot;EN: DateOfTNMClassification&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]DatumTNMClassificatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De datum waarop de TNM-Classificatie (de waarde) is vastgesteld.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399651003 399651003] Date of report&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.3&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14149 Title=&amp;quot;EN: TNMVersion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]TNMVersie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| TNM-classificatie versie (AJCC of UICC) en de gebruikte editie (7e, 8e etc.).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (assessment scale)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=273249006 273249006] Assessment scales&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#TNMVersieCodelijst]]||[[#TNMVersieCodelijst|TNMVersieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.4&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14137 Title=&amp;quot;EN: IntegratedTNMValue&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]GeintegreerdeTNMWaarde&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De vastgestelde TNM-classificatie (de waarde), op basis van elke T-, N- en M-categorie (evt. incl. het aantal primaire tumoren (m) en/of de lokalisatie van M).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399703000 399703000] Integrated TNM category&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: ST.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.5&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14146 Title=&amp;quot;EN: Explanation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Toelichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Toelichting met betrekking tot de interpretatie van de geïntegreerde TNM waarde zoals deze is geclassificeerd.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=243814003 243814003] Interpretation of findings&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.6&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14138 Title=&amp;quot;EN: TL_LymphaticInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]L_LymfatischeInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van lymfatische invasie, de L-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=395715009 395715009] Status of lymphatic (small vessel) invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#L_LymfatischeInvasieCodelijst]]||[[#L_LymfatischeInvasieCodelijst|L_LymfatischeInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.7&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14150 Title=&amp;quot;EN: Pn_PerineuralInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Pn_PerineuraleInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van perineurale invasie, de Pn-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371513001 371513001] Status of perineural invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#Pn_PerineuraleInvasieCodelijst]]||[[#Pn_PerineuraleInvasieCodelijst|Pn_PerineuraleInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.8&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14151 Title=&amp;quot;EN: V_VenousInvasion&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]V_VeneuzeInvasie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
| De aan- of afwezigheid van veneuze invasie, de V-categorie. Het betreft een additionele beschrijving binnen de TNM-classificatie die door een patholoog wordt bepaald.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=371493002 371493002] Status of venous (large vessel) invasion by tumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#V_VeneuzeInvasieCodelijst]]||[[#V_VeneuzeInvasieCodelijst|V_VeneuzeInvasieCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.9&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14135 Title=&amp;quot;EN: AnatomicalStage&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]AnatomischStadium&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het stadium van de ziekte is de groepering op basis van de anatomische uitbreiding en verspreiding van de ziekte (de T, N en M categorieën).&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399390009 399390009] TNM stage grouping&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#AnatomischStadiumCodelijst]]||[[#AnatomischStadiumCodelijst|AnatomischStadiumCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.10&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14147 Title=&amp;quot;EN: PrognosticStage&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]PrognostischStadium&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Het prognostisch stadium van de ziekte. Hierin wordt in de groepering naast de anatomische uitbreiding en verspreiding van de ziekte ook additionele prognostische factoren meegenomen.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=399390009 399390009] TNM stage grouping&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#PrognostischStadiumCodelijst]]||[[#PrognostischStadiumCodelijst|PrognostischStadiumCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:4.27.11&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14152 Title=&amp;quot;EN: R_ResidualTumor&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]R_ResidueleTumor&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De aan- of afwezigheid van residuele tumor na behandeling, de R-categorie.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT (observable entity)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=17964000 17964000] Residual tumor stage&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#R_ResidueleTumorCodelijst]]||[[#R_ResidueleTumorCodelijst|R_ResidueleTumorCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
Kolommen Concept en DefinitieCode: houdt de muis boven de waarde voor meer informatie&amp;lt;!--imHover--&amp;gt;&amp;lt;BR&amp;gt;&lt;br /&gt;
Voor uitleg over de gebruikte symbolen, zie de legenda pagina&amp;lt;!--imLegend--&amp;gt; [[Bestand:list2.png|link=Legenda&amp;lt;!--wikiLegend--&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
==Example Instances==&lt;br /&gt;
{|class=&amp;quot;wikitable&amp;quot; width=&amp;quot;689px&amp;quot; style= &amp;quot;font-size: 9.5pt;&amp;quot;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;TNMTumorClassificatie&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;datumTNMClassificatie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;TNMVersie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Geintegreerde TNMWaarde&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|01/08/2020&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|AJCC 8e editie&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|cT3N2M1&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AnatomischStadium&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;PrognostischStadium&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;R_ResidueleTumor&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Stage IV&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|Stage IV&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Opmerking&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|HER2 negatief, ER negatief, PR negatief&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;L_LymfatischeInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Pn_PerineuraleInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;V_VeneuzeInvasie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|&amp;lt;noWiki&amp;gt;-&amp;lt;/noWiki&amp;gt;-&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Primaire Tumor&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;m_PrimaireTumorAantal&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;T_tumor&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;G_DifferentiatiegraadTumor&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|1&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|cT3&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|G2&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;Afwijking&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #D9E2F3; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AfwijkingNummer&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #D9E2F3; width: 69%; &amp;quot;|&amp;lt;b&amp;gt;Morfologie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|1&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|Infiltrerend ductaal carcinoom, (8500/3)&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;TumorLokalisatie -  AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie SNOMED CT&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|(C50.5) Laterale onderkwadrant van borst&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van laterale onderkwadrant van mamma (33564002)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #D9E2F3; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;AfwijkingNummer&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #D9E2F3; width: 69%; &amp;quot;|&amp;lt;b&amp;gt;Morfologie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|2&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|Fibroadenoom (9010/0)&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #4472C4; width: 100%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Regionale Lymfeklieren&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;N_RegionaleLymfeklieren&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|cN2&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;RegionaleLymfeklieren Localisatie - AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie &amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C77.3 Infraclaviculaire lymfeklier&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van infraclaviculaire lymfeklier (9659009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;RegionaleLymfeklieren Localisatie - AnatomischeLocatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Locatie ICD-O-3&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie &amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C77.3 Axillaire lymfeklier&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|structuur van nodus lymphoideus axillaris (68171009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 31%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;AfstandsMetastasen&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 38%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #4472C4; width: 31%; &amp;quot;|&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #B4C6E7; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;M_Afstandsmetastasen&amp;lt;/b&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;width: 69%; &amp;quot;|cM1&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #B4C6E7; width: 100%; &amp;quot;|&amp;lt;b&amp;gt;AfstandsMetastasen Lokalisatie&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt; Locatie (ICD-O-3)&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 38%; &amp;quot;|&amp;lt;b&amp;gt;Locatie&amp;lt;/b&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #E2EFD9; width: 31%; &amp;quot;|&amp;lt;b&amp;gt;Lateraliteit&amp;lt;/b&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|C34.1 Bovenkwab van long&lt;br /&gt;
| style=&amp;quot;width: 38%; &amp;quot;|Structuur van lobus superior pulmonis (45653009)&lt;br /&gt;
| style=&amp;quot;width: 31%; &amp;quot;|Rechts&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Instructions==&lt;br /&gt;
&amp;lt;b&amp;gt;Van een generieke TNM classificatie naar een ziekte specifieke TNM classificatie&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het uitwerken van een tumor specifieke TNM-bouwsteen of implementatie moet gekeken worden hoe de waardelijsten kunnen worden &amp;lt;u&amp;gt;ingeperkt&amp;lt;/u&amp;gt;, &amp;lt;u&amp;gt;toegepast&amp;lt;/u&amp;gt; of &amp;lt;u&amp;gt;uitgebreid&amp;lt;/u&amp;gt;.&amp;lt;BR&amp;gt;&lt;br /&gt;
Inperken wil zeggen dat items in een codelijst worden weggelaten of specifiek worden gemaakt door binnen het voorgeschreven code systeem andere termen te kiezen. Het is de bedoeling dat in de toekomst kant en klare codelijsten per kankeraandoening beschikbaar worden gemaakt (zie ook issues).&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Codesystemen&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
In deze zib worden 2 internationale codesystemen gebruikt:&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;SNOMED CT (beheerder international SNOMED international, Nederlands beheer door Nictiz)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;International Classification of Diseases for Oncology, version 3 (ICD-O-3) beheerd door de WHO.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
Waar toepassing van één van deze codesystemen niet zinvol werd geacht of mogelijk was is gekozen voor beheer ervan als onderdeel van het beheer van de zibs. Wanneer er een eenduidige internationale verwijzing mogelijk is naar de TNM standaard zelf als codesysteem met waardelijsten kunnen deze worden aangepast in een volgende versie van de zib. &amp;lt;b&amp;gt;Uitgangspunten vanuit de TNM standaard&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Eén TNM-classificatie per orgaan, maar in geval van gepaarde organen is er één classificatie per zijde. Bijvoorbeeld bij borstkanker met in iedere borst een primaire tumor zijn er dan dus ook twee instantiaties van de zib, waarbij de ene lateraliteit links en de andere lateraliteit rechts heeft (beiderzijds is niet toegestaan bij gepaarde organen).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Niet alleen de uitkomst van de TNM, maar ook de exacte lokalisatie van de primaire tumor(en), positieve lymfeklieren en metastasen kan worden aangeduid.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;In het geval van meerdere primaire tumoren in één orgaan, moet de tumor met de hoogste T-categorie worden geclassificeerd en moet de veelvoud of het aantal tumoren tussen haakjes worden vermeld, bijvoorbeeld T2 (m) of T2 (5).De afwijking met de hoogste T-categorie bepaalt de classificatie van de tumor. Om het onderscheid hierin te maken en alle afwijkingen te kunnen weergeven bestaat de container ‘afwijking’ in de zib. Elke afwijking heeft een nummer. Welke afwijking (b.v. 1, 2 of 4) de hoogste t-categorie heeft wordt niet in de zib aangegeven. Dit is logische want dit is pas duidelijk na de inschatting van de zorgverlener o.b.v. de pathologie dan wel beeldvorming.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Gebruikte versie van de [http://www.uicc.org/resources/tnm UICC]/[//http://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx AJCC] TNM Classification of Malignant Tumours.&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Hoewel er geen verschillen in definities en verwoordingen tussen AJCC en UICC TNM classificaties zouden mogen voorkomen zijn er helaas wel enkele verschillen ingeslopen (bijvoorbeeld bij de definitie van regionale lymfeklieren bij slokdarm- en endometriumcarcinomen). Daarom kan in deze zib gekozen worden tussen de UICC en AJCC versie. Criteria die in het TNM-classificatiesysteem worden gebruikt, zijn in de loop van de jaren veranderd en er zijn verschillende edities uitgebracht. Als gevolg hiervan kan een bepaalde stagering een heel andere prognose hebben, afhankelijk van welke editie wordt gebruikt. Verder is een belangrijke overweging het effect van een verbeterde behandeling in de tijd&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;Naast de stagering via UICC of AJCC classificaties is er ook ‘Essential TNM’. Dit is een versimpelde vorm van TNM die is gemaakt voor het weergeven van het voorkomen van kanker in lage lonen landen. In deze landen zijn vaak de middelen voor vroege diagnose niet aanwezig en het gebruik van TNM beperkt (kanker wordt in de regel in deze landen pas in een zeer laat stadium ontdekt). Deze speciale TNM is niet meegenomen in de uitwerking van deze zib. Overigens wordt deze speciale TNM meestal alleen gebruikt voor het kunnen betrekken van deze landen in de statistiek over het voorkomen van bepaalde kankers in deze landen.&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&amp;lt;b&amp;gt;Prefix en suffix zijn geïntegreerd in codelijsten.&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Alhoewel het mogelijk zou zijn om voor de mogelijke voor en achtervoegsels op zowel de T, N en M losse codelijsten te maken is voor het eenvoudig toepassen ervan gekozen om deze te integreren in de codelijsten. Dit is besloten omdat de huidige inzichten zijn dat hiermee het maken van verkeerde combinaties wordt voorkomen&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Prefix &amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;c: &amp;lt;/b&amp;gt;Klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;yc:&amp;lt;/b&amp;gt; Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;p:&amp;lt;/b&amp;gt; De post-chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;yp:&amp;lt;/b&amp;gt; Classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;rc:&amp;lt;/b&amp;gt; Klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;rp:&amp;lt;/b&amp;gt; Post-operatieve pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;&amp;lt;b&amp;gt;a:&amp;lt;/b&amp;gt; Classificatie vastgesteld tijdens autopsie&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Suffix&amp;lt;/b&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mi): Gevallen met alleen micrometastase&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(sn): Gevallen waarbij schildwachtklier onderzoek heeft plaatsgevonden.&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(f): Gevallen waarbij FNA of biopsie heeft plaatsgevonden op de regionale lymfeklieren&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(i-): negatieve morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(i+): positieve morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mol-): negatieve niet-morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(mol+): positieve niet- morfologische bevindingen voor geïsoleerde tumorcellen&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(0): zonder verhoogd lactaatdehydrogenase (LDH)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;(1): met verhoogd lactaatdehydrogenase (LDH)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Issues==&lt;br /&gt;
Bruikbaarheid van deze zib als ook de ziekte specifieke codelijsten worden gemaakt in de eerste proeftuin(en), gepland in de zomer van 2020. Gedurende dit project zal IKNL het beheer voor deze codelijsten verzorgen. Wanneer deze proeftuin(en) zijn afgerond worden de bevindingen meegenomen als wijzigingsverzoeken in het reguliere beheerproces van het zib centrum.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;ol&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;TNM Classification of Malignant Tumours, 8th Edition -  James D. Brierley (Editor), Mary K. Gospodarowicz (Editor), Christian Wittekind (Editor)- International Union Against Cancer (UICC)- ISBN:  9781119263562 (epub)&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;https://www.uicc.org/resources/tnm [ONLINE geraadpleegd: 04 mei 2020]&amp;lt;/li&amp;gt;&lt;br /&gt;
	&amp;lt;li&amp;gt;International Classification of diseases for oncology (ICD-O) – 3&amp;lt;sup&amp;gt;rd&amp;lt;/sup&amp;gt; edition, 1&amp;lt;sup&amp;gt;st&amp;lt;/sup&amp;gt; revision – April Frits, Constance Percy, Andrew Jack, Kanagaratnam Shanmugaratnam, Leslie Sobin, D Max Parkin, Sharon Whelan – World Health Organisation – WHO library cataloguing – ISBN 978 92 4 069212 1 (PDF)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Valuesets ==&lt;br /&gt;
=== aM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.25&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0&lt;br /&gt;
|aM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1&lt;br /&gt;
|aM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a&lt;br /&gt;
|aM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b&lt;br /&gt;
|aM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c&lt;br /&gt;
|aM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d&lt;br /&gt;
|aM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|aM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand voor een classificatie vastgesteld tijdens autopsie. &lt;br /&gt;
=== aN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.24&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX&lt;br /&gt;
|aNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0&lt;br /&gt;
|aN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1&lt;br /&gt;
|aN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi&lt;br /&gt;
|aN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a&lt;br /&gt;
|aN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b&lt;br /&gt;
|aN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c&lt;br /&gt;
|aN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2&lt;br /&gt;
|aN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a&lt;br /&gt;
|aN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b&lt;br /&gt;
|aN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c&lt;br /&gt;
|aN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3&lt;br /&gt;
|aN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a&lt;br /&gt;
|aN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b&lt;br /&gt;
|aN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c&lt;br /&gt;
|aN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|aN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De regionale lymfeklieren (N) voor een classificatie vastgesteld tijdens autopsie&lt;br /&gt;
=== AnatomischStadiumCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.1&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|Stage0&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium I&lt;br /&gt;
|StageI&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium I&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|StageIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|StageIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|StageIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|StageIA3&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|StageIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|StageIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|StageIB1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|StageIB2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|StageIs&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium II&lt;br /&gt;
|StageII&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium II&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|StageIIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|StageIIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|StageIIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|StageIIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|StageIIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium III&lt;br /&gt;
|StageIII&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium III&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|StageIIIA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|StageIIIA1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|StageIIIA2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|StageIIIB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|StageIIIC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|StageIIIC1&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|StageIIIC2&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|StageIIID&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|StageIV&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|StageIVA&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|StageIVB&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|StageIVC&lt;br /&gt;
|AnatomischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|}&lt;br /&gt;
=== aT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.15&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTx&lt;br /&gt;
|aTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT0&lt;br /&gt;
|aT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTa&lt;br /&gt;
|aTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis&lt;br /&gt;
|aTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aTis pu&lt;br /&gt;
|aTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1&lt;br /&gt;
|aT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1mi&lt;br /&gt;
|aT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a&lt;br /&gt;
|aT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a1&lt;br /&gt;
|aT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1a2&lt;br /&gt;
|aT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b&lt;br /&gt;
|aT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b1&lt;br /&gt;
|aT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1b2&lt;br /&gt;
|aT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c&lt;br /&gt;
|aT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c1&lt;br /&gt;
|aT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c2&lt;br /&gt;
|aT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1c3&lt;br /&gt;
|aT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT1d&lt;br /&gt;
|aT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2&lt;br /&gt;
|aT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a&lt;br /&gt;
|aT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a1&lt;br /&gt;
|aT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2a2&lt;br /&gt;
|aT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2b&lt;br /&gt;
|aT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2c&lt;br /&gt;
|aT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT2d&lt;br /&gt;
|aT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3&lt;br /&gt;
|aT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3a&lt;br /&gt;
|aT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3b&lt;br /&gt;
|aT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3c&lt;br /&gt;
|aT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3d&lt;br /&gt;
|aT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT3e&lt;br /&gt;
|aT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4&lt;br /&gt;
|aT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4a&lt;br /&gt;
|aT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4b&lt;br /&gt;
|aT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4c&lt;br /&gt;
|aT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4d&lt;br /&gt;
|aT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|aT4e&lt;br /&gt;
|aT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|aT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een classificatie vastgesteld tijdens autopsie.&lt;br /&gt;
=== cN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.18&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX&lt;br /&gt;
|cNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0&lt;br /&gt;
|cN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1&lt;br /&gt;
|cN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi&lt;br /&gt;
|cN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a&lt;br /&gt;
|cN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b&lt;br /&gt;
|cN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c&lt;br /&gt;
|cN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2&lt;br /&gt;
|cN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a&lt;br /&gt;
|cN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b&lt;br /&gt;
|cN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c&lt;br /&gt;
|cN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3&lt;br /&gt;
|cN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a&lt;br /&gt;
|cN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b&lt;br /&gt;
|cN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c&lt;br /&gt;
|cN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|cN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De regionale lymfeklieren (N) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken.&lt;br /&gt;
=== cpM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.28&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0&lt;br /&gt;
|cM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1&lt;br /&gt;
|cM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a&lt;br /&gt;
|cM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b&lt;br /&gt;
|cM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c&lt;br /&gt;
|cM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d&lt;br /&gt;
|cM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|cM1d(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1&lt;br /&gt;
|pM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a&lt;br /&gt;
|pM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b&lt;br /&gt;
|pM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c&lt;br /&gt;
|pM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d&lt;br /&gt;
|pM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|pM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie. &lt;br /&gt;
=== cT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.9&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTx&lt;br /&gt;
|cTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT0&lt;br /&gt;
|cT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTa&lt;br /&gt;
|cTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis&lt;br /&gt;
|cTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cTis pu&lt;br /&gt;
|cTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1&lt;br /&gt;
|cT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1mi&lt;br /&gt;
|cT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a&lt;br /&gt;
|cT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a1&lt;br /&gt;
|cT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1a2&lt;br /&gt;
|cT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b&lt;br /&gt;
|cT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b1&lt;br /&gt;
|cT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1b2&lt;br /&gt;
|cT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c&lt;br /&gt;
|cT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c1&lt;br /&gt;
|cT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c2&lt;br /&gt;
|cT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1c3&lt;br /&gt;
|cT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT1d&lt;br /&gt;
|cT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2&lt;br /&gt;
|cT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a&lt;br /&gt;
|cT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a1&lt;br /&gt;
|cT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2a2&lt;br /&gt;
|cT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2b&lt;br /&gt;
|cT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2c&lt;br /&gt;
|cT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT2d&lt;br /&gt;
|cT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3&lt;br /&gt;
|cT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3a&lt;br /&gt;
|cT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3b&lt;br /&gt;
|cT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3c&lt;br /&gt;
|cT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3d&lt;br /&gt;
|cT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT3e&lt;br /&gt;
|cT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4&lt;br /&gt;
|cT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4a&lt;br /&gt;
|cT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4b&lt;br /&gt;
|cT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4c&lt;br /&gt;
|cT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4d&lt;br /&gt;
|cT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|cT4e&lt;br /&gt;
|cT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|cT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie, gebaseerd op gegevens vóór behandeling, zoals klinisch onderzoek, beeldvorming, endoscopie, biopten, chirurgische exploratie of onderzoek onder narcose, en andere onderzoeken&lt;br /&gt;
=== G_DifferentiatiegraadTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.17&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|GX&lt;br /&gt;
|GX&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Differentiatiegraad kan niet beoordeeld worden.Grade cannot be assessed.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G1&lt;br /&gt;
|G1&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Goed gedifferentieerd.Well differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G2&lt;br /&gt;
|G2&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Matig gedifferentieerd.Moderately differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G3&lt;br /&gt;
|G3&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Slecht gedifferentieerd.Poorly differentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G3-4&lt;br /&gt;
|G3-4&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Slecht gedifferentieerd of ongedifferentieerd.poorly differentiated or undifferentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G4&lt;br /&gt;
|G4&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|Ongedifferentieerd.Undifferentiated.&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|G5&lt;br /&gt;
|G5&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|G5&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|LowMitoticRate&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|G_DifferentiatiegraadTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5&lt;br /&gt;
|HighMitoticRate&lt;br /&gt;
|}&lt;br /&gt;
=== L_LymfatischeInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.2&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|LX&lt;br /&gt;
|LX&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Aanwezigheid van Lymfatische invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|L0&lt;br /&gt;
|L0&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Geen Lymfatische invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|L1&lt;br /&gt;
|L1&lt;br /&gt;
|L_LymfatischeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.9&lt;br /&gt;
|Lymfatische invasie&lt;br /&gt;
|}&lt;br /&gt;
=== m_AantalPrimaireTumorenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.8&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(m)&lt;br /&gt;
|(m)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|Meerdere primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(1)&lt;br /&gt;
|(1)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|1 primaire tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(2)&lt;br /&gt;
|(2)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|2 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(3)&lt;br /&gt;
|(3)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|3 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(4)&lt;br /&gt;
|(4)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|4 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(5)&lt;br /&gt;
|(5)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|5 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(6)&lt;br /&gt;
|(6)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|6 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(7)&lt;br /&gt;
|(7)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|7 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(8)&lt;br /&gt;
|(8)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|8 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(9)&lt;br /&gt;
|(9)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|9 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|(10)&lt;br /&gt;
|(10)&lt;br /&gt;
|m_AantalPrimaireTumoren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.12&lt;br /&gt;
|10 primaire tumoren&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Other&lt;br /&gt;
|OTH&lt;br /&gt;
|nullflavor&lt;br /&gt;
|2.16.840.1.113883.5.1008&lt;br /&gt;
|Anders, specificeer.&lt;br /&gt;
|}&lt;br /&gt;
=== MorfologieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.16&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|International Classification of Diseases for Oncology, version 3 (Morphology codes)&lt;br /&gt;
|ICD-O-3&lt;br /&gt;
|2.16.840.1.113883.6.43.1&lt;br /&gt;
|}&lt;br /&gt;
=== Pn_PerineuraleInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.3&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|PnX&lt;br /&gt;
|PnX&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.&lt;br /&gt;
|Aanwezigheid van Perineurale invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Pn0&lt;br /&gt;
|Pn0&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3&lt;br /&gt;
|Geen Perineurale invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Pn1&lt;br /&gt;
|Pn1&lt;br /&gt;
|Pn_PerineuraleInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3&lt;br /&gt;
|Perineurale invasie&lt;br /&gt;
|}&lt;br /&gt;
=== pN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.20&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX&lt;br /&gt;
|pNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0&lt;br /&gt;
|pN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1&lt;br /&gt;
|pN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi&lt;br /&gt;
|pN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a&lt;br /&gt;
|pN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b&lt;br /&gt;
|pN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c&lt;br /&gt;
|pN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2&lt;br /&gt;
|pN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a&lt;br /&gt;
|pN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b&lt;br /&gt;
|pN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c&lt;br /&gt;
|pN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3&lt;br /&gt;
|pN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a&lt;br /&gt;
|pN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b&lt;br /&gt;
|pN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c&lt;br /&gt;
|pN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|pN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&lt;br /&gt;
=== PrognostischStadiumCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.4&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|Stage0&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium 0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium I&lt;br /&gt;
|StageI&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium I&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|StageIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|StageIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|StageIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|StageIA3&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IA3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|StageIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|StageIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|StageIB1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|StageIB2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IB2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|StageIS&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IS&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium II&lt;br /&gt;
|StageII&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium II&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|StageIIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|StageIIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|StageIIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|StageIIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|StageIIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium III&lt;br /&gt;
|StageIII&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium III&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|StageIIIA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|StageIIIA1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|StageIIIA2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIA2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|StageIIIB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|StageIIIC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|StageIIIC1&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|StageIIIC2&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIIC2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|StageIIID&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IIID&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|StageIV&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IV&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|StageIVA&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVA&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|StageIVB&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVB&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|StageIVC&lt;br /&gt;
|PrognostischStadium&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.7&lt;br /&gt;
|Stadium IVC&lt;br /&gt;
|}&lt;br /&gt;
=== pT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.11&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTx&lt;br /&gt;
|pTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT0&lt;br /&gt;
|pT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTa&lt;br /&gt;
|pTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis&lt;br /&gt;
|pTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pTis pu&lt;br /&gt;
|pTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1&lt;br /&gt;
|pT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1mi&lt;br /&gt;
|pT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a&lt;br /&gt;
|pT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a1&lt;br /&gt;
|pT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1a2&lt;br /&gt;
|pT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b&lt;br /&gt;
|pT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b1&lt;br /&gt;
|pT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1b2&lt;br /&gt;
|pT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c&lt;br /&gt;
|pT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c1&lt;br /&gt;
|pT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c2&lt;br /&gt;
|pT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1c3&lt;br /&gt;
|pT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT1d&lt;br /&gt;
|pT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2&lt;br /&gt;
|pT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a&lt;br /&gt;
|pT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a1&lt;br /&gt;
|pT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2a2&lt;br /&gt;
|pT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2b&lt;br /&gt;
|pT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2c&lt;br /&gt;
|pT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT2d&lt;br /&gt;
|pT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3&lt;br /&gt;
|pT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3a&lt;br /&gt;
|pT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3b&lt;br /&gt;
|pT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3c&lt;br /&gt;
|pT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT3d&lt;br /&gt;
|pT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4&lt;br /&gt;
|pT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4a&lt;br /&gt;
|pT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4b&lt;br /&gt;
|pT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4c&lt;br /&gt;
|pT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4d&lt;br /&gt;
|pT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|pT4e&lt;br /&gt;
|pT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|pT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een post chirurgische histologische pathologische classificatie. Dit is gebaseerd op de gegevens van voor de behandeling, aangevuld met pathologisch onderzoek na een heelkundige behandeling.&lt;br /&gt;
=== R_ResidueleTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.5&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|RX&lt;br /&gt;
|RX&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Aanwezigheid van residuele tumor kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R0&lt;br /&gt;
|R0&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Geen residuele tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R1&lt;br /&gt;
|R1&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Microscopische residuele tumor&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|R2&lt;br /&gt;
|R2&lt;br /&gt;
|R_ResidueleTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4&lt;br /&gt;
|Macroscopische residuele tumor&lt;br /&gt;
|}&lt;br /&gt;
=== rcN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.22&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX&lt;br /&gt;
|rcNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0&lt;br /&gt;
|rcN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1&lt;br /&gt;
|rcN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a&lt;br /&gt;
|rcN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b&lt;br /&gt;
|rcN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c&lt;br /&gt;
|rcN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2&lt;br /&gt;
|rcN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a&lt;br /&gt;
|rcN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b&lt;br /&gt;
|rcN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c&lt;br /&gt;
|rcN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3&lt;br /&gt;
|rcN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a&lt;br /&gt;
|rcN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b&lt;br /&gt;
|rcN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c&lt;br /&gt;
|rcN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rcN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rcrpM_AfstandsMetastasenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.27&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0&lt;br /&gt;
|rcM0&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1&lt;br /&gt;
|rcM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a&lt;br /&gt;
|rcM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b&lt;br /&gt;
|rcM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c&lt;br /&gt;
|rcM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d&lt;br /&gt;
|rcM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rcM1d(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1&lt;br /&gt;
|rpM1&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a&lt;br /&gt;
|rpM1a&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1a(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b&lt;br /&gt;
|rpM1b&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1b(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c&lt;br /&gt;
|rpM1c&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1c(1)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d&lt;br /&gt;
|rpM1d&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d(0)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|M_Afstandsmetastase&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3&lt;br /&gt;
|rpM1d(1)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar metastase op afstand (M) voor een klinische of postchirurgische histologische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rcT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.13&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTx&lt;br /&gt;
|rcTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT0&lt;br /&gt;
|rcT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTa&lt;br /&gt;
|rcTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis&lt;br /&gt;
|rcTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1&lt;br /&gt;
|rcT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a&lt;br /&gt;
|rcT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b&lt;br /&gt;
|rcT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c&lt;br /&gt;
|rcT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT1d&lt;br /&gt;
|rcT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2&lt;br /&gt;
|rcT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a&lt;br /&gt;
|rcT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2b&lt;br /&gt;
|rcT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2c&lt;br /&gt;
|rcT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT2d&lt;br /&gt;
|rcT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3&lt;br /&gt;
|rcT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3a&lt;br /&gt;
|rcT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3b&lt;br /&gt;
|rcT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3c&lt;br /&gt;
|rcT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3d&lt;br /&gt;
|rcT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT3e&lt;br /&gt;
|rcT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4&lt;br /&gt;
|rcT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4a&lt;br /&gt;
|rcT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4b&lt;br /&gt;
|rcT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4c&lt;br /&gt;
|rcT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4d&lt;br /&gt;
|rcT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rcT4e&lt;br /&gt;
|rcT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rcT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rpN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.23&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX&lt;br /&gt;
|rpNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0&lt;br /&gt;
|rpN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1&lt;br /&gt;
|rpN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a&lt;br /&gt;
|rpN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b&lt;br /&gt;
|rpN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c&lt;br /&gt;
|rpN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2&lt;br /&gt;
|rpN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a&lt;br /&gt;
|rpN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b&lt;br /&gt;
|rpN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c&lt;br /&gt;
|rpN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3&lt;br /&gt;
|rpN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a&lt;br /&gt;
|rpN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b&lt;br /&gt;
|rpN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c&lt;br /&gt;
|rpN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|rpN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een postchirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== rpT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.14&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTx&lt;br /&gt;
|rpTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT0&lt;br /&gt;
|rpT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTa&lt;br /&gt;
|rpTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis&lt;br /&gt;
|rpTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1&lt;br /&gt;
|rpT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a&lt;br /&gt;
|rpT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b&lt;br /&gt;
|rpT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c&lt;br /&gt;
|rpT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT1d&lt;br /&gt;
|rpT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2&lt;br /&gt;
|rpT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a&lt;br /&gt;
|rpT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2b&lt;br /&gt;
|rpT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2c&lt;br /&gt;
|rpT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT2d&lt;br /&gt;
|rpT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3&lt;br /&gt;
|rpT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3a&lt;br /&gt;
|rpT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3b&lt;br /&gt;
|rpT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3c&lt;br /&gt;
|rpT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT3d&lt;br /&gt;
|rpT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4&lt;br /&gt;
|rpT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4a&lt;br /&gt;
|rpT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4b&lt;br /&gt;
|rpT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4c&lt;br /&gt;
|rpT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4d&lt;br /&gt;
|rpT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|rpT4e&lt;br /&gt;
|rpT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|rpT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een post chirurgische pathologische classificatie in geval van een recidiverende tumor (na een ziektevrij interval).&lt;br /&gt;
=== TNMVersieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.6&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 1ste editie&lt;br /&gt;
|AJCCTNM1&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 1ste editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 2e editie&lt;br /&gt;
|AJCCTNM2&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 2e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 3e editie&lt;br /&gt;
|AJCCTNM3&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 3e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 4e editie&lt;br /&gt;
|AJCCTNM4&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 4e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 5e editie&lt;br /&gt;
|AJCCTNM5&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 5e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 6e editie&lt;br /&gt;
|AJCCTNM6&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 6e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 7e editie&lt;br /&gt;
|AJCCTNM7&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 7e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 8e editie&lt;br /&gt;
|AJCCTNM8&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 8e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|AJCC 9e editie&lt;br /&gt;
|AJCCTNM9&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|AJCC TNM 9e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC  1ste editie&lt;br /&gt;
|UICCTNM1&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 1ste editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 2e editie&lt;br /&gt;
|UICCTNM2&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 2e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 3e editie&lt;br /&gt;
|UICCTNM3&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 3e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 4e editie&lt;br /&gt;
|UICCTNM4&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 4e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 5e editie&lt;br /&gt;
|UICCTNM5&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 5e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 6e editie&lt;br /&gt;
|UICCTNM6&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 6e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 7e editie&lt;br /&gt;
|UICCTNM7&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 7e editie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|UICC 8e editie&lt;br /&gt;
|UICC TNM8&lt;br /&gt;
|TNMVersie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.8&lt;br /&gt;
|UICC TNM 8e editie&lt;br /&gt;
|}&lt;br /&gt;
=== V_VeneuzeInvasieCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.7&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|VX&lt;br /&gt;
|VX&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Aanwezigheid van veneuze invasie kan niet beoordeeld worden&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V0&lt;br /&gt;
|V0&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Geen veneuze invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V1&lt;br /&gt;
|V1&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Microscopische veneuze invasie&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|V2&lt;br /&gt;
|V2&lt;br /&gt;
|V_VeneuzeInvasie&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4&lt;br /&gt;
|Macroscopische veneuze invasie&lt;br /&gt;
|}&lt;br /&gt;
=== ycN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.19&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX&lt;br /&gt;
|ycNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0&lt;br /&gt;
|ycN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1&lt;br /&gt;
|ycN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a&lt;br /&gt;
|ycN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b&lt;br /&gt;
|ycN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c&lt;br /&gt;
|ycN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2&lt;br /&gt;
|ycN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a&lt;br /&gt;
|ycN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b&lt;br /&gt;
|ycN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c&lt;br /&gt;
|ycN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN2c(sn)&lt;br /&gt;
|ycN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3&lt;br /&gt;
|ycN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3(f)&lt;br /&gt;
|ycN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3(sn)&lt;br /&gt;
|ycN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a&lt;br /&gt;
|ycN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a(f)&lt;br /&gt;
|ycN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3a(sn)&lt;br /&gt;
|ycN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b&lt;br /&gt;
|ycN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b(f)&lt;br /&gt;
|ycN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3b(sn)&lt;br /&gt;
|ycN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c&lt;br /&gt;
|ycN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c(f)&lt;br /&gt;
|ycN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycN3c(sn)&lt;br /&gt;
|ycN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ycN0(mol+)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&lt;br /&gt;
=== ycT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.10&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTx&lt;br /&gt;
|ycTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT0&lt;br /&gt;
|ycT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTa&lt;br /&gt;
|ycTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis&lt;br /&gt;
|ycTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1&lt;br /&gt;
|ycT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a&lt;br /&gt;
|ycT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b&lt;br /&gt;
|ycT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c&lt;br /&gt;
|ycT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT1d&lt;br /&gt;
|ycT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2&lt;br /&gt;
|ycT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a&lt;br /&gt;
|ycT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2b&lt;br /&gt;
|ycT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2c&lt;br /&gt;
|ycT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT2d&lt;br /&gt;
|ycT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3&lt;br /&gt;
|ycT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3a&lt;br /&gt;
|ycT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3b&lt;br /&gt;
|ycT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3c&lt;br /&gt;
|ycT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3d&lt;br /&gt;
|ycT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT3e&lt;br /&gt;
|ycT3e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT3e&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4&lt;br /&gt;
|ycT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4a&lt;br /&gt;
|ycT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4b&lt;br /&gt;
|ycT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4c&lt;br /&gt;
|ycT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4d&lt;br /&gt;
|ycT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ycT4e&lt;br /&gt;
|ycT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ycT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een klinische classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (zijnde niet- chirurgisch).&lt;br /&gt;
=== ypN_RegionaleLymfeklierenCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.21&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX&lt;br /&gt;
|ypNX&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypNX(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0&lt;br /&gt;
|ypN0&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(i+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol-)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol-)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol+)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN0(mol+)(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1&lt;br /&gt;
|ypN1&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1mi(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a&lt;br /&gt;
|ypN1a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b&lt;br /&gt;
|ypN1b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c&lt;br /&gt;
|ypN1c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN1c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2&lt;br /&gt;
|ypN2&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a&lt;br /&gt;
|ypN2a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b&lt;br /&gt;
|ypN2b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c&lt;br /&gt;
|ypN2c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN2c(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3&lt;br /&gt;
|ypN3&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a&lt;br /&gt;
|ypN3a&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3a(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b&lt;br /&gt;
|ypN3b&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3b(sn)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c&lt;br /&gt;
|ypN3c&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c(f)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|N_RegionaleLymfeklieren&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2&lt;br /&gt;
|ypN3c(sn)&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De uitbreiding naar regionale lymfeklieren (N) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&lt;br /&gt;
=== ypT_PrimaireTumorCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.4.27.12&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Extensible&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Conceptcode&amp;lt;!--vsConceptCode--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|Omschrijving&amp;lt;!--vsDescription--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTx&lt;br /&gt;
|ypTx&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTx&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT0&lt;br /&gt;
|ypT0&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT0&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTa&lt;br /&gt;
|ypTa&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTa&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis&lt;br /&gt;
|ypTis&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (DCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (LAMN)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (LCIS)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis (Paget)&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypTis pu&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1&lt;br /&gt;
|ypT1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1mi&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a&lt;br /&gt;
|ypT1a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b&lt;br /&gt;
|ypT1b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1b2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c&lt;br /&gt;
|ypT1c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1c3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT1d&lt;br /&gt;
|ypT1d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT1d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2&lt;br /&gt;
|ypT2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a&lt;br /&gt;
|ypT2a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a1&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2a2&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2b&lt;br /&gt;
|ypT2b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2c&lt;br /&gt;
|ypT2c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT2d&lt;br /&gt;
|ypT2d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT2d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3&lt;br /&gt;
|ypT3&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3a&lt;br /&gt;
|ypT3a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3b&lt;br /&gt;
|ypT3b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3c&lt;br /&gt;
|ypT3c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT3d&lt;br /&gt;
|ypT3d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT3d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4&lt;br /&gt;
|ypT4&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4a&lt;br /&gt;
|ypT4a&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4a&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4b&lt;br /&gt;
|ypT4b&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4b&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4c&lt;br /&gt;
|ypT4c&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4c&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4d&lt;br /&gt;
|ypT4d&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4d&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|ypT4e&lt;br /&gt;
|ypT4e&lt;br /&gt;
|T_PrimaireTumor&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.1&lt;br /&gt;
|ypT4e&lt;br /&gt;
|}&lt;br /&gt;
Opm.:&amp;lt;!--vsNotes--&amp;gt; De primaire tumor (T) voor een classificatie uitgevoerd tijdens of na een initiële multimodaliteitsbehandeling (waaronder ook chirurgische behandeling).&lt;br /&gt;
&lt;br /&gt;
==Deze bouwsteen in overige publicaties&amp;lt;!--ftOtherReleases--&amp;gt;==&lt;br /&gt;
&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.4.27(NL)|2|2020}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Bouwsteen verwijzingen&amp;lt;!--ftReferences--&amp;gt;==&lt;br /&gt;
====Deze bouwsteen verwijst naar&amp;lt;!--ftRefersTo--&amp;gt;====&lt;br /&gt;
*[[AnatomischeLocatie-v1.0(2020NL)|AnatomischeLocatie-v1.0]]&lt;br /&gt;
====Deze bouwsteen wordt gebruikt in&amp;lt;!--ftReferredBy--&amp;gt;====&lt;br /&gt;
:--&lt;br /&gt;
==Technische specificaties in HL7v3 CDA en HL7 FHIR&amp;lt;!--ftHeader--&amp;gt;==&lt;br /&gt;
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.&amp;lt;BR&amp;gt;Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:&amp;lt;!--ftReferenceIntro--&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving&amp;lt;!--ftArtDecorReference--&amp;gt; [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2020bbr-?id=2.16.840.1.113883.2.4.3.11.60.10.4.2.4.27&amp;amp;effectiveDate=2020-09-01T00:00:00&amp;amp;language=nl-NL&amp;amp;scenariotree=false [[File:artdecor.jpg|16px|link=]]]&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry&amp;lt;!--ftSimplifierReference--&amp;gt; {{SimplefierLinks|2020}}&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
==Downloads&amp;lt;!--ftDownloadTitle--&amp;gt;==&lt;br /&gt;
De bouwsteen is ook beschikbaar als [[Media:nl.zorg.TNMTumorClassificatie-v1.0(2020NL).pdf|pdf bestand]] [[File:PDF.png|link=]] of als [[Media:nl.zorg.TNMTumorClassificatie-v1.0(2020NL).xlsx|spreadsheet]] [[File:xlsx.png|link=]]&amp;lt;!--ftDownloads--&amp;gt;&lt;br /&gt;
==Over deze informatie&amp;lt;!--ftHeader2--&amp;gt;==&lt;br /&gt;
De informatie in deze wiki pagina is gebaseerd op de&amp;lt;!--ftInfoBase--&amp;gt; Publicatie 2020 &amp;lt;BR&amp;gt;&lt;br /&gt;
SNOMED CT en LOINC codes zijn gebaseeerd op:&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;SNOMED Clinical Terms version: 20200309 [R] (March 2020 Interim Release)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;LOINC version 2.67&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Deze pagina is gegenereerd op 05/09/2020 22:12:20 met ZibExtraction v. 4.0.7553.39553&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21314</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21314"/>
		<updated>2020-09-08T12:05:40Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;19&amp;quot;|12||rowspan=&amp;quot;19&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Visus||2.16.840.1.113883.2.4.3.11.60.40.4.27||VisusMeetkaart&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21313</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=21313"/>
		<updated>2020-09-08T11:57:42Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;27&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21312</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21312"/>
		<updated>2020-09-08T11:54:48Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TNMTumorClassificatie||4.27||Actief&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|Diversen||rowspan=&amp;quot;5&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgTeam||17.3||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Actief&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21311</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21311"/>
		<updated>2020-09-08T11:54:12Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TNMTumorClassificatie||4.27||Actief&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|Diversen||rowspan=&amp;quot;5&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgTeam||17.3||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Actief&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21310</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21310"/>
		<updated>2020-09-08T11:52:27Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TNMTumorClassificatie||4.27||Actief&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|Diversen||rowspan=&amp;quot;5&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgTeam||17.3||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Actief&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21309</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21309"/>
		<updated>2020-09-08T11:50:04Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TumorClassificatie||4.27||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|Diversen||rowspan=&amp;quot;5&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgTeam||17.3||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Actief&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21308</id>
		<title>Zib Nummering</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Nummering&amp;diff=21308"/>
		<updated>2020-09-08T11:46:43Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Overzicht uitgegeven Id&amp;#039;s */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Iedere bouwsteen heeft een uniek Id. Van dit Id worden de unieke Id&#039;s van de concepten en de waardenlijsten afgeleid.&amp;lt;br&amp;gt;&lt;br /&gt;
De structuur en de afleiding van deze Id&#039;s staat [[Information model: diagram#Codering van de concepten | hier]] beschreven.&amp;lt;br&amp;gt;&lt;br /&gt;
Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&amp;lt;br&amp;gt;&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Ten behoeve van het uitgeven van nieuwe bouwsteen Id&#039;s staat hier onder een overzicht van de reeds uitgegeven Id&#039;s en hun status.&amp;lt;br&amp;gt;&lt;br /&gt;
Het statusveld kan drie waarden aannemen. Naast &#039;actief&#039; en &#039;vervallen&#039; wordt de waarde &#039;test&#039; gebruikt.&amp;lt;br&amp;gt;&lt;br /&gt;
Deze status wordt toegekend aan bouwstenen die in ontwikkeling zijn (zoals b.v. kandidaat-zib&#039;s) en waaraan wel al een Id is toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Hergebuik van een nummer van een vervallen bouwsteen wordt afgeraden.&lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven zib Id&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe Id&#039;s en bij het wijzigen van een status moet deze pagina bijgewerkt worden.&lt;br /&gt;
&lt;br /&gt;
==Overzicht uitgegeven Id&#039;s==&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!KlasseNaam!!Nummer!!Bouwsteen!!Nummerextensie!!Status&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Header||0||Patient||0.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Betaalgegevens||1||Betaler ||1.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Behandelaanwijzingen||rowspan=&amp;quot;2&amp;quot;|2||BehandelAanwijzing||2.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contactpersonen||rowspan=&amp;quot;2&amp;quot;|3||Contactpersoon||3.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|HulpVanAnderen||3.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;35&amp;quot;|4||FunctioneleStatus||4.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|BarthelIndex||4.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Mobiliteit||4.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ondervoeding||4.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore||4.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore||4.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotEten||4.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotDrinken||4.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OverdrachtValrisico||4.9||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichWassen||4.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZichKleden||4.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotHaarverzorging||4.12||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotMondverzorging||4.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Blaasfunctie||4.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Darmfunctie||4.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZien||4.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FunctieHoren||4.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voelen||4.18||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ruiken||4.19||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Proeven||4.20||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Slaapfunctie||4.21||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotToiletgang||4.22||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Menstruatiecyclus||4.23||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|HulpBijMedicatie||4.24||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctieZintuigelijkeWaarneming||4.25||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|FunctioneleOfMentaleStatus||4.26||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TumorClassificatie||4.27||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore||4.28||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore||4.29||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score||4.30||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VoedingspatroonZuigeling||4.31||Actief&lt;br /&gt;
|-&lt;br /&gt;
|OntwikkelingKind||4.32||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotUiterlijkeVerzorging||4.33||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotVerpleegtechnischeHandelingen||4.34||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VermogenTotZelfstandigMedicatiegebruik||4.35||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Problemen||rowspan=&amp;quot;2&amp;quot;|5||Probleem||5.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||5.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Familieanamnese||6||Familieanamnese ||6.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;15&amp;quot;|Sociale anamnese||rowspan=&amp;quot;15&amp;quot;|7||TabakGebruik||7.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlcoholGebruik||7.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Drugsgebruik||7.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Levensovertuiging||7.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Nationaliteit||7.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Woonsituatie ||7.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|BurgerlijkeStaat||7.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Opleiding ||7.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Voedingsadvies||7.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Taalvaardigheid||7.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gezinssituatie||7.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zwangerschap||7.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||7.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GezinssituatieKind||7.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|JuridischeSituatie||7.17||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Alerts||rowspan=&amp;quot;3&amp;quot;|8||Alert||8.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Alert||8.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AllergieIntolerantie||8.2||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;14&amp;quot;|Medicatie||rowspan=&amp;quot;14&amp;quot;|9||Medicatie||9.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieFeitelijkGebruik||9.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening||9.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVerstrekking||9.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieVoorschrift||9.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Medicatieafspraak||9.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FarmaceutischProduct||9.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Toedieningsafspraak||9.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekking||9.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Verstrekkingsverzoek||9.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieGebruik||9.11||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Gebruiksinstructie||9.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieToediening ||9.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|MedicatieContraIndicatie||9.14||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Medische hulpmiddelen||rowspan=&amp;quot;6&amp;quot;|10||MedischHulpmiddel||10.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Infuus||10.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SondeSysteem||10.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Stoma||10.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UrineStoma||10.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|UrineKatheter||10.6||Vervallen&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Vaccinaties||11||Vaccinatie||11.1||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|Vitale functies||rowspan=&amp;quot;21&amp;quot;|12||Gewicht||12.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Lengte ||12.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Hartfrequentie||12.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Bloeddruk ||12.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Ademhaling||12.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Temperatuur||12.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Polsfrequentie ||12.7||Actief&lt;br /&gt;
|-&lt;br /&gt;
|GlasgowComaScale||12.8||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnscore ||12.9||Actief&lt;br /&gt;
|-&lt;br /&gt;
|O2Saturatie ||12.10||Actief&lt;br /&gt;
|-&lt;br /&gt;
|PijnBeleving||12.11||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore||12.12||Actief&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore||12.13||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Schedelomvang||12.14||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Vochtbalans||12.15||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ApgarScore||12.16||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijngedrag||12.17||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Das||12.18||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Visus||12.19||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Refractie||12.20||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Pijnkenmerken||12.21||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Uitslagen||rowspan=&amp;quot;6&amp;quot;|13||LabUitslag ||13.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|TekstUitslag||13.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AlgemeneMeting||13.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|UitkomstVanZorg||13.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Behandeldoel||13.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|SOEPVerslag||13.6||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|Verrichtingen||rowspan=&amp;quot;6&amp;quot;|14||Verrichting||14.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeInterventie||14.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelen||14.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeMaatregelenGGZ||14.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VerpleegkundigeActie||14.5||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|VrijheidsbeperkendeInterventie||14.6||Actief&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Contacten||rowspan=&amp;quot;2&amp;quot;|15||Contact||15.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Patientbespreking||15.2||Gereserveerd&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|Diversen||rowspan=&amp;quot;5&amp;quot;|16||GeplandeZorgactiviteit||16.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Zorgafspraak||16.2||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|Hulpvraag||16.3||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|KlinischeHerinnering||16.4||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgEpisode||16.6||Gereserveerd&lt;br /&gt;
&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Zorgverleners||rowspan=&amp;quot;3&amp;quot;|17||Zorgverlener||17.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgaanbieder||17.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Zorgteam||17.3||Gereserveerd&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Mentale status||rowspan=&amp;quot;7&amp;quot;|18||AlgemeneMentaleFuncties||18.1||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|IntellectueleFuncties||18.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Communicatievaardigheden||18.3||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|SpecifiekeMentaleFuncties||18.4||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Ziektebeleving||18.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|ParticipatieInMaatschappij||18.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|DOSScore||18.7||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|Huid||rowspan=&amp;quot;4&amp;quot;|19||Decubitus||19.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Wond||19.2||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Huidaandoening||19.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Brandwond||19.4||Actief&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|Sub-bouwstenen||rowspan=&amp;quot;7&amp;quot;|20||Amount||20.1||Actief&lt;br /&gt;
|-&lt;br /&gt;
|RangePQ||20.2||Vervallen&lt;br /&gt;
|-&lt;br /&gt;
|Tijdsinterval||20.3||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Naamgegevens||20.4||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Adresgegevens||20.5||Actief&lt;br /&gt;
|-&lt;br /&gt;
|Contactgegevens||20.6||Actief&lt;br /&gt;
|-&lt;br /&gt;
|AnatomischeLocatie||20.7||Gereserveerd&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|Blauwdruk zibs||rowspan=&amp;quot;3&amp;quot;|21||Meting||21.1||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgVragenlijst||21.2||Gereserveerd&lt;br /&gt;
|-&lt;br /&gt;
|ZorgNotitie||21.3||Gereserveerd&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Gebruik nummerextensie==&lt;br /&gt;
Met behulp van de nummerextensie worden de OID&#039;s van een bouwsteen afgeleid:&lt;br /&gt;
* ZIB OID: 2.16.840.1.113883.2.4.3.11.60.40.3.&amp;lt;nummerextensie&amp;gt;&lt;br /&gt;
* ZIB informatiemodel conceptId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.1.&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;, afgekort tot NL-CM:&amp;lt;nummerextensie&amp;gt;.&amp;lt;conceptvolgnummer&amp;gt;&lt;br /&gt;
* ZIB informatiemodel valuesetId&#039;s: 2.16.840.1.113883.2.4.3.11.60.40.2.&amp;lt;nummerextensie&amp;gt;.&amp;lt;valuesetvolgnummer&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
De volgnummers tellen vanaf 1.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Verrichting-v5.2(2020NL)&amp;diff=21307</id>
		<title>Verrichting-v5.2(2020NL)</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Verrichting-v5.2(2020NL)&amp;diff=21307"/>
		<updated>2020-09-08T11:31:19Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Information Model */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.14.1(NL)|1|Verrichting-v5.2(2020NL)}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Algemeen&amp;lt;!--hdGeneralInformation--&amp;gt;==&lt;br /&gt;
Naam&amp;lt;!--hdName--&amp;gt;: &#039;&#039;&#039;nl.zorg.Verrichting&#039;&#039;&#039; [[Bestand:EN.png|link=Procedure-v5.2(2020EN)]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Versie&amp;lt;!--hdVersion--&amp;gt;: &#039;&#039;&#039;5.2&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
ZIB Status&amp;lt;!--hdStatus--&amp;gt;:Final&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie&amp;lt;!--hdPublication--&amp;gt;: &#039;&#039;&#039;2020&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie status&amp;lt;!--hdPublicationStatus--&amp;gt;: Published&amp;lt;br&amp;gt;&lt;br /&gt;
Publicatie datum&amp;lt;!--hdPublicationDate--&amp;gt;: 01-09-2020&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Metadata==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:90%; width: 750px&amp;quot;&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CoderList||Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Address||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Name||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContactInformation.Telecom||*&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ContentAuthorList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::CreationDate||6-6-2012&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DeprecatedDate||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::DescriptionLanguage||nl&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Address||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Name||PM&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::EndorsingAuthority.Telecom||&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.14.1&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::KeywordList||procedure,verrichting&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::LifecycleStatus||Final&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ModelerList||Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Name||nl.zorg.Verrichting&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationDate||01-09-2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::PublicationStatus||Published&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens &amp;amp; Kerngroep Registratie aan de Bron&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::RevisionDate||16-07-2020&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Supersedes||nl.zorg.Verrichting-v5.1&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|DCM::Version||5.2&lt;br /&gt;
|- &lt;br /&gt;
|style=&amp;quot;width:250px; &amp;quot;|HCIM::PublicationLanguage||NL&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Revision History==&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-collapsible mw-collapsed&amp;quot;&amp;gt;&lt;br /&gt;
&#039;&#039; &amp;lt;!--noTranslation--&amp;gt;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.0&amp;lt;/u&amp;gt; (15-02-2013)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.1&amp;lt;/u&amp;gt; (01-07-2013)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-55 | ZIB-55 ]]&lt;br /&gt;
|RFC Bouwsteen Procedure&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-24 | ZIB-24 ]]&lt;br /&gt;
|Diagnostische verrichtingen onderdeel van Results&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 1.2&amp;lt;/u&amp;gt; (01-04-2015)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-84 | ZIB-84 ]]&lt;br /&gt;
|Klinische bouwsteen nl.nfu.OverdrachtProcedure uitbreiden met Aanvrager (n.a.v. issue #077)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-93 | ZIB-93 ]]&lt;br /&gt;
|Bouwsteennaam Procedure wijzigen in Verrichting&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-95 | ZIB-95 ]]&lt;br /&gt;
|Elementen in Example of the Instrument OverdrachtProcedure komen niet terug in model&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-122 | ZIB-122 ]]&lt;br /&gt;
|De definitie van de sectie Concept van de bouwsteen OverdrachtProcedure aanpassen.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-270 | ZIB-270 ]]&lt;br /&gt;
|Aanpassen DCM::DefinitionCode van rootconcept Verrichting van NL-CM-14.1.1 naar NL-CM:14.1.1.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-271 | ZIB-271 ]]&lt;br /&gt;
|In de klinische bouwsteen OverdrachtProcedure DCM::ValueSet SNOMED CT aangepast van concept AnatomischeLokalisatie naar tagged value DCM::ContentExpression.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-272 | ZIB-272 ]]&lt;br /&gt;
|In klinische bouwsteen OverdrachtProcedure DCM::ValueSet CBV verrichtingen van concept VerrichtingType aangepast naar tagged value DCM::CodeSystem.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-273 | ZIB-273 ]]&lt;br /&gt;
|Tagged value DCM::ReferencedDefinitionCode is onjuist voor classes UitgevoerdDoor::Zorgverlener en AangevraagdDoor::Zorgverlener, dit zou NL-CM:17.1.1 moeten zijn i.p.v. NL-CM:17.1.2.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-308 | ZIB-308 ]]&lt;br /&gt;
|Prefix Overdracht weggehaald bij de generieke bouwstenen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-325 | ZIB-325 ]]&lt;br /&gt;
|AnatomischeLokaisatie wijzigen in AnatomischeLocatie&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-353 | ZIB-353 ]]&lt;br /&gt;
|Tagged values DCM::CodeSystem aanpassen naar DCM::ValueSet incl. gekoppelde codelijst.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Incl. algemene wijzigingsverzoeken: &lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-94 | ZIB-94 ]]&lt;br /&gt;
|Aanpassen tekst van Disclaimer, Terms of Use &amp;amp; Copyrights&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-154 | ZIB-154 ]]&lt;br /&gt;
|Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-200 | ZIB-200 ]]&lt;br /&gt;
|Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-201 | ZIB-201 ]]&lt;br /&gt;
|Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-309 | ZIB-309 ]]&lt;br /&gt;
|EOI aangepast &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-324 | ZIB-324 ]]&lt;br /&gt;
|Codelijsten Name en Description beginnen met een Hoofdletter&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-326 | ZIB-326 ]]&lt;br /&gt;
|Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 3.0&amp;lt;/u&amp;gt; (01-05-2016)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-401 | ZIB-401 ]]&lt;br /&gt;
|CBV Verrichtingen mist geldig OID&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-453 | ZIB-453 ]]&lt;br /&gt;
|Wijziging naamgeving ZIB&#039;s en logo&#039;s door andere opzet van beheer&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 3.1&amp;lt;/u&amp;gt; (04-09-2017)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-475 | ZIB-475 ]]&lt;br /&gt;
|Terminologiekoppeling Drugsgebruik&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-549 | ZIB-549 ]]&lt;br /&gt;
|De Engelse naam van de bouwsteen en het rootconcept zijn niet correct&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-564 | ZIB-564 ]]&lt;br /&gt;
|Aanpassing/harmonisatie Engelse conceptnamen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-576 | ZIB-576 ]]&lt;br /&gt;
|Aanpassen bouwstenen die nog de prefix overdracht hebben, zodat de prefix kan vervallen.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-578 | ZIB-578 ]]&lt;br /&gt;
|Aan het concept anatomische locatie moet een concept Laterariteit toegevoegd worden.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 4.0&amp;lt;/u&amp;gt; (04-09-2017)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-457 | ZIB-457 ]]&lt;br /&gt;
|Uitbreiding AnatomischeLocatieCodelijst met Snomed qualifiers&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-458 | ZIB-458 ]]&lt;br /&gt;
|Uitbreiding met dataelement &amp;quot;werkwijze&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-515 | ZIB-515 ]]&lt;br /&gt;
|Geen informatie&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-518 | ZIB-518 ]]&lt;br /&gt;
|Geen informatie&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-549 | ZIB-549 ]]&lt;br /&gt;
|De Engelse naam van de bouwsteen en het rootconcept zijn niet correct&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-564 | ZIB-564 ]]&lt;br /&gt;
|Aanpassing/harmonisatie Engelse conceptnamen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-574 | ZIB-574 ]]&lt;br /&gt;
|Alleen verwijzen naar het rootconcept van de ZIB.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-576 | ZIB-576 ]]&lt;br /&gt;
|Aanpassen bouwstenen die nog de prefix overdracht hebben, zodat de prefix kan vervallen.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-578 | ZIB-578 ]]&lt;br /&gt;
|Aan het concept anatomische locatie moet een concept Laterariteit toegevoegd worden.&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-581 | ZIB-581 ]]&lt;br /&gt;
|Geen informatie&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-585 | ZIB-585 ]]&lt;br /&gt;
|Toevoegen concept Lateraliteit aan het concept Anatomische Locatie&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 4.1&amp;lt;/u&amp;gt; (31-12-2017)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-646 | ZIB-646 ]]&lt;br /&gt;
|Aanpassing SNOMED codes&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Publicatieversie 4.2&amp;lt;/u&amp;gt; (26-02-2019)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-624 | ZIB-624 ]]&lt;br /&gt;
|Waardelijsten met DHD en Nationale Kernset Patiëntproblemen V&amp;amp;VN niet implementeerbaar&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-633 | ZIB-633 ]]&lt;br /&gt;
|Toevoegen SNOMED CT als codelijst aan VerrichtingType, naast de DHD Verrichtingenthesaurus&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-625 | ZIB-625 ]]&lt;br /&gt;
|Verrichting: uitbreiden VerrichtingTypeCodelijst met codestelsel NZa&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-675 | ZIB-675 ]]&lt;br /&gt;
|toevoegen CBV codelijst aan verrichtingtype&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;5.0&amp;lt;/u&amp;gt; (06-07-2019)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-821 | ZIB-821 ]]&lt;br /&gt;
|OverdrachtGeplandeZorgactiviteit laten vervallen en onderliggende zibs aanpassen&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;5.1&amp;lt;/u&amp;gt; (31-01-2020)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-954 | ZIB-954 ]]&lt;br /&gt;
|correctie omschrijving van VerrichtingType&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-908 | ZIB-908 ]]&lt;br /&gt;
|Ontbrekende OIDs toevoegen voor NzE, CBV en VT &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Publicatieversie &amp;lt;u&amp;gt;5.2&amp;lt;/u&amp;gt; (01-09-2020)&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-666 | ZIB-666 ]]&lt;br /&gt;
|Graag toevoegen ggz DBC verrichtingen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-993 | ZIB-993 ]]&lt;br /&gt;
|DatumTijd in relatie to Start/Eind concepten voor verrichting gebaseerde zibs&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-1087 | ZIB-1087 ]]&lt;br /&gt;
|Naamswijziging zib Verrichting naar zib Behandeling&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-1088 | ZIB-1088 ]]&lt;br /&gt;
|Toevoegen tabel 49 aan zib Verrichting&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-1095 | ZIB-1095 ]]&lt;br /&gt;
|Verrichting geschikt maken voor behandeladvies&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;width:75px; &amp;quot;|[[ZIBIssues#ZIB-1116 | ZIB-1116 ]]&lt;br /&gt;
|Geen informatie&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Concept==&lt;br /&gt;
Het concept Verrichting beschrijft een therapeutische of diagnostische verrichting, die de patiënt heeft ondergaan of zal ondergaan. Het concept kan in de juiste context zowel historische, toekomstige als geadviseerde verrichtingen beschrijven. &amp;lt;BR&amp;gt;&lt;br /&gt;
Een verrichting kan een simpele bloeddrukmeting zijn maar ook een complexe hartoperatie.&amp;lt;BR&amp;gt;&lt;br /&gt;
In sommige zorgsectoren wordt in plaats van  de term verrichting de term behandeling gebruikt.&lt;br /&gt;
&lt;br /&gt;
==Purpose==&lt;br /&gt;
Een verrichting wordt uitgevoerd of gepland in het kader van een uitgezet beleid of voor het verkrijgen van aanvullende informatie in het diagnostisch proces. Het vastleggen van verrichtingen dient om inzicht te krijgen in de behandeling van de patiënt. Daarnaast worden verrichtingen vastgelegd ten behoeve van administratieve doeleinden zoals facturering en werklastmeting, wetenschappelijk onderzoek en/of onderwijs.&lt;br /&gt;
&lt;br /&gt;
==Information Model==&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
&amp;lt;imagemap&amp;gt; Bestand:Verrichting-v5.2Model(2020NL).png | center &lt;br /&gt;
rect 37 437 181 487 [[#VerrichtingTypeNZaCodelijst]]&lt;br /&gt;
rect 37 507 181 557 [[#VerrichtingTypeCBVCodelijst]]&lt;br /&gt;
rect 697 415 833 485 [[AnatomischeLocatie-v1.0(2020NL)]]&lt;br /&gt;
rect 37 367 181 417 [[#VerrichtingTypeGGZCodelijst]]&lt;br /&gt;
rect 439 507 607 557 [[#VerrichtingMethodeCodelijst]]&lt;br /&gt;
rect 458 409 588 479 [[#13108]]&lt;br /&gt;
rect 219 507 363 557 [[#VerrichtingTypeDHDCodelijst]]&lt;br /&gt;
rect 697 311 830 381 [[Zorgverlener-v3.5(2020NL)]]&lt;br /&gt;
rect 229 214 359 284 [[Probleem-v4.4(2020NL)]]&lt;br /&gt;
rect 229 117 359 187 [[#13106]]&lt;br /&gt;
rect 460 117 586 187 [[#13097]]&lt;br /&gt;
rect 697 214 830 284 [[Zorgaanbieder-v3.4(2020NL)]]&lt;br /&gt;
rect 229 311 359 381 [[MedischHulpmiddel-v3.3.1(2020NL)]]&lt;br /&gt;
rect 229 409 359 481 [[#13094]]&lt;br /&gt;
rect 697 116 830 186 [[Zorgverlener-v3.5(2020NL)]]&lt;br /&gt;
rect 463 262 583 342 [[#13096]]&lt;br /&gt;
rect 35 297 181 347 [[#VerrichtingTypeNHGCodelijst]]&lt;br /&gt;
desc none&lt;br /&gt;
&amp;lt;/imagemap&amp;gt;&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
{| border= &amp;quot;1&amp;quot;  width=&amp;quot;1500px&amp;quot; style = &amp;quot;font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;&amp;quot; cellpadding = &amp;quot;3px&amp;quot; cellspacing =&amp;quot;0px&amp;quot; &lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; &amp;quot;&lt;br /&gt;
|style=&amp;quot;width:30px;&amp;quot;|Type&amp;lt;!--imType--&amp;gt;||style=&amp;quot;width:100px;&amp;quot;|Id&amp;lt;!--imId--&amp;gt;||colspan=&amp;quot;6 &amp;quot; style=&amp;quot;width:140px;&amp;quot;|Concept&amp;lt;!--imConcept--&amp;gt;||Card.&amp;lt;!--imCard--&amp;gt;||style=&amp;quot;width: 600px;&amp;quot;|Definitie&amp;lt;!--imDefinition--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|DefinitieCode&amp;lt;!--imDefinitionCode--&amp;gt;||style=&amp;quot;width:200px;&amp;quot;|Verwijzing&amp;lt;!--imReference--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: block.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.1&lt;br /&gt;
|colspan =&amp;quot;6&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13096 Title=&amp;quot;EN: Procedure&amp;quot;&amp;gt;[[Bestand: arrowdown.png | 10px | link=]]Verrichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|&lt;br /&gt;
|Rootconcept van de bouwsteen Verrichting. Dit rootconcept bevat alle gegevenselementen van de bouwsteen Verrichting.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Procedure (procedure)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=71388002 71388002] Verrichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:14.1.2&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13106 Title=&amp;quot;EN: ProcedureStartDate&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]VerrichtingStartDatum&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De (gewenste) startdatum (en eventueel starttijd) van de verrichting. Een vage datum, bv. alleen een jaartal, is toegestaan.&lt;br /&gt;
Het element biedt de mogelijkheid om de start van de periode van een reeks bij elkaar behorende verrichtingen aan te geven.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: TS.png| 16px | link=]]&lt;br /&gt;
||NL-CM:14.1.3&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13097 Title=&amp;quot;EN: ProcedureEndDate&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]VerrichtingEindDatum&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De einddatum (en eventueel eindtijd) van de verrichting. Een vage datum, bijv. alleen een jaartal, is toegestaan.&lt;br /&gt;
Het element biedt de mogelijkheid om het einde van de periode van een reeks bij elkaar behorende verrichtingen aan te geven. De element einddatum wordt alleen gebruikt bij een verrichting die enige tijd duurt en wordt dan altijd toegepast. Als de verrichting nog voortduurt wordt de waarde leeg gelaten. Voor instantane of heel kort durende  verrichtingen wordt het element weggelaten. &lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:14.1.4&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13094 Title=&amp;quot;EN: ProcedureType&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]VerrichtingType&amp;lt;/span&amp;gt;&lt;br /&gt;
|1&lt;br /&gt;
|De naam van de verrichting. &lt;br /&gt;
Gekozen kan worden uit de DHD verrichtingenthesaurus, het verrichtingenbestand (CBV), de zorgactiviteiten (NZa), de GGZ Verrichtingenlijst (GGZ) en NHG Ingrepen en behandelingen tabel (NHG). &lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingTypeCBVCodelijst]]||[[#VerrichtingTypeCBVCodelijst|VerrichtingTypeCBVCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingTypeDHDCodelijst]]||[[#VerrichtingTypeDHDCodelijst|VerrichtingTypeDHDCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingTypeGGZCodelijst]]||[[#VerrichtingTypeGGZCodelijst|VerrichtingTypeGGZCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingTypeNHGCodelijst]]||[[#VerrichtingTypeNHGCodelijst|VerrichtingTypeNHGCodelijst]]&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingTypeNZaCodelijst]]||[[#VerrichtingTypeNZaCodelijst|VerrichtingTypeNZaCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: CD.png| 16px | link=]]&lt;br /&gt;
||NL-CM:14.1.12&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13108 Title=&amp;quot;EN: ProcedureMethod&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]VerrichtingMethode&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|De methode of de techniek die toegepast is bij het uitvoeren van de verrichting, zoals toegangsmethode, lavage, pressuring, etc&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Method (attribute)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=260686004 260686004] Methode&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: List2.png | link=#VerrichtingMethodeCodelijst]]||[[#VerrichtingMethodeCodelijst|VerrichtingMethodeCodelijst]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.13&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=14064 Title=&amp;quot;EN: ProcedureAnatomicalLocation::AnatomicalLocation&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]VerrichtingAnatomischeLocatie::AnatomischeLocatie&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|Anatomische locatie die de focus is van de verrichting.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Procedure site - Direct (attribute)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=405813007 405813007] Directe locatie van verrichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=AnatomischeLocatie-v1.0(2020NL)]]||[[AnatomischeLocatie-v1.0(2020NL) |AnatomischeLocatie]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.9&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13109 Title=&amp;quot;EN: Indication::Problem&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Indicatie::Probleem&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|De indicatie is de reden voor het uitvoeren van de verrichting.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Has focus (attribute)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=363702006 363702006] Heeft focus&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=Probleem-v4.4(2020NL)]]||[[Probleem-v4.4(2020NL) |Probleem]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.7&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13098 Title=&amp;quot;EN: MedicalDevice&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]MedischHulpmiddel&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|Het product waarvan het plaatsen in of aan het lichaam het doel is van de verrichting, bijv. het plaatsen van een implantaat.&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;span title = &amp;quot;Codesystem: SNOMED CT; Procedure device (attribute)&amp;quot; &amp;gt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=405815000 405815000] Hulpmiddel voor verrichting&amp;lt;/span&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=MedischHulpmiddel-v3.3.1(2020NL)]]||[[MedischHulpmiddel-v3.3.1(2020NL) |MedischHulpmiddel]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.5&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13099 Title=&amp;quot;EN: Location::HealthcareProvider&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Locatie::Zorgaanbieder&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..1&lt;br /&gt;
|De zorginstelling waar de verrichting is, wordt of zal worden uitgevoerd.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=Zorgaanbieder-v3.4(2020NL)]]||[[Zorgaanbieder-v3.4(2020NL) |Zorgaanbieder]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.6&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13101 Title=&amp;quot;EN: Performer::HealthProfessional&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Uitvoerder::Zorgverlener&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|De zorgverlener die de verrichting heeft uitgevoerd of zal uitvoeren. In de meeste gevallen wordt alleen het specialisme en niet de naam van de zorgverlener doorgegeven.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=Zorgverlener-v3.5(2020NL)]]||[[Zorgverlener-v3.5(2020NL) |Zorgverlener]]&lt;br /&gt;
|}&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: transparent; &amp;quot;&lt;br /&gt;
|style = &amp;quot;text-align:center&amp;quot; |[[Bestand: Verwijzing.png| 20px | link=]]&lt;br /&gt;
||NL-CM:14.1.10&lt;br /&gt;
|style = &amp;quot;width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;&amp;quot; |&lt;br /&gt;
|colspan =&amp;quot;5&amp;quot; style =&amp;quot;padding-left: 0px&amp;quot;|&amp;lt;span Id=13104 Title=&amp;quot;EN: Requester::HealthProfessional&amp;quot;&amp;gt;[[Bestand: arrowright.png | 10px | link=]]Aanvrager::Zorgverlener&amp;lt;/span&amp;gt;&lt;br /&gt;
|0..*&lt;br /&gt;
|De zorgverlener die de verrichting heeft aangevraagd.&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand: block.png | link=Zorgverlener-v3.5(2020NL)]]||[[Zorgverlener-v3.5(2020NL) |Zorgverlener]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
Kolommen Concept en DefinitieCode: houdt de muis boven de waarde voor meer informatie&amp;lt;!--imHover--&amp;gt;&amp;lt;BR&amp;gt;&lt;br /&gt;
Voor uitleg over de gebruikte symbolen, zie de legenda pagina&amp;lt;!--imLegend--&amp;gt; [[Bestand:list2.png|link=Legenda&amp;lt;!--wikiLegend--&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
==Example Instances==&lt;br /&gt;
{|class=&amp;quot;wikitable&amp;quot; width=&amp;quot;1248px&amp;quot; style= &amp;quot;font-size: 9.5pt;&amp;quot;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 8%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;VerrichtingType&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Verrichting&amp;lt;/b&amp;gt;&amp;lt;BR&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Anatomische&amp;lt;/b&amp;gt;&amp;lt;BR&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Locatie&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 8%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Verrichting Lateraliteit&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 8%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Verrichting&amp;lt;/b&amp;gt;&amp;lt;BR&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Start&amp;lt;/b&amp;gt;&amp;lt;BR&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Datum&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;3&amp;quot; style=&amp;quot;background-color: #1F497D; width: 25%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Product&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #1F497D; width: 24%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Indicatie&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Uitgevoerd&amp;lt;/b&amp;gt;&amp;lt;BR&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Door&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #1F497D; width: 8%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Locatie&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 9%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;ProductType&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|colspan=&amp;quot;2&amp;quot; style=&amp;quot;background-color: #548DD4; width: 16%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;ProductID&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 7%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;ProbleemNaam&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 16%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Toelichting&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 9%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;Specialisme&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
| style=&amp;quot;background-color: #548DD4; width: 8%; &amp;quot;|&amp;lt;font color=#FFFFFF&amp;gt;&amp;lt;b&amp;gt;OrganisatieNaam&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 9%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 9%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 7%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 16%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 9%; &amp;quot;|&lt;br /&gt;
| style=&amp;quot;background-color: #D9D9D9; width: 8%; &amp;quot;|&lt;br /&gt;
|-style=vertical-align:top;&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|Knie - prothese implantatie gewricht&lt;br /&gt;
| style=&amp;quot;width: 9%; &amp;quot;|Knie&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|Links&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|05-06-2012&lt;br /&gt;
| style=&amp;quot;width: 9%; &amp;quot;|Orthopedic surgical implants&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|(01)05050474530799&amp;lt;BR&amp;gt;(17)160131&amp;lt;BR&amp;gt;(21)1148130801&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|Implantant, Gen 2 Tibia Insert 5/6-9mm&lt;br /&gt;
| style=&amp;quot;width: 7%; &amp;quot;|Artrose&lt;br /&gt;
| style=&amp;quot;width: 16%; &amp;quot;|Beperking bij het bewegen van het gewricht, drukpijn door slijtage van twee compartimenten van de linker knie.&lt;br /&gt;
| style=&amp;quot;width: 9%; &amp;quot;|Orthopedie&lt;br /&gt;
| style=&amp;quot;width: 8%; &amp;quot;|UMCG&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
1. Waardelijst GGZ-Verrichtingen [Online] Beschikbaar op: http://https://www.vippggz.nl/waardelijst-ggz-verrichtingen.html [Geraadpleegd: 03-08-2020].&lt;br /&gt;
&lt;br /&gt;
== Valuesets ==&lt;br /&gt;
=== VerrichtingMethodeCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|SNOMED CT: &amp;lt;[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=129264002 129264002]&amp;lt;noWiki&amp;gt;|&amp;lt;/noWiki&amp;gt;&amp;lt;span title = &amp;quot;Action (qualifier value)&amp;quot;&amp;gt;Handeling&amp;lt;/span&amp;gt;&amp;lt;noWiki&amp;gt;|&amp;lt;/noWiki&amp;gt;&lt;br /&gt;
|SNOMED CT&lt;br /&gt;
|2.16.840.1.113883.6.96&lt;br /&gt;
|}&lt;br /&gt;
=== VerrichtingTypeCBVCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.6&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Alle waarden&lt;br /&gt;
|CBV codes&lt;br /&gt;
|2.16.840.1.113883.2.4.3.120.5.3&lt;br /&gt;
|}&lt;br /&gt;
=== VerrichtingTypeDHDCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Alle waarden&lt;br /&gt;
|DHD Verrichtingenthesaurus&lt;br /&gt;
|2.16.840.1.113883.2.4.3.120.5.2&lt;br /&gt;
|}&lt;br /&gt;
=== VerrichtingTypeGGZCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.7&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Alle waarden&lt;br /&gt;
|GGZ Verrichtingenijst&lt;br /&gt;
|2.16.840.1.113883.3.3210.14.2.2.15&lt;br /&gt;
|}&lt;br /&gt;
=== VerrichtingTypeNHGCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.8&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Alle waarden&lt;br /&gt;
|NHG tabel 49 Ingrepen en behandelingen&lt;br /&gt;
|2.16.840.1.113883.2.4.4.30.49&lt;br /&gt;
|}&lt;br /&gt;
=== VerrichtingTypeNZaCodelijst===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=&amp;quot;60%&amp;quot; &lt;br /&gt;
|-style=&#039;vertical-align:top; background-color: #E8D7BE;&#039;&lt;br /&gt;
|Valueset OID&amp;lt;!--vsValuesetOID--&amp;gt;: 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.5&lt;br /&gt;
|Binding&amp;lt;!--vsBindingTag--&amp;gt;: Required&lt;br /&gt;
|}&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;  width=&amp;quot;60% &amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D; color: white; font-weight: bold; &amp;quot;&lt;br /&gt;
|Conceptnaam&amp;lt;!--vsConceptName--&amp;gt;&lt;br /&gt;
|Codestelselnaam&amp;lt;!--vsConceptSystemName--&amp;gt;||Codesysteem OID&amp;lt;!--vsConceptSystemOID--&amp;gt;&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; &amp;quot;&lt;br /&gt;
|Alle waarden&lt;br /&gt;
|NZa codes&lt;br /&gt;
|2.16.840.1.113883.2.4.3.27.15.5&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Deze bouwsteen in overige publicaties&amp;lt;!--ftOtherReleases--&amp;gt;==&lt;br /&gt;
&amp;lt;!-- Hieronder wordt een transclude page aangeroepen --&amp;gt;&lt;br /&gt;
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.14.1(NL)|2|2020}}&lt;br /&gt;
&amp;lt;!-- Tot hier de transclude page --&amp;gt;&lt;br /&gt;
==Bouwsteen verwijzingen&amp;lt;!--ftReferences--&amp;gt;==&lt;br /&gt;
====Deze bouwsteen verwijst naar&amp;lt;!--ftRefersTo--&amp;gt;====&lt;br /&gt;
*[[AnatomischeLocatie-v1.0(2020NL)|AnatomischeLocatie-v1.0]]&lt;br /&gt;
*[[MedischHulpmiddel-v3.3.1(2020NL)|MedischHulpmiddel-v3.3.1]]&lt;br /&gt;
*[[Probleem-v4.4(2020NL)|Probleem-v4.4]]&lt;br /&gt;
*[[Zorgaanbieder-v3.4(2020NL)|Zorgaanbieder-v3.4]]&lt;br /&gt;
*[[Zorgverlener-v3.5(2020NL)|Zorgverlener-v3.5]]&lt;br /&gt;
====Deze bouwsteen wordt gebruikt in&amp;lt;!--ftReferredBy--&amp;gt;====&lt;br /&gt;
*[[Contact-v4.0.1(2020NL)|Contact-v4.0.1]]&lt;br /&gt;
*[[Patientbespreking-v1.0(2020NL)|Patientbespreking-v1.0]]&lt;br /&gt;
*[[TekstUitslag-v4.4(2020NL)|TekstUitslag-v4.4]]&lt;br /&gt;
==Technische specificaties in HL7v3 CDA en HL7 FHIR&amp;lt;!--ftHeader--&amp;gt;==&lt;br /&gt;
Om informatie op basis van zorginformatiebouwstenen uit te wisselen zijn aanvullende, meer technische specificaties nodig.&amp;lt;BR&amp;gt;Niet iedere omgeving kan met dezelfde technische specificaties overweg. Om deze reden zijn er meerdere typen technische specificaties:&amp;lt;!--ftReferenceIntro--&amp;gt;&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® versie 3 CDA compatibele specificaties, beschikbaar via de Nictiz ART-DECOR® omgeving&amp;lt;!--ftArtDecorReference--&amp;gt; [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2020bbr-?id=2.16.840.1.113883.2.4.3.11.60.10.4.2.14.1&amp;amp;effectiveDate=2020-09-01T00:00:00&amp;amp;language=nl-NL&amp;amp;scenariotree=false [[File:artdecor.jpg|16px|link=]]]&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;HL7® FHIR® compatibele specificaties, beschikbaar via de Nictiz-omgeving op de Simplifier FHIR Registry&amp;lt;!--ftSimplifierReference--&amp;gt; {{SimplefierLinks|2020}}&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
==Downloads&amp;lt;!--ftDownloadTitle--&amp;gt;==&lt;br /&gt;
De bouwsteen is ook beschikbaar als [[Media:nl.zorg.Verrichting-v5.2(2020NL).pdf|pdf bestand]] [[File:PDF.png|link=]] of als [[Media:nl.zorg.Verrichting-v5.2(2020NL).xlsx|spreadsheet]] [[File:xlsx.png|link=]]&amp;lt;!--ftDownloads--&amp;gt;&lt;br /&gt;
==Over deze informatie&amp;lt;!--ftHeader2--&amp;gt;==&lt;br /&gt;
De informatie in deze wiki pagina is gebaseerd op de&amp;lt;!--ftInfoBase--&amp;gt; Publicatie 2020 &amp;lt;BR&amp;gt;&lt;br /&gt;
SNOMED CT en LOINC codes zijn gebaseeerd op:&lt;br /&gt;
&amp;lt;ul&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;SNOMED Clinical Terms version: 20200309 [R] (March 2020 Interim Release)&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;LOINC version 2.67&amp;lt;/li&amp;gt;&lt;br /&gt;
&amp;lt;/ul&amp;gt;&lt;br /&gt;
De voorwaarden van gebruik staan op de beginpagina&amp;lt;!--ftConditions--&amp;gt; [[Bestand:list2.png|link=ZIB_Hoofdpagina&amp;lt;!--wikiMainpage--&amp;gt;]]&amp;lt;BR&amp;gt;&lt;br /&gt;
Deze pagina is gegenereerd op 03/09/2020 00:43:56 met ZibExtraction v. 4.0.7547.38945&amp;lt;!--ftDate--&amp;gt; &amp;lt;BR&amp;gt;&lt;br /&gt;
-----&lt;br /&gt;
&amp;lt;div style=&amp;quot;text-align: right; direction: ltr; margin-left: 1em;&amp;quot; &amp;gt;[[Bestand: Back 16.png| link= ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL)]] [[ZIB_Publicatie&amp;lt;!--wikiReleasePage--&amp;gt;_2020(NL) |Terug naar ZIB overzicht&amp;lt;!--hdBackToMainPage--&amp;gt; ]]&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20076</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20076"/>
		<updated>2020-08-24T13:08:57Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan nieuwe codestelsels voor het vullen van een waardelijst wordt voor deze codestelsels een nieuwe branch van de root OID aangemaakt met een branche één hoger dan het hoogst uitgegeven nummer.&amp;lt;br&amp;gt;&lt;br /&gt;
Het hoogst uitgegeven nummer staat boven aan de lijst met codestelsels. Na het uitgeven van een nieuw nummer moet dit getal aangepast worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor ieder nieuw codestelstel binnen de zib wordt de branche uitgebreid, beginnend met .1, dus ook als er slecht één codestelsel wordt toegevoegd.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;25&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;5&amp;quot;|0||rowspan = &amp;quot;5&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|Opleiding||2.16.840.1.113883.2.4.3.11.60.40.4.24.1||CBS-SOI2016AGG3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.24.2||CBS-CTO2016&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|14||rowspan=&amp;quot;2&amp;quot;|Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|-&lt;br /&gt;
|BehandelAanwijzing2||2.16.840.1.113883.2.4.3.11.60.40.4.25.1||BehandelBesluiten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja [Deprecated]||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee [Deprecated]||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen [Deprecated]||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Information_model&amp;diff=20030</id>
		<title>Information model</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Information_model&amp;diff=20030"/>
		<updated>2020-07-16T07:42:08Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Algemeen */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Het informatie model geeft een visuele representatie van de gegevens die een bouwsteen bevat en hun onderlinge relaties.&amp;lt;br&amp;gt;&lt;br /&gt;
Het is een conceptueel, deel logisch model en bevat geen technische (implementatie) details en het kan één of meedere submodellen omvatten.&amp;lt;br&amp;gt;&lt;br /&gt;
Een model bevat tenminste een rootconcept en één gegevenselement.&amp;lt;br&amp;gt;&lt;br /&gt;
{| &lt;br /&gt;
|+&lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant: small-caps; text-align: center&amp;quot;|Voorbeeld van een informatie model&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:Alert-v3.2Model(2017NL).png | 550px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Classes toevoegen==&lt;br /&gt;
&lt;br /&gt;
===Algemeen===&lt;br /&gt;
Ieder informatiemodel begint met een rootconcept,  dat de essentie van de bouwsteen vertegenwoordigt. Het rootconcept, en daarmee de bouwsteen, is altijd een enkelvoudige representatie van een begrip, geen lijst, dus Probleem en niet Problemen.&lt;br /&gt;
&lt;br /&gt;
Om classes (rootconcept, container, dataelement, etc) toe te kunnen voegen aan het informatie model , moet het model eerst geopend worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Daaerna kunnen ze op twee manieren toegevoegd worden:&lt;br /&gt;
{| &lt;br /&gt;
|1.&lt;br /&gt;
|Selecteer in de Toolbox, sectie Class de Class en sleep deze op het informatie model&lt;br /&gt;
|-&lt;br /&gt;
||&lt;br /&gt;
|&lt;br /&gt;
{|&lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot; |Class toevoegen via de toolbox&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:Toolbox.png]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|&lt;br /&gt;
| style=&amp;quot;vertical-align: top&amp;quot;|2.&lt;br /&gt;
|Selecteer in de Project Browser Common&amp;gt;DCM Datatypes en vervolgens het gewenste datatype.&amp;lt;br&amp;gt;Sleep dit op het informatie model en kies Drop as Child. Vul de gewenste naam in.&lt;br /&gt;
|-&lt;br /&gt;
|| &lt;br /&gt;
|&lt;br /&gt;
{| style=&amp;quot;border:1px solid lightgray; border-collapse:collapse&amp;quot;&lt;br /&gt;
|+ &lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border-bottom:1px solid lightgray&amp;quot; colspan=3|Class toevoegen via DCM datatypes&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:ProjectBrowser1.png| width = 250px]]&lt;br /&gt;
| width=&amp;quot;25px&amp;quot;| &lt;br /&gt;
| style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:PasteChild.png]]&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Doubleclick op de toegevoegde class. Het eigenschappen scherm opent zich.&amp;lt;br&amp;gt;&lt;br /&gt;
Selecteer Stereotype en vul de gewenste waarde (rootconcept, container, data).&amp;lt;br&amp;gt;&lt;br /&gt;
Tevens kunnen hier ook de benodigde tagged values ingevuld worden.&lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Eigenschappen venster van de class&lt;br /&gt;
|-&lt;br /&gt;
||[[Bestand:ClassProperties.png| 600px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Als de juiste versie van de DCM Stereotypes file geladen is, worden de kleur en lijndikte automatisch goed ingesteld.&lt;br /&gt;
&lt;br /&gt;
===Naamgeving concepten===&lt;br /&gt;
Veel bouwstenen hebben generieke concepten als &#039;Toelichting&#039; of &#039;Naam&#039; logischerwijs dezelfde naam. Hierdoor kunnen veel items ontstaan met dezelfde naam (evt. zelfs binnen de bouwsteen).&amp;lt;br&amp;gt;&lt;br /&gt;
Daaarom moeten generieke namen, indien deze tot verwarring kunnen leiden, verder verbijzonderd worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor wordt de volgorde Item-Attribuut gebruikt. Dus: ProbleemType. Namen van concepten als &#039;BeginDatum&#039;, &#039;Type&#039; en &#039;Status&#039; hoeven niet perse te beginnen met de naam van de bouwsteen.&amp;lt;br&amp;gt;&lt;br /&gt;
Een begindatum hoeft dus niet perse &#039;BehandelaanwijzingBegindatum&#039; te heten indien de naam &#039;Begindatum&#039; maar geen verwarring kan opleveren binnen die bouwsteen.&amp;lt;br&amp;gt; &lt;br /&gt;
Met de DCM::ConceptId krijgt het concept alsnog een unieke definitie zodat verwarring over de bouwstenen heen is uitgesloten.&amp;lt;br&amp;gt; &lt;br /&gt;
Het is echter wel toegestaan om de naam van het concept te beginnen met de naam van de bouwsteen. In dat geval staat de bouwsteennaam altijd vooraan, bijvoorbeeld: &#039;AlertType&#039;, ‘ProbleemType.&lt;br /&gt;
&lt;br /&gt;
Het rootconcept van een bouwsteen heeft dezelfde naam als de bouwsteen met weglating van de namespace, b.v. het rootconcept van de bouwsteen nl.zorg.Bloeddruk heet Bloeddruk.&lt;br /&gt;
&lt;br /&gt;
Bij de naamgeving wordt PascalCasing (ook wel UpperCamelCasing) gebruikt. Dit houdt in dat de naam geen spaties mag bevatten en dat bij woorden die normaliter met een spatie gescheiden worden, de spatie en de daarop volgende letter vervangen worden door de corresponderende hoofdletter. In tegenstelling tot lowerCamelCasing begint de naam ook met een hoofdletter.&lt;br /&gt;
&lt;br /&gt;
===Definitie concepten===&lt;br /&gt;
Als een klasse met stereotype &#039;Rootconcept&#039; of &#039;Container&#039; wordt toegevoegd, worden [[Zib_afspraken#Standaardteksten | standaardteksten]] opgenomen in de definitie.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor de overige concepten bevat de definitie een korte maar heldere omschrijving van het concept. Overwegingen die geleid hebben tot deze tekst, horen hier niet bij.&amp;lt;br&amp;gt;&lt;br /&gt;
Soms is het noodzakelijk om naast de definitie iets op te nemen over de context waarin de definitie gehanteerd wordt.&lt;br /&gt;
&lt;br /&gt;
== Welke items/class vullen ==&lt;br /&gt;
Naast de naam en de definitie kunnen bij ieder concept een &#039;alias&#039; en één of meer attributen worden vastgelegd in de vorm van &#039;tagged values&#039;.&lt;br /&gt;
In de sectie [[Zib_afspraken | Afspraken en eisen]] staat voor de zibs uit de landelijke set opgegeven hoe het &#039;alias&#039; gevuld moet worden en welke &#039;tagged values&#039; per type concept vastgelegd kunnen of moeten worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Zie ook secties [[#Verwijzingen naar andere bouwstenen|Verwijzingen naar andere bouwstenen]] en [[#Valuesets en codes|Valuesets en codes]]&lt;br /&gt;
&lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Tagged Values window&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:TaggedValueWindow.png]]&lt;br /&gt;
|}&lt;br /&gt;
Als het Tagged Values window niet zichtbaar is is dit op te roepen via tabblad &#039; Start/Explore&#039;, item &#039; Properties&#039; &amp;gt; &#039;Tagged Values&#039;. (EA versie 14)&lt;br /&gt;
&lt;br /&gt;
== Codering van de concepten ==&lt;br /&gt;
&lt;br /&gt;
De DCM standaard eist dat voor ieder concept een definition code gedefinieerd wordt. Zonder codering is alles betekenisloos. Daarin kan alleen een Snomed CT code staan als je zeker weet dat het de juiste is, anders moet je een eigen code opvoeren en deze goed definieren. Die “eigen” code kan ook een Snomed CT extensie zijn. Foute SNOMED codes zouden juist misverstanden kunnen introduceren doordat je toch &#039;misbruik&#039; maakt van een concept uit bv SNOMED, wat eigenlijk een semantische fout introduceert. Ook zijn er vaak geen definition codes voor ons type containers.&amp;lt;br&amp;gt;&lt;br /&gt;
Daarnaast is het noodzakelijk om ieder concept uniek te kunnen identificeren. Daarvoor is de DCM::ConceptId tag geintroduceerd. Deze bevat als waarde een wereldwijd uniek id in de vorm van een OID.&amp;lt;br&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Hiervoor is een projectOID toegekend onder de Nictiz OID. Onder deze OID zijn branches aangemaakt voor nummering van zibs, concepten en valuestes.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*De project OID : 2.16.840.1.113883.2.4.3.11.60.40&amp;lt;br&amp;gt;&lt;br /&gt;
*De OID voor elementen: 2.16.840.1.113883.2.4.3.11.60.40.1 (substituut hele OID = NL-CM)&amp;lt;br&amp;gt;&lt;br /&gt;
*De OID voor valuesets: 2.16.840.1.113883.2.4.3.11.60.40.2 &amp;lt;br&amp;gt;&lt;br /&gt;
*De OID voor [[Zib_Nummering |bouwstenen]]: 2.16.840.1.113883.2.4.3.11.60.40.3 &amp;lt;br&amp;gt;&lt;br /&gt;
*De OID voor [[Zib_Codestelsels | eigen codesystemen]]: 2.16.840.1.113883.2.4.3.11.60.40.4 &amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In de DCM nemen we per concept een DCM::ConceptId op in de vorm: &amp;lt;br&amp;gt;&lt;br /&gt;
DCM::ConceptId = NL-CM: &amp;lt;klassenummer&amp;gt;.&amp;lt;DCMvolgnummer&amp;gt;.&amp;lt;elementnummer&amp;gt; &amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt; &amp;lt;br&amp;gt;&lt;br /&gt;
NL-CM staat voor : &amp;quot;Netherlands Content Model Elements&amp;quot;.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Bij de elementnummering wordt begonnen bij het rootconcept. Dit krijgt elementnummer 1. Voor de overige elementen wordt geen vaste volgorde voorgeschreven.&amp;lt;br&amp;gt; &lt;br /&gt;
 Voorbeeld:&lt;br /&gt;
 De eerste elementen van de eerste Bouwsteen in klasse social history  zijn NL-CM:7.1.1, NL-CM:7.1.2 etc.&lt;br /&gt;
 De elementen van de tweede Bouwsteen zouden dan zijn NL-CM:7.2.1, NL-CM:7.2.2 etc.&lt;br /&gt;
&lt;br /&gt;
Voor valuesets wordt gebruikelijk geen notatie in de vorm van een root en een extensie gebruikt, maar wordt achter de root OID doorgenummerd, met punten als scheidingsteken. Een alias is hierbij niet gebruikelijk. De notatie voor de valuesets wordt dan: 2.16.840.1.113883.2.4.3.11.60.40.2.x.y.z, echter Z is hier het volgnummer van de valueset binnen de DCM en niet het volgnummer van het element waar de valueset bij hoort. (let op het verschil in notatie, een ‘.’ ipv ‘:)&amp;lt;br&amp;gt;&lt;br /&gt;
 Voorbeeld: &lt;br /&gt;
 De eerste valueset/codelijst in de eerste DCM binnen de klasse social history is dan 2.16.840.1.113883.2.4.3.11.60.40.2.7.1.1&lt;br /&gt;
&lt;br /&gt;
Voor codesystemen bestaat voor de extensie voor bouwsteen gebaseerde nummermethodiek. Deze worden naar behoefte uitgegeven.&lt;br /&gt;
&lt;br /&gt;
Voor DCM’s is de nummering in de vorm:&amp;lt;br&amp;gt;&lt;br /&gt;
Project OID.3.x.y waarin:  &lt;br /&gt;
*X = Klassenummer&lt;br /&gt;
*Y = DCM volgnummer&lt;br /&gt;
Als er slechts één (1) DCM in de sectie voorkomt, dan heeft Y de waarde ‘1’ (en mag dan dus niet weggelaten worden).&lt;br /&gt;
&lt;br /&gt;
Samenvattend zijn de afspraken voor het coderen van de element van de bouwstenen:&lt;br /&gt;
*Ieder element krijgt een code uit het NL-CM systeem, zoals hierboven beschreven.&lt;br /&gt;
*Het rootconcept krijgt binnen de bouwsteen elementnummer 1&lt;br /&gt;
*Het rootconcept krijgt nooit een andere(bv SNOMED-CT) code.&lt;br /&gt;
*Andere elementen inclusief containers kunnen wel codes uit andere codesystemen, zoals SNOMED-CT krijgen, uitsluitend als het element overeenkomt met het concept van de code.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt; Historisch zijn de bouwsteen Id&#039;s uitgegeven aan de hand van de CCR/CCD sectienummers waarin de betreffende bouwstenen gepositioneerd waren.&lt;br /&gt;
Hoewel deze indeling niet meer leidend is, wordt de nummering nog wel gehandhaafd om de bouwstenen in klasses van gerelateerde concepten in te delen.&lt;br /&gt;
Deze indeling is niet heel strak en de nummering heeft in principe geen belangrijke betekenis aangezien de Id&#039;s per definitie betekenisloos zijn.&lt;br /&gt;
&lt;br /&gt;
== Relaties maken ==&lt;br /&gt;
Met uitzondering van het legenda element worden alle elementen van een informatie model met elkaar verbonden door relaties.&amp;lt;br&amp;gt;&lt;br /&gt;
De grafische representatie van zo&#039;n relatie is een pijl. Zie ook de [[Gebruik_van_UML_voor_DCM_modellering#Het_vastleggen_van_relaties_tussen_elementen  | sectie over UML modellering]].&amp;lt;br&amp;gt;&lt;br /&gt;
In de zibs gebruiken we een aantal relatietypes:&lt;br /&gt;
{|&lt;br /&gt;
|&lt;br /&gt;
*&lt;br /&gt;
*&lt;br /&gt;
*&lt;br /&gt;
*&lt;br /&gt;
*&lt;br /&gt;
|[[Bestand:Relations.png | 165px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
In de zib&#039;s is de standaard toegepaste relatie een compositie (Composition to the whole). Een compositie-relatie loopt in de zibs altijd van een class of container element naar een container of rootconcept.&amp;lt;br&amp;gt;&lt;br /&gt;
Aan de source kant van de relatie (niet-pijl kant) wordt de cardinaliteit van de relatie aangegeven. Deze kan zijn:&lt;br /&gt;
* 0..1&lt;br /&gt;
* 1&lt;br /&gt;
* 0..*&lt;br /&gt;
* 1..*&lt;br /&gt;
&lt;br /&gt;
De cardinaliteit aan de destination kant van de relatie wordt altijd &#039;1&#039; verondersteld.&amp;lt;br&amp;gt;&lt;br /&gt;
In [[#Aggregatie |speciale gevallen]] wordt een aggregatie relatie toegepast (Aggregation to the whole). De richting afspraak is daarbij hetzelfde.&lt;br /&gt;
&lt;br /&gt;
Specialisaties worden in het informatie model van de zibs zelden gebruikt. Als iets echter echt een generalisatie/specialisatie is, kan die ook zo gemodelleerd worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In tegenstelling tot compositie/aggregatie relaties kunnen generalisatie relaties wel class elementen aan elkaar verbinden.&amp;lt;br&amp;gt;&lt;br /&gt;
Een voorbeeld daarvan zijn de relaties met de DCM datatypes. Van ieder class element van een bepaald type loopt een generalisatie relatie naar dat datatype (deze is in het model echter niet als pijl zichtbaar).&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Een notelink relatie wordt gebruikt tussen een [[#Notes | note]] of [[#Constraints | constraint]] en het element waar deze betrekking op heeft.&amp;lt;br&amp;gt;&lt;br /&gt;
Een dependency komt tussen een [[#Valuesets en codes | document artifact]] (valueset document) en het class element waar deze valueset bij hoort.&lt;br /&gt;
&lt;br /&gt;
Een relatie wordt aangebracht door:&lt;br /&gt;
# de bron class te selecteren en met de muis de pijl rechtsboven naast de class vast te pakken&lt;br /&gt;
# de pijl naar de bestemming container te slepen&lt;br /&gt;
# de pijl los te laten en het juiste type te selecteren&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Het aanbrengen van een relatie&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:makeRelation.png | 800px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Aggregatie ==&lt;br /&gt;
Een bijzonder geval van relaties tussen class elementen en een container is indien er slechts één element tegelijk mag voorkomen van de elementen die tot de aggregatie behoren.&amp;lt;br&amp;gt;&lt;br /&gt;
Ga dan in het model als volgt te werk:&lt;br /&gt;
*Voeg een Boundary toe (uit de common elements van de toolbox)&lt;br /&gt;
*Voeg een Constraint toe met de tekst &amp;lt;noWiki&amp;gt;&#039;&amp;lt;/noWiki&amp;gt;&#039;&#039;Precies één concept uit deze keuze box moet geselecteerd worden&#039;&#039;&#039; en verbind deze constraint via een NoteLink met de Boundary.&lt;br /&gt;
*Verbind ieder concept binnen de boundary met de boundary met een aggregation relatie.&amp;lt;br&amp;gt;Dit doe je door vanaf het concept een dependency relatie te leggen naar de boundary, deze relatie daarna te selecteren en met de rechtermuisknop &#039;Advanced&amp;gt;Change Type...&#039; te kiezen.&amp;lt;br&amp;gt;In de keuzebox die dan opkomt kan &#039;Aggregation&#039; gekozen worden.&amp;lt;br&amp;gt;Let op: zolang het concept binnen de boundary staat is de relatie niet zichtbaar in het diagram&amp;lt;br&amp;gt;Het bestaan van de relatie kan gecontroleerdworden door het concept tijdelijk buiten de boundary te slepen&amp;lt;br&amp;gt; &amp;lt;br&amp;gt; &lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Keuzebox met aggregaties&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:Aggregatie.png]]&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
De container boven de boundary geeft de rol aan die de onderstaande concepten hebben in de bouwsteen.&amp;lt;br&amp;gt;&lt;br /&gt;
Alle concepten binnen de boundary moeten deze rol ook kunnen vervullen. Indien dit niet zo is, moet een extra container geplaatst worden.&lt;br /&gt;
&lt;br /&gt;
== Notes ==&lt;br /&gt;
Notes elementen worden eventueel gebruikt om extra algemene informatie in het informatie model op te nemen over data, container, rootconcept of valueset artifacten.&lt;br /&gt;
Werkwijze:&lt;br /&gt;
* Sleep een &amp;quot;Note&amp;quot; component uit de &amp;quot;Common&amp;quot; sectie van de toolbox naar het diagram.&lt;br /&gt;
* DoubleClick op het &#039;Note&#039; element.&lt;br /&gt;
* De notes editor gaat dan open. Vul de gewenste tekst is en druk op &#039;OK&#039;. &lt;br /&gt;
* [[#Relaties maken | Verbind]] de Note met een Notelink relatie met het bijhehorende element.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{| style=&amp;quot;border:1px solid lightgray; border-collapse:collapse&amp;quot;&lt;br /&gt;
|+ &lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border-bottom:1px solid lightgray&amp;quot; |Aanmaken van een note&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:NewNotes.png | 700px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Constraints ==&lt;br /&gt;
Constaint elementen worden indien gewenst een inperking op de geldigheid, waardebereik, o.i.d. aan te geven die geldt voor een bepaald element, b.v. bij een valueset dat de set alleen geldig is voor volwassenen ouder dan 18 jaar.&lt;br /&gt;
Werkwijze:&lt;br /&gt;
* Sleep een &amp;quot;Constaint&amp;quot; component uit de &amp;quot;Common&amp;quot; sectie van de toolbox naar het diagram.&lt;br /&gt;
* DoubleClick op het &#039;Constraint&#039; element.&lt;br /&gt;
* De constraint editor gaat dan open. Vul de gewenste tekst is en druk op &#039;OK&#039;. Het Constraint Type veld wordt niet gebruikt.&lt;br /&gt;
* [[#Relaties maken | Verbind]] de Constraint met een Notelink relatie met het bijhehorende element.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{| style=&amp;quot;border:1px solid lightgray; border-collapse:collapse&amp;quot;&lt;br /&gt;
|+ &lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border-bottom:1px solid lightgray&amp;quot; |Aanmaken van een constraint&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:NewConstraints.png | 700px]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Verwijzingen naar andere bouwstenen ==&lt;br /&gt;
===Algemeen===&lt;br /&gt;
&lt;br /&gt;
Als in een bouwsteen verwezen wordt naar (een rootconcept van) een andere bouwsteen wordt een generieke klasse aangemaakt met stereotype &amp;lt;&amp;lt;context&amp;gt;&amp;gt; of &amp;lt;nowiki&amp;gt;&amp;lt;&amp;lt;data&amp;gt;&amp;gt;&amp;lt;/nowiki&amp;gt; &#039;&#039;&#039;én stereotype&#039;&#039;&#039; &amp;lt;&amp;lt;reference&amp;gt;&amp;gt;.&amp;lt;br&amp;gt;&lt;br /&gt;
Welk eerste stereotype gekozen wordt, hangt van de aard van het verwijzende concept af. Zo zal de verwijzing bij hoofdbehandelaar naar het rootconcept van de bouwsteen Zorgverlener &amp;lt;&amp;lt;context, reference&amp;gt;&amp;gt; zijn en de verwijzing van indicatie naar probleem uit Probleem &amp;lt;&amp;lt;data, reference&amp;gt;&amp;gt; zijn.&lt;br /&gt;
 Let op de volgorde! Om hier zeker van te zijn, verdient het aanbeveling om eerst stereotype &amp;lt;&amp;lt;context&amp;gt;&amp;gt; of &amp;lt;nowiki&amp;gt;&amp;lt;&amp;lt;data&amp;gt;&amp;gt;&amp;lt;/nowiki&amp;gt; te selecteren en te accepteren en daarna stereotype &amp;lt;&amp;lt;reference&amp;gt;&amp;gt; en niet tegelijk.&lt;br /&gt;
Bij verwijzing wordt altijd naar het rootconcept van een bouwsteen verwezen. Indien de noodzaak bestaat om naar een deel van een andere bouwsteen te verwijzen, is dat een indicatie dat de bouwsteen waarnaar verwezen wordt, wellicht te groot is.&amp;lt;br&amp;gt;&lt;br /&gt;
De naam van de klasse wordt &#039;&#039;Conceptnaam&#039;&#039;::&#039;&#039;GerefereerdeConceptnaam&#039;&#039;. De eerste conceptnaam is de naam in de verwijzende bouwsteen, de tweede is de naam in de de  bouwsteen waarna verwezen wordt.&amp;lt;br&amp;gt;&lt;br /&gt;
Beide conceptnamen benoemen is niet verplicht. Dit wordt alleen gebruikt als het nodig en zinvol is. Vaak zal de eerste naam een aanduiding zijn van de rol die de bouwsteen waarnaar verwezen wordt, speelt in verwijzende bouwsteen, b.v. Voorschrijver::Zorgverlener.&amp;lt;br&amp;gt;&lt;br /&gt;
In de minimale vorm is de naam van de klasse &#039;&#039;GerefereerdeConceptnaam&#039;&#039;. De hele tekst van de klasse heeft 40% grijs als kleur (handmatig instellen). &amp;lt;br&amp;gt;&lt;br /&gt;
De verwijzing wordt gecomplementeerd door bij het verwijzende concept de tag DCM::ReferencedConceptId te vullen met de unieke DCM::ConceptId van het rootconcept van de bouwsteen waarnaar verwezen wordt. &amp;lt;br&amp;gt;&lt;br /&gt;
Bovendien wordt in het notes-veld bij de DCM::ReferencedConceptId een [[Zib_afspraken#Standaardteksten | standaardtekst]] opgenomen, zodat ook voor de menselijke lezer duidelijk is naar welk concept verwezen wordt.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Bij verwijzing naar een rootconcept wordt impliciet ook naar de onder dit rootconcept hangende concepten verwezen. &amp;lt;br&amp;gt;&lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Verwijzing naar een andere bouwsteen&lt;br /&gt;
|-&lt;br /&gt;
||[[Bestand:Bouwsteenverwijzing.png]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Bij verwijzing naar een andere bouwsteen komt het soms voor dat deze bouwsteen één of meerdere valuesets bevat die veel generieker zijn dan in de verwijzing zinvol is (bv. een heel codesysteem als SNOMEC CT).&amp;lt;br&amp;gt;&lt;br /&gt;
Vaak bestaat dan de wens om de valueset in de verwijzing in te perken. Indien de ingeperkte valueset een subset van de oorspronkelijke valueset is, wordt de bouwsteen feitelijk niet gewijzigd en is de ingeperkte valueset eigenlijk alleen een implementatie aanwijzing die het inzicht in de verwijzing en het gebruik van de bouwsteen eenvoudiger maakt. &amp;lt;br&amp;gt;&lt;br /&gt;
Daarom is het inperken van een valueset bij verwijzing alleen onder bovengenoemde voorwaarde toegestaan.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In het model wordt dit als volgt gerealiseerd:&lt;br /&gt;
*Voeg een Boundary toe (uit de common elements van de toolbox) en geef deze de naam &amp;quot;Bouwsteen &amp;lt;naam zib zonder namespace&amp;gt;&amp;quot;.&lt;br /&gt;
*Plaat de bouwsteen verwijzing (meestal data reference) binnen de boundary en voeg eveneens binnen de boundary een (nieuw) element toe en geef het dezelfde naam als het element uit de bouwsteen waar naar verwezen wordt en waar de betreffende waardelijst aan verbonden is.&amp;lt;br&amp;gt;De relatie tussen de bouwsteen verwijzing en de bovenliggende container blijft behouden.&lt;br /&gt;
*Verbind ieder concept binnen de boundary met de boundary met een aggregation relatie.&amp;lt;br&amp;gt;Dit doe je door vanaf het concept een dependency relatie te leggen naar de boundary, deze relatie daarna te selecteren en met de rechtermuisknop &#039;Advanced&amp;gt;Change Type...&#039; te kiezen.&amp;lt;br&amp;gt;In de keuzebox die dan opkomt kan &#039;Aggregation&#039; gekozen worden.&amp;lt;br&amp;gt;Let op: zolang het concept binnen de boundary staat is de relatie niet zichtbaar in het diagram&amp;lt;br&amp;gt;Het bestaan van de relatie kan gecontroleerdworden door het concept tijdelijk buiten de boundary te slepen&lt;br /&gt;
*Voeg buiten de boundary een [[#Valuesets en codes | waardenlijst document artifact]] toe met de ingeperkte waardenlijst&lt;br /&gt;
&lt;br /&gt;
Het toegevoegde concept waar de waardenlijst mee verbonden is, moet het DCM::ConceptID krijgen van de zib waar naar wordt verwezen, de waardelijst krijgt een OID conform de regels voor waardenlijst OID&#039;s binnen de nummerruimte van de bouwsteen waar uit vandaan verwezen wordt.&lt;br /&gt;
{| &lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot;|Verwijzing naar een andere bouwsteen met ingeperkte waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
||[[Bestand:Bouwsteenverwijzing2.png]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Valuesets en codes ==&lt;br /&gt;
===Valueset vermelding===&lt;br /&gt;
&lt;br /&gt;
Bij een concept van het type CD of CO wordt het waardebereik vastgelegd in een &#039;losse&#039; valueset die in een document artifact aan het bijbehorende concept wordt gerelateerd (en dus &#039;&#039;&#039;niet&#039;&#039;&#039; als enumeratie attributen van dat concept).&amp;lt;br&amp;gt;&lt;br /&gt;
Iedere valueset (dus ieder document artifact) krijgt in het CD/CO element een tagged value &#039;DCM::Valueset&#039; waarbij het &#039;waarde&#039; veld gevuld wordt met de naam van de valueset en het &#039;notes&#039; veld de OID van die valueset. Hiermee wordt de naam van de valueset aan de OID van die valueset gekoppeld.&amp;lt;br&amp;gt;&lt;br /&gt;
Voorbeeld:&lt;br /&gt;
 DCM::Valueset = SocialeAnamneseTypeCodelijst en in de notes OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.1.1&lt;br /&gt;
Het notes veld van een tagged value wordt gevuld door de tagged value te selecteren en vervolgens het Notes icon te kiezen.&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot; |Notes van een tagged value&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:TaggedValueNotes.png]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Bij het concept waarop één of meer valuesets van toepassing zijn, worden alle relevante valuesets in een tagged value (DCM::Valueset) vermeld. Dit geldt voor valuesets die een vergelijkbaar waardebereik vastleggen.&amp;lt;br&amp;gt;&lt;br /&gt;
Bij implementatie moet dan gekozen worden welke valueset toegepast wordt.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien het waardenbereik een verzameling is van meerdere valuestes of codesystemen, moet een valueset aangemaakt worden die alle waarden bevat.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Naamgeving en nummering===&lt;br /&gt;
Alle valuesets hebben een naam en een nummer in de vorm van een OID.&lt;br /&gt;
Soms kunnen voor de bouwsteen bestaande valuesets gebruikt worden. Hierbij wordt een eigen naam en een OID toegekend.&amp;lt;br&amp;gt;&lt;br /&gt;
Hierbij is de afspraak, dat&lt;br /&gt;
*de naam wordt &amp;lt;Conceptnaam&amp;gt;Codelijst , waarbij &amp;lt;Conceptnaam&amp;gt; vervangen wordt door de naam van het concept waar de valueset aan gekoppeld is.&lt;br /&gt;
:Indien er meerdere valuesets aan één concept gekoppeld wordt, worden de namen &amp;lt;Conceptnaam&amp;gt;&amp;lt;Toevoeging&amp;gt;Codelijst, bv. IngredientCodeATCCodelijst en IngredientCodeGPKCodelijst bij concept IngredientCode.&lt;br /&gt;
*de OID wordt toegekend zoals in [[#Codering van de concepten|&#039;Codering van de concepten&#039;]] is beschreven.&lt;br /&gt;
&lt;br /&gt;
===Opstellen valueset===&lt;br /&gt;
Bij de zibs is er voor gekozen om waardelijsten niet vast te leggen als enumeratie attributen bij het concept maar de waardenlijst aan het concept te koppelen middels een ‘document artifact’ (uit de Common elements). Dit doen we in alle gevallen voor enumeratie, dus niet alleen voor lange waardelijsten, maar ook voor korte.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Werkwijze:&lt;br /&gt;
* Op de [[Downloads | download pagina]] vind je een Word-template waarin je de waardelijst kunt intikken (template voor valuesets.docx).&lt;br /&gt;
* Hierbij geldt de afspraak dat in de kolom ConceptName de de beschrijving staat zoals die in het codesysteem gegeven wordt. Dit zal dus vaak een Engelse term zijn. In de kolom Description komt de Nederlandse vertaling van het begrip met eventueel een additionele toelichting.&lt;br /&gt;
* Sleep een &amp;quot;Document&amp;quot; component uit de &amp;quot;Common&amp;quot; sectie van de toolbox naar het diagram.&lt;br /&gt;
* DoubleClick op het &#039;artifact&#039;&lt;br /&gt;
* De document editor gaat dan open. Plak via copy/paste de waardelijst (tabel) uit het Word-document in de document editor.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;border:1px solid lightgray; border-collapse:collapse&amp;quot;&lt;br /&gt;
|+ &lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border-bottom:1px solid lightgray&amp;quot; |Aanmaken van een valueset&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:CreateArtifact.PNG]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
* Sluit de document editor.&lt;br /&gt;
* Het document wordt vervolgens met het concept verbonden met een ‘Dependency Link’ (vanaf het document naar het concept). Vervolgens wordt de pijlkop van de link verwijderd door met de rechtermuisknop te kiezen: Advanced-&amp;gt;Change Directions-&amp;gt;Unspecified &amp;lt;br&amp;gt;&lt;br /&gt;
 Let op!: Doe dit eenmalig en edit daarna eventuele wijzigingen direct in de document editor van EA. Dit om te voorkomen dat je de waardelijst op twee plaatsen (in het Word-bestand en in EA) actueel moet houden.&lt;br /&gt;
&lt;br /&gt;
N.B. Indien het waardebereik van een concept uit een compleet codesysteem bestaat, wordt een valueset aangemaakt die de naam en OID van dit codesysteem bevat en als conceptnaam &#039;Alle waarden&#039;.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Het waardelijstelement kent twee tagged values&lt;br /&gt;
* DCM::ValuesetID : het eerder genoemde OID&lt;br /&gt;
* DCM::ValuesetBinding : Waarde die aangeeft in welke mate het gebruik van de waardenlijst verplicht is. Mogelijke waarden zijn Required, Extensible, Preferred, Example.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;Required&#039;&#039;&#039; &amp;lt;br&amp;gt;Om conform te zijn met de zib, moeten alle elementen uit de gespecificeerde valueset komen.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;Extensible&#039;&#039;&#039; &amp;lt;br&amp;gt;To be conformant, the concept in this element SHALL be from the specified value set if any of the codes within the value set can apply to the concept being communicated. If the value set does not cover the concept (based on human review), alternate codings (or, data type allowing, text) may be included instead.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;Preferred&#039;&#039;&#039; &amp;lt;br&amp;gt; Instances are encouraged to draw from the specified codes for interoperability purposes but are not required to do so to be considered conformant.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;Example&#039;&#039;&#039; &amp;lt;br&amp;gt; Instances are not expected or even encouraged to draw from the specified value set. The value set merely provides examples of the types of concepts intended to be included.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;TODO vertalen&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{|&lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot; | Concept met valueset&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:Valueset.png]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Bij zibs voor de nationale set worden valuesets uit één zib niet hergebruikt in een andere zib. Alle valuesets zijn gebonden (mede door hun OID&#039;s) aan de zib waarvoor ze aangemaakt zijn.&amp;lt;br&amp;gt;&lt;br /&gt;
Als eenzelfde valueset ook nodig is in een andere zib wordt daar een kopie aangemaakt met een andere OID en evt. een andere naaam.&lt;br /&gt;
&lt;br /&gt;
===Waarden buiten Valueset===&lt;br /&gt;
 &lt;br /&gt;
Elk concept van het type CD of CO heeft naast de value set een ‘overige’ mogelijkheid om te voorkomen dat bij gebrek aan een juiste waarde een foute waarde geselecteerd wordt (zeker bij verplichte items). Afspraak is dat deze overige waarden  niet gecodeerde vrije tekst is. (in HL7 zal dit nullflavour OTH zijn met de tekst in originalText).&amp;lt;br&amp;gt;&lt;br /&gt;
Indien de DCM::ValuesetBinding de waarde Extensible heeft, is het mogelijk de waardelijst uit te breiden met een code uit het codesysteem waartoe ook de andere waarden van de waardelijst behoren.&amp;lt;br&amp;gt;&lt;br /&gt;
Het verdient aanbeveling om vervolgens de waardelijst formeel met de gekozen waarde uit te laten breiden.&lt;br /&gt;
&lt;br /&gt;
== Subdiagrammen ==&lt;br /&gt;
Als een diagram te groot of te complex wordt, kan het diagram opgeknipt worden in een hoofddiagram en subdiagrammen.&amp;lt;br&amp;gt;&lt;br /&gt;
De verbinding tussen hoofd- en subdiagrammen verloopt via een gemeenschappelijke container. Als dit op de juiste manier gedaan wordt, kan met een dubbelclick op deze container in het hoofddiagram automatisch naar het subdiagram gesprongen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
De werkwijze daarvoor is als volgt. Uitgangssituatie is dat er een hoofdiagram is en dat de gemeenschappelijke container daar nog niet instaat.&lt;br /&gt;
*Voeg aan het Information Model een nieuw package toe.&lt;br /&gt;
*Indien dit niet automatisch gebeurt, voeg aan dit package een class diagram toe.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot; | Subdiagram aanmaken&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:AddPackage.png]]&lt;br /&gt;
| width=&amp;quot;50px&amp;quot;| &lt;br /&gt;
| rowspan =3 style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:NewDiagram2.png]]&lt;br /&gt;
|-&lt;br /&gt;
|height= &amp;quot;25px&amp;quot;|&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:NewDiagram.png]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Vul het diagram met de gewenste concepten incl. de gemeenschappelijke container.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{|&lt;br /&gt;
|+ style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border:1px solid lightgray&amp;quot; | Subdiagram vullen&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:NewDiagram3.png]]&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
*Selecteer in het subdiagram de container en kies via de rechtermuisknop &#039;Add &amp;gt; Select Composite Diagram&#039; en selecteer het subdiagram.&lt;br /&gt;
*Ga naar het hoofddiagram en sleep de gemeenschappelijke container vanuit de Project Browser van het subdiagram naar het hoofddiagram als &#039;Link&#039;. &lt;br /&gt;
*Leg in het hoofddiagram vervolgens de relatie naar de bovenliggende container of het rootconcept en geef de cardinaliteit aan.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;BR&amp;gt;&lt;br /&gt;
{| style=&amp;quot;border:1px solid lightgray; border-collapse:collapse&amp;quot;&lt;br /&gt;
|+ &lt;br /&gt;
|style=&amp;quot;font-size:75%; font-variant:small-caps; text-align:center; border-bottom:1px solid lightgray&amp;quot; colspan=3|Hoofddiagram en subdiagram&lt;br /&gt;
|-&lt;br /&gt;
|[[Bestand:Hoofddiagram.png]]&lt;br /&gt;
| width=&amp;quot;25px&amp;quot;| &lt;br /&gt;
| style=&amp;quot;vertical-align: top&amp;quot;|[[Bestand:Subdiagram.png]]&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Opzetten_EA_omgeving&amp;diff=20027</id>
		<title>Opzetten EA omgeving</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Opzetten_EA_omgeving&amp;diff=20027"/>
		<updated>2020-06-11T08:11:33Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Installeren MDG Technology bestanden */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}}&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Voor het opzetten van een EA omgeving voor het maken van zib documentie zijn benodigd:&lt;br /&gt;
* Enterprise Architect (nieuwste versie is 15; bij Nictiz in gebruik is versie 14.1; info per 17-10-2019))&lt;br /&gt;
* MDG Technology for HCIM (Zorginformatie bouwstenen)&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt;&lt;br /&gt;
* MDG Technology for HCIM to Wiki Extraction&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt;&lt;br /&gt;
* (optioneel) DCM Stereotypes&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;&lt;br /&gt;
* (optioneel) DCM standaard datatypes&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;&lt;br /&gt;
* (optioneel) RTF Template(s)&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;&lt;br /&gt;
* (optioneel) Zib startproject file (*.EAP file met daarin 0 of meer bouwstenen, de juiste RTF rapporttemplates en de standaard DCM data types die worden gebruikt)&lt;br /&gt;
* (optioneel) Zib bouwsteen template (XMI file met een &#039;schone&#039; lege bouwsteen)&lt;br /&gt;
* (optioneel) XMI file(s) van bestaande bouwstenen&lt;br /&gt;
&lt;br /&gt;
Met uitzondering van Enterprise Architect zijn bovenstaande bestanden te vinden op de [[Downloads |download pagina]].&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt; Installatie gebonden bestanden: moeten bij iedere nieuwe (her)installatie van Enterprise Architect geinstalleerd worden.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; Projectfile (eap) gebonden bestanden: moeten aan ieder nieuw zib project toegevoegd worden. Indien een bestaande projectfile wordt gebruikt (incl. het startproject) hoeft dit niet meer gedaan te worden.&lt;br /&gt;
&lt;br /&gt;
==Enterprise Architect==&lt;br /&gt;
Begin eventueel met de 30 dagen gratis versie&amp;lt;br&amp;gt;&lt;br /&gt;
Hierna kan het pakket aangeschaft worden via https://www.sparxsystems.eu/enterprise-architect/ea-pricing-purchasing/?gclid=Cj0KCQjwoqDtBRD-ARIsAL4pviAVr6im7DwSsEvQvESVtSdXMlj5pLebf3g_zVEoXDyQWl_hhp6J8hAaAgfrEALw_wcB of via de binnen de organisatie gebruikelijke procedure.&amp;lt;br&amp;gt;&lt;br /&gt;
Elke versie is geschikt, de goedkoopste is de Professional versie. Voor medewerkers van onderwijsinstellingen waaronder UMC&#039;s is een (goedkopere) Academic version beschikbaar.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Apple of Linux users==&lt;br /&gt;
Sparx geeft aan dat EA o.a. werkt via crossover of wine (check de versies op de website van Sparx). &lt;br /&gt;
&lt;br /&gt;
Als je meer windows applicaties wil draaien is VirtualBox van Oracle is een gratis optie (https://www.virtualbox.org) of Parallels (licentie en kosten maar ook beschikbaar via surfspot voor onderwijsinstellingen waaronder UMC&#039;s. Je moet dan nog wel een windows licentie kopen en installeren.&lt;br /&gt;
&lt;br /&gt;
==Installeren MDG Technology bestanden==&lt;br /&gt;
[[Bestand:Add_MDG_technology.png|200px|thumb|right|screenshot]]&lt;br /&gt;
*Download de &#039;MDG Technology&#039; files en onthoud de locatie.&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 12)&#039;&#039;&#039;&amp;lt;/span&amp;gt; Let op! De bestanden moeten daar na het doorlopen van deze procedure blijven staan en beschikbaar blijven. Installeer ze dus niet op een netwerkschijf of verwijderbaar medium als b.v. een USB stick.&amp;lt;br&amp;gt;&lt;br /&gt;
*Start Enterprise Architect en &lt;br /&gt;
:&amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 12)&#039;&#039;&#039;&amp;lt;/span&amp;gt;&lt;br /&gt;
:*kies via het menu &#039;Extensions&#039; en vervolgens &#039;MDG Technologies&#039;&lt;br /&gt;
:*Klik onderaan op de knop &#039;Advanced&#039;&lt;br /&gt;
:*Klik onderaan op de knop &#039;Add&#039; en vervolgens optie &#039;Add Path&#039;&lt;br /&gt;
:*Selecteer de folder waar de files zijn gedownload&lt;br /&gt;
:&amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 14)&#039;&#039;&#039;&amp;lt;/span&amp;gt;&lt;br /&gt;
:*kies via tabblad &#039;Specialize&#039; en item &#039;Publish&#039; en vervolgens &#039;Import MDG Technologies&#039;&lt;br /&gt;
:*Selecteer de &#039;MDG Technology&#039; file&lt;br /&gt;
:*Selecteer &#039;Import To Model&#039;&lt;br /&gt;
*Klik op &#039;OK&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
:&amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 15)&#039;&#039;&#039;&amp;lt;/span&amp;gt;&lt;br /&gt;
:*kies via tabblad &#039;Specialize&#039; en item &#039;Publish-Tech&#039; en vervolgens &#039;Import MDG Technologies&#039;&lt;br /&gt;
:*Selecteer de &#039;MDG Technology&#039; file&lt;br /&gt;
:*Selecteer &#039;Import To Model&#039;&lt;br /&gt;
*Klik op &#039;OK&#039; &amp;lt;br&amp;gt;*Sluit EA af en &#039;&#039;&#039;herstart zodat de DCM MDG Technology wordt geladen&#039;&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
*Kijk via &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 12)&#039;&#039;&#039;&amp;lt;/span&amp;gt; menu &#039;Settings&#039; en vervolgens &#039; MDG Technologies&#039; cq. &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 14)&#039;&#039;&#039;&amp;lt;/span&amp;gt; tabblad &#039;Specialize&#039;, item &#039;Manage&#039;  &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;&#039;&#039;&#039;(EA versie 15)&#039;&#039;&#039;&amp;lt;/span&amp;gt; tabblad &#039;Specialize&#039;, item &#039;Manage-Tech&#039; of de HCIM MDG Technologies is geladen (zie voorbeeld) &amp;lt;br&amp;gt;&lt;br /&gt;
Doe dit voor beide &#039;MDG Technology&#039; files.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Alternatief kunnen de MDG bestanden ook geplaatst worden in de bestaande map &#039;..\Program Files (x86)\Sparx Systems\EA\MDGTechnologies&#039;, maar daar zijn wel administrator rechten voor nodig.&amp;lt;br&amp;gt;&lt;br /&gt;
Wanneer bestaande MDG Technology bestanden moeten worden vervangen door een nieuwere, verwijder dan eerst de oude uit de AppData filder (windows 10 C:\Users\username|AppData\Roaming\Sparx Systems\EA )&lt;br /&gt;
&lt;br /&gt;
==Aan de slag==&lt;br /&gt;
Om aan de slag te gaan met het modelleren van zibs na de installatie van Enterprise Architect en de MDG Technology bestanden, zijn er drie mogelijkheden:&amp;lt;br&amp;gt;&lt;br /&gt;
1: Start met een nieuwe projectfile:&lt;br /&gt;
*Start Enterprise Architect en maak een nieuwe projectfile aan.&lt;br /&gt;
*[[Importeren_en_exporteren#DCM Stereotypes|Importeer]] de DCM Stereotypes.&lt;br /&gt;
*[[Importeren_en_exporteren#XMI_bestanden|Importeer]] het xmi bestand met DCM standaard datatypes (importeren, &#039;&#039;&#039;niet&#039;&#039;&#039; als kopie).&lt;br /&gt;
*[[Importeren_en_exporteren#XMI_bestanden|Importeer]] het xmi bestand met de Zib bouwsteen template (importeren, als kopie).&lt;br /&gt;
*[[Importeren_en_exporteren#RTF_templates|Importeer]] de gewenste RTF template bestanden.  &lt;br /&gt;
&lt;br /&gt;
2: Start met het Zib startproject:&lt;br /&gt;
*Download het Zib startproject en onthoud de locatie.&lt;br /&gt;
*Start Enterprise Architect en open het project. &lt;br /&gt;
&lt;br /&gt;
3: Start met een bestaande Zib projectfile (.eap)&lt;br /&gt;
*Start Enterprise Architect en open het project.&lt;br /&gt;
Hierna is het mogelijk om ook andere XMI bestanden te [[Importeren_en_exporteren#XMI_bestanden|importeren]].&amp;lt;br&amp;gt;&lt;br /&gt;
Als een bestaande zib gebruikt wordt als startpunt voor een nieuwe zib moet deze als kopie geïmporteerd worden.&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20026</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20026"/>
		<updated>2020-06-07T10:35:36Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam/Branch&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_RegionaleLymfeklierenTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||AnatomischStadium (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||PrognostischStadium (branch)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20025</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20025"/>
		<updated>2020-06-07T08:38:45Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam/Branch&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_RegionaleLymfeklierenTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||AnatomischStadium (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||PrognostischStadium (branch)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20024</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20024"/>
		<updated>2020-06-02T21:08:20Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam/Branch&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_RegionaleLymfeklierenTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||Stadium (branch)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20023</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20023"/>
		<updated>2020-06-02T20:59:35Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam/Branch&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||R_ResidueleTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||Stadium (branch)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20022</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20022"/>
		<updated>2020-06-02T15:19:21Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam/Branch&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase (branch)&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20021</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20021"/>
		<updated>2020-06-02T12:01:47Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld waardelijsten beheerd door IKNL&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20020</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20020"/>
		<updated>2020-06-02T12:00:42Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;&#039;&#039;Voorbeeld&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor.&#039;&#039; &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker.&#039;&#039; &amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20019</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20019"/>
		<updated>2020-06-02T11:59:03Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Voorbeeld&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor. &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;Deze heeft zelf (bij IKNL) momenteel meerdere waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor. &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker. &amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20018</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20018"/>
		<updated>2020-06-02T11:58:09Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt worden via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Voorbeeld&#039;&#039;&#039;&lt;br /&gt;
&amp;lt;li&amp;gt;&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;Elke waardelijst binnen deze branch krijgt weer een opvolgend nummer. Een waardelijst in deze branch is &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5&#039;&#039;&#039; voor de waardelijst T_primaireTumor. &amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;li&amp;gt;Deze heeft zelf (bij IKNL) momenteel 7 waardelijsten waaronder  bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1&#039;&#039;&#039; voor waardelijst cT_primaireTumor. &amp;lt;br&amp;gt; &lt;br /&gt;
&amp;lt;li&amp;gt;Deze branche kan vervolgens in de toekomst weer een branch krijgen van bijvoorbeeld &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1.1&#039;&#039;&#039; voor cT_primaire tumor_borstkanker. &amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20017</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20017"/>
		<updated>2020-06-02T11:53:19Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20016</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20016"/>
		<updated>2020-05-29T07:30:53Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1||cT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.2||ycT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.3||pT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.4||ypT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.5||rcT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.6||rpT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.7||aT_PrimaireTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.1||cN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.2||ycN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.3||pN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.4||ypN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.5||rcN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.6||rpN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.7||aN_LymfeklierenTumor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.1||c/pM_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.2||rc/pM_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.3||aM_AfstandsMetastase&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20015</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20015"/>
		<updated>2020-05-29T07:27:05Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;25&amp;quot;|1||rowspan=&amp;quot;25&amp;quot;|IKNL||rowspan=&amp;quot;25&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.2||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.4||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.5||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.6||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.7||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.1||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.2||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.4||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.5||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.6||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.7||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.1||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.2||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.3||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20014</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20014"/>
		<updated>2020-05-29T07:26:44Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;24&amp;quot;|1||rowspan=&amp;quot;24&amp;quot;|IKNL||rowspan=&amp;quot;24&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.2||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.4||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.5||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.6||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.7||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||N_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.1||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.2||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.4||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.5||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.6||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.7||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||M_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.1||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.2||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.3||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20013</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20013"/>
		<updated>2020-05-29T07:25:04Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;22&amp;quot;|1||rowspan=&amp;quot;22&amp;quot;|IKNL||rowspan=&amp;quot;22&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||T_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.2||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.4||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.5||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.6||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.7||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.1||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.2||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.4||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.5||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.6||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.7||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.1||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.2||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.3||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20012</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20012"/>
		<updated>2020-05-29T07:21:44Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;22&amp;quot;|1||rowspan=&amp;quot;22&amp;quot;|IKNL||rowspan=&amp;quot;22&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.1||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.2||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.4||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.5||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.6||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5.7||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.1||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.2||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.4||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.5||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.6||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6.7||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.1||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.2||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7.3||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20011</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20011"/>
		<updated>2020-05-29T07:16:38Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;22&amp;quot;|1||rowspan=&amp;quot;22&amp;quot;|IKNL||rowspan=&amp;quot;22&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.19||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.20||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.21||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.22||G_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20010</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20010"/>
		<updated>2020-05-29T07:16:21Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;22&amp;quot;|1||rowspan=&amp;quot;22&amp;quot;|IKNL||rowspan=&amp;quot;22&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.19||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.20||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.21||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.22||aG_differentiatiegraadTumor?&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20009</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20009"/>
		<updated>2020-05-29T07:15:53Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;22&amp;quot;|1||rowspan=&amp;quot;22&amp;quot;|IKNL||rowspan=&amp;quot;22&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||L_LymfatischeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||Pn_PerineuraleInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||V_VeneuzeInvasie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.19||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.20||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.21||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.22||aG_differentiatiegraadTumor?|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20008</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20008"/>
		<updated>2020-05-28T20:47:54Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;21&amp;quot;|1||rowspan=&amp;quot;21&amp;quot;|IKNL||rowspan=&amp;quot;21&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cc1&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||cc2&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||cc3&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.19||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.20||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.21||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20007</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20007"/>
		<updated>2020-05-28T20:46:48Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|1||rowspan=&amp;quot;18&amp;quot;|IKNL||rowspan=&amp;quot;18&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cc1&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||cc2&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||cc3&lt;br /&gt;
&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.19||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.20||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.21||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20006</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20006"/>
		<updated>2020-05-28T19:49:23Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Coding System Name!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|1||rowspan=&amp;quot;18&amp;quot;|IKNL||rowspan=&amp;quot;18&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20005</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20005"/>
		<updated>2020-05-28T19:37:14Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|1||rowspan=&amp;quot;18&amp;quot;|IKNL||rowspan=&amp;quot;18&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.4||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.5||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.6||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.7||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.8||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.9||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.10||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.11||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.12||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.13||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.14||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.15||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.16||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.17||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.18||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20004</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20004"/>
		<updated>2020-05-28T19:35:45Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|1||rowspan=&amp;quot;18&amp;quot;|IKNL||rowspan=&amp;quot;18&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rc/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aM_AfstandsMetastaseCodelijst&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20003</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20003"/>
		<updated>2020-05-28T19:34:14Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|1||rowspan=&amp;quot;18&amp;quot;|IKNL||rowspan=&amp;quot;18&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rc/pMN_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rc/pMN_AfstandsMetastaseCodelijst&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20002</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20002"/>
		<updated>2020-05-28T19:31:10Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Extern beheerde Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor beherende organisatie is &#039;&#039;&#039;1&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;17&amp;quot;|1||rowspan=&amp;quot;17&amp;quot;|IKNL||rowspan=&amp;quot;17&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||cN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ycN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||ypN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rcN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rpN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||aN_LymfeklierenTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||c/pM_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rc/pMN_AfstandsMetastaseCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||rc/pMN_AfstandsMetastaseCodelijst&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20001</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20001"/>
		<updated>2020-05-28T19:00:36Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijst elementen die niet door Nictiz worden beheerd maar door een externe partij is de volgende root OID gereserveerd: &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien in een zib behoefte is aan verwijzing naar een externe waardelijst een branche aangemaakt met een nummer voor de beherende organisatie &amp;lt;br&amp;gt;&lt;br /&gt;
Gerelateerde waardelijsten die in zibs worden gebruikt wordt via deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
Bijvoorbeeld, &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;3&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;10&amp;quot;|1||rowspan=&amp;quot;10&amp;quot;|IKNL||rowspan=&amp;quot;10&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20000</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=20000"/>
		<updated>2020-05-28T16:00:43Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Codestelsels voor extern beheerde waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijsten die niet door Nictiz worden beheerd maar door een externe partij is een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien Binnen een zib behoefte is aan verwijzing naar een waardelijst een branche aangemaakt hoger dan 0. &amp;lt;br&amp;gt;&lt;br /&gt;
Vooraan elkaar gerelateerde waardelijsten die in zibs worden gebruikt wordt deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens weer een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;3&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;10&amp;quot;|1||rowspan=&amp;quot;10&amp;quot;|IKNL||rowspan=&amp;quot;10&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
	<entry>
		<id>https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=19999</id>
		<title>Zib Codestelsels</title>
		<link rel="alternate" type="text/html" href="https://zibs.test-nictiz.nl/index.php?title=Zib_Codestelsels&amp;diff=19999"/>
		<updated>2020-05-28T15:58:54Z</updated>

		<summary type="html">&lt;p&gt;Linda Mook: /* Waardelijsten */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!--Inhoudsopgave transclude pagina--&amp;gt;&lt;br /&gt;
{{DocumentationTOC}} &lt;br /&gt;
__FORCETOC__&lt;br /&gt;
==Inleiding==&lt;br /&gt;
Bepaalde types concepten en waardelijsten van concepten in sommige bouwstenen bevatten elementen waarvoor geen SNOMED CT (of ander codestelsel) concept bestaat  en waarvoor ook geen code aangemaakt gaat worden.&amp;lt;br&amp;gt;&lt;br /&gt;
In deze gevallen wordt een &#039;eigen&#039; codestelsel aangemaakt, zodat de waarden die deze zib concepten aan kunnen nemen toch gecodeerd kunnen worden vastgelegd en uitgewisseld.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Hiervoor is binnen het Zib centrum een root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Bij het maken van &#039;eigen&#039; codes wordt onderscheid gemaakt tussen codes voor concepten en codes voor waarden van waardelijsten.&lt;br /&gt;
====Codestelsels voor concepten====&lt;br /&gt;
Voor codes voor concepten is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.0&#039;&#039;&#039; gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;Eigen&#039; codes worden pas toegepast na overleg met het Terminologie centrum en na het opstellen van regels om het type elementen waarvoor dit geldt te identificeren.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor concepten geldt dat voor ieder type concept dat in aanmerking komt voor een &#039;eigen&#039; code een nieuwe branch wordt aangemaakt onder de branch 2.16.840.1.113883.2.4.3.11.60.40.4.0.&amp;lt;br&amp;gt;&lt;br /&gt;
De conceptcode en de conceptcode naam worden in dit geval afgeleid van de DCM::ConceptId en de concept naam:&lt;br /&gt;
*ConceptCode: DCM::ConceptId is van de vorm NL-CM:m.n.p (m,n en p zijn integers), de code wordt dan mnp, waarbij iedere integer altijd in drie cijfers wordt uitgedrukt, incl. nullen&lt;br /&gt;
:Voorbeeld: DCM::ConceptId = NL-CM:12.2.4 dan wordt de code 12002004, waarbij overall leading zero&#039;s weggelaten mogen worden.&lt;br /&gt;
*ConceptCodeNaam: Om de naam voldoende context te geven wordt de conceptnaam vooraf gegaan door de naam van het rootconcept van de zib.&lt;br /&gt;
:Voorbeeld: voor het concept Benen uit de zib FLACCpijnScore wordt de conceptcodenaam &#039;FLACCpijnScore Benen&#039;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor waardelijsten====&lt;br /&gt;
Voor codes voor waardelijst elementen is de branch &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.4.1&#039;&#039;&#039; en hoger gereserveerd.&amp;lt;br&amp;gt;&lt;br /&gt;
Indien binnen een zib behoefte is aan een nieuw codestelsel voor het vullen van een waardelijst wordt een nieuwe branch van de root OID aangemaakt met een branche hoger dan 0.&amp;lt;br&amp;gt;&lt;br /&gt;
Voor aan elkaar gerelateerde waardelijsten en codestelsels binnen zo&#039;n zib wordt deze branche verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Codestelsels voor extern beheerde waardelijsten ====&lt;br /&gt;
Voor codes voor waarden van waardelijsten die niet door Nictiz worden beheerd maar door een externe partij is de root OID gereserveerd, te weten &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5&#039;&#039;&#039;&amp;lt;br&amp;gt;&lt;br /&gt;
Indien Binnen een zib behoefte is aan verwijzing naar een waardelijst een branche aangemaakt hoger dan 0. &amp;lt;br&amp;gt;&lt;br /&gt;
Vooraan elkaar gerelateerde waardelijsten die in zibs worden gebruikt wordt deze branch verder uitgebreid.&amp;lt;br&amp;gt;&lt;br /&gt;
&#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1&#039;&#039;&#039; verwijst naar waardelijsten beheerd door IKNL. Elke waardelijst binnen deze externe branch krijgt vervolgens weer een opvolgend nummer. &amp;lt;br&amp;gt;De eerste waardelijst in deze branch is dus &#039;&#039;&#039;2.16.840.1.113883.2.4.3.11.60.40.5.1.1&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==Overzicht codestelsels==&lt;br /&gt;
In onderstaande tabellen zijn de tot nu te uitgegeven OID&#039;s weergegeven. &lt;br /&gt;
 Let op! Dit is tevens de bronregistratie van de uitgegeven OID&#039;s&lt;br /&gt;
 Bij het uitgeven van nieuwe OID&#039;s moet deze pagina bijgewerkt worden.&lt;br /&gt;
====Concepten====&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.0.1||[[#Codesysteem ScoreObservaties|ScoreObservaties]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;23&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Klasse!!Bouwsteen!!Codestelsel OID!!Codestelselnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|0||rowspan = &amp;quot;3&amp;quot;|Administratief||ContactPersoon||2.16.840.1.113883.2.4.3.11.60.40.4.23.1||ExtraRolcodes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|JuridischeSituatie||2.16.840.1.113883.2.4.3.11.60.40.4.23.2||JuridischeStatus&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.23.3||JuridischeVertegenwoordiging&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|1||SubBouwstenen||Contactgegevens||2.16.840.1.113883.2.4.3.11.60.40.4.22.1||TelecomDeviceTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan = &amp;quot;35&amp;quot;|4||rowspan=&amp;quot;35&amp;quot;|Functionele status||rowspan=&amp;quot;10&amp;quot;|BarthelIndex||2.16.840.1.113883.2.4.3.11.60.40.4.1.1||BarthelDarm&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.2||BarthelBlaas&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.3||BarthelUiterlijkeVerzorging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.4||BarthelToiletgebruik&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.5||BarthelEten&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.6||BarthelTransfer&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.7||BarthelMobiliteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.8||BarthelAanUitkleden&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.9||BarthelTrappenLopen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.1.10||BarthelBadenDouchen&lt;br /&gt;
|-&lt;br /&gt;
|Defecatie||2.16.840.1.113883.2.4.3.11.60.40.4.3.1||BristolStoolTypes&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|MUSTScore||2.16.840.1.113883.2.4.3.11.60.40.4.4.1||MUST_BMI&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.2||MUST_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.4.3||MUST_Ziekte&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|SNAQScore||2.16.840.1.113883.2.4.3.11.60.40.4.5.1||SNAQ_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.2||SNAQ_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.5.3||SNAQ_Voeding&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|StrongKidsScore||2.16.840.1.113883.2.4.3.11.60.40.4.17.1||SK_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.2||SK_Ziektebeeld&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.3||SK_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.17.4||SK_Voedingstoestand&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQ65+Score||2.16.840.1.113883.2.4.3.11.60.40.4.18.1||SNAQ65+_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.2||SNAQ65+_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.3||SNAQ65+_Inspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.18.4||SNAQ65+_BovenarmOmtrek&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;4&amp;quot;|SNAQrcScore||2.16.840.1.113883.2.4.3.11.60.40.4.19.1||SNAQrc_Gewichtsverlies&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.2||SNAQrc_Eetlust&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.3||SNAQrc_Voeding&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.19.4||SNAQrc_HulpBijEten&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;6&amp;quot;|TumorClassificatie||2.16.840.1.113883.2.4.3.11.60.40.4.10.1||T_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.2||N_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.3||M_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.4||R_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.5||G_Score_7Ed&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.10.6||StageGrouping_7Ed&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;2&amp;quot;|7||rowspan=&amp;quot;2&amp;quot;|Sociale anamnese||Woonsituatie||2.16.840.1.113883.2.4.3.11.60.40.4.13.1||WoningType&lt;br /&gt;
|-&lt;br /&gt;
|Wilsverklaring||2.16.840.1.113883.2.4.3.11.60.40.4.14.1||WilsverklaringType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|10||Medische hulpmiddelen||Infuus||2.16.840.1.113883.2.4.3.11.60.40.4.12.1||LijnStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;18&amp;quot;|12||rowspan=&amp;quot;18&amp;quot;|Vitale functies||Bloeddruk||2.16.840.1.113883.2.4.3.11.60.40.4.15.1||ManchetType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|GlasgowComaScale||2.16.840.1.113883.2.4.3.11.60.40.4.2.1||GCS_Eyes&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.2||GCS_Motor&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.2.3||GCS_Verbal&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;7&amp;quot;|ComfortNeoScale||2.16.840.1.113883.2.4.3.11.60.40.4.20.1||CN_Alertheid&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.2||CN_Kalmte_Agitatie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.3||CN_Ademhalingsreactie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.4||CN_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.5||CN_Lichaamsbeweging&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.6||CN_Gezichtsspanning&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.20.7||CN_Spierspanning&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;5&amp;quot;|FLACCPainScore||2.16.840.1.113883.2.4.3.11.60.40.4.21.1||FLACC_Gezicht&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.2||FLACC_Benen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.3||FLACC_Activiteit&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.4||FLACC_Huilen&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.21.5||FLACC_Troostbaar&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|Gewicht||2.16.840.1.113883.2.4.3.11.60.40.4.8.1||ContextKleding&lt;br /&gt;
|-&lt;br /&gt;
|PijnScore||2.16.840.1.113883.2.4.3.11.60.40.4.9.1||PijnMeetmethode&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|13|| Resultaten||LaboratoriumUitslag&amp;lt;br&amp;gt;TekstUitslag||2.16.840.1.113883.2.4.3.11.60.40.4.16.1||ResultaatStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|14||Verrichtingen||VrijheidsbeperkendeMaatregelen||2.16.840.1.113883.2.4.3.11.60.40.4.6.1||InstemmingStatus&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|15||Contacten||Patientbespreking||2.16.840.1.113883.2.4.3.11.60.40.4.11.1||PatientbesprekingType&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;3&amp;quot;|19||rowspan=&amp;quot;3&amp;quot;|Huid||rowspan=&amp;quot;3&amp;quot;|Wond||2.16.840.1.113883.2.4.3.11.60.40.4.7.1||OncoUlcerWeefsel&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.2||WondWeefselWCS&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.4.7.3||WondVochtigheid&lt;br /&gt;
|}&lt;br /&gt;
==== Extern beheerde Waardelijsten====&lt;br /&gt;
Het hoogst uitgegeven branchnummer voor waardelijst elementen is momenteel &#039;&#039;&#039;3&#039;&#039;&#039;.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Nummer!!Beheerder!!Bouwsteen!!Waardelijst OID!!Waardelijstnaam&lt;br /&gt;
|- style=&amp;quot;vertical-align:top;&lt;br /&gt;
|rowspan=&amp;quot;10&amp;quot;|1||rowspan=&amp;quot;10&amp;quot;|IKNL||rowspan=&amp;quot;10&amp;quot;|TNM||2.16.840.1.113883.2.4.3.11.60.40.5.1.1||TNMVersie&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.2||cT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|2.16.840.1.113883.2.4.3.11.60.40.5.1.3||pT_PrimaireTumorCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Codesysteem ScoreObservaties==&lt;br /&gt;
Dit codestelsel bevat uitsluitend codes voor concepten die onderdeel zijn van een gestandaardiseerde scorelijst.&amp;lt;br&amp;gt;&lt;br /&gt;
In overleg met het Terminologie centrum is besloten daar geen SNOMED CT codes voor aan te maken.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+OID: 2.16.840.1.113883.2.4.3.11.60.40.4.0.1&lt;br /&gt;
!ConceptNaam!!ConceptCode&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Gezicht||12017003	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Mond||12017004	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Grimas||12017005	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag VerdrietigeBlik||12017006	 &lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Ogen||12017007	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Paniek||12017008	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Kreunen||12017009	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Huilen||12017010	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Onrustgeluiden||12017011	&lt;br /&gt;
|-&lt;br /&gt;
|ChecklistPijnGedrag Tranen||12017012	&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Alertheid||12012003&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Kalmte_Agitatie||12012004&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Ademhalingsreactie||12012005&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Huilen||12012006&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Lichaamsbeweging||12012008&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Gezichtsspanning||12012009&lt;br /&gt;
|-&lt;br /&gt;
|ComfortScore Spierspanning||12012010&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Gezicht||12013003&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Benen||12013004&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Activiteit||12013005&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Huilen||12013006&lt;br /&gt;
|-&lt;br /&gt;
|FLACCpijnScore Troostbaar||12013007&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore BMIScore||4005003&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore GewichtsverliesScore||4005004&lt;br /&gt;
|-&lt;br /&gt;
|MUSTScore ZiekteScore||4005005&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore GewichtsverliesScore||4006003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore EetlustScore||4006004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQScore VoedingsScore||4006005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore GewichtsverliesScore||4029003	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore EetlustScore||4029004	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQrcScore BMIScore||4029005	&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score GewichtsverliesScore||4030003&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score BovenarmOmtrekScore||4030008&lt;br /&gt;
|-&lt;br /&gt;
|SNAQ65+Score EetlustScore||4030004&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore GewichtsverliesScore||4028003	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore ZiekteBeeldScore||4028004	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingsScore||4028005	&lt;br /&gt;
|-&lt;br /&gt;
|StrongKidsScore VoedingstoestandScore||4028008	&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Weescodes==&lt;br /&gt;
In een aantal oudere bouwstenen wordt nog gebruik gemaakt van een verzamelcodestelsel voor alle verweesde codes die niet in een ander codelstelsel uitgedrukt kunnen worden.&amp;lt;br&amp;gt;&lt;br /&gt;
Dit codestelsel heeft het bovengenoemde root OID (2.16.840.1.113883.2.4.3.11.60.40.4) als identifier het heeft de naam NL-CM-CS.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In onderstaande tabel staan de nog in gebruik zijnde weescodes met de zib en waardelijst waarin deze gebruikt worden.&lt;br /&gt;
 Let op! Deze lijst dient niet meer verder uitgebreid te worden.&lt;br /&gt;
 Nieuwe eigen codes dienen bij voorkeur in SNOMED CT opgenomen worden of&lt;br /&gt;
 in sporadische gevallen in een eigen codesysteem zoals hierboven aangegeven.&lt;br /&gt;
&lt;br /&gt;
{| class = &amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+Codestelsel: NL-CM-CS; OID: 2.16.840.1.113883.2.4.3.11.60.40.4&lt;br /&gt;
!ConceptNaam!!ConceptCode!!Description!!Bouwsteen!!Waardenlijst&lt;br /&gt;
|-&lt;br /&gt;
|Geen geloof||GeenGeloof||Geen geloof||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Humanist||Humanist||Humanist||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Mormoon||Mormoon||Mormoon||Levensovertuiging||LevensovertuigingCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja||JA||Behandeling is toegestaan en/of wenselijk.||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Nee||NEE||Behandeling niet toegestaan en/of wenselijk||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Ja, maar met beperkingen||JA_MAAR||Behandeling toegestaan en/of wenselijk maar met beperkingen die dan ook vermeld moeten worden||BehandelAanwijzing||BehandelingToegestaanCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Forgotten to administer||FORGOT||Vergeten toe te dienen||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|-&lt;br /&gt;
|Administration performer not available||APNA||Toediener niet aanwezig||MedicatieToediening2||MedicatieToedieningRedenVanAfwijkenCodelijst&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Linda Mook</name></author>
	</entry>
</feed>